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ABSTRACT
Bloom's syndrome (BS) is a rare inherited disorder associated with growth retardation, 
immunodeficiency and a predisposition to cancers of all types. At a cellular level BS is 
associated with marked chromosomal instability, as manifest by interchanges between 
homologous chromosomes and sister chromatids. BS arises as a consequence of defects 
in a DNA helicase, BLM, which is a member of the RecQ family of helicases. Defects in 
other RecQ family helicases, derived from prokaryotic and lower eukaryotic cells, also 
result in a loss of genomic integrity. This suggests that this group of helicase subfamily 
share a degree of functional conservation.
In this thesis, the validity of using the budding yeast, S.cerevisiae, as a model system for 
BS has been assessed. In this organism, the structural homologue of the BLM protein is 
Sgslp. Deletion of Sgslp is associated with mitotic hyperrecombination and defective 
chromosome segregation. Deletion of SGSl also suppresses the slow growth and 
hyperrecombination phenotype of top3 mutants, which are defective in topoisomerase III. 
Ectopic expression of a wild type SGSl gene in sgslAtopSA mutants reinduced the slow 
growth defect, and this effect was reproduced when the human BLM gene was 
expressed. This result suggested firstly, that the yeast and human proteins share 
functional similarities and secondly, that the interaction between the RecQ family 
helicases and topoisomerase m  is highly conserved. On this basis, the remainder of this 
thesis focussed upon the role of topoisomerase HI.
Deletion of the S.cerevisiae TOPS gene leads to a slow growth phenotype accompanied 
by an accumulation of cells with a late S/G2 content of DNA. topSA mutants exhibit a 
RAD24/RAD9-doponà&al delay in the G2 phase, suggesting a role for topoisomerase m  
in the resolution of abnormal DNA structures/damage arising during S-phase. Consistent 
with this notion, topSA strains are defective in the intra-S-phase checkpoint that slows the 
rate of S-phase progression following exposure to DNA damaging agents and are 
sensitive to killing by a variety of DNA damaging agents, including ultra-violet light, y- 
rays and the alkylating agent MMS. This S-phase checkpoint defect was not associated 
with a failure to induce expression of DNA damage response genes. Consistent with an 
S-phase specific role for topoisomerase HI, expression of the TOPS mRNA is activated in 
the late G1 phase, and DNA damage checkpoints operating outside of S-phase are 
unaffected by deletion of TOPS. All of the phenotypic consequences of loss of 
topoisomerase m  function were suppressed by deletion of SGSl. These data implicate 
topoisomerase m  and, by inference, Sgslp in a checkpoint role in response to DNA 
damage arising during S-phase. A model to explain the role of these proteins during 
DNA rephcation is proposed.
Chapter 3 Assessment of the ability of BLM  to complement 
S.cerevisiae sg s lA  m utants
Chapter 4 An evaluation of the cell cycle defect in 
S.cerevisiae top3A m utants
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Chapter 1
Introduction
1.1 Introduction
The loss of genomic integrity is an invariant property of tumour cells. The study of 
inherited cancer-prone disorders has shed considerable light upon the means by which 
human cells maintain genomic integrity. Interpretation of the accumulating data in this 
field has been facilitated by comparative analyses in prokaryotic and eukaryotic model 
systems. These studies have demonstrated, for the most part, a remarkable degree of 
functional conservation of the individual players and pathways involved in the 
maintenance of genome stability in all organisms.
In the last decade, the cloning of genes defective in the disorders ataxia 
telangiectasia, xeroderma pigmentosum and hereditary non-polyposis colon cancer has 
generated important information regarding the role of cell cycle checkpoints, nucleotide 
excision repair and mismatch repair, respectively, in preventing genome instability and 
suppressing cancer (Shiloh, 1997; Wood, 1997; Jiricny, 1996). The prior dissection of 
many aspects of these processes in model systems was such that, at least in the cases 
cited above, putative functions could be assigned to many of the cloned human genes 
almost as soon as their protein coding sequences were available.
In this thesis, a yeast model has been employed in order to understand in greater 
detail, the basis for the loss of genomic integrity associated with the cancer-prone 
disorder. Bloom's syndrome (BS). This disorder arises as a consequence of a defect in a 
DNA helicase, which has structural similarity to a family of helicases found in 
prokaryotes and lower eukaryotes, the so-called RecQ family (Ellis et al., 1995). Defects 
in another RecQ family helicase are also found in another inherited disease, the progeria­
like syndrome Werner's syndrome (WS) (Yu et al., 1996). To date, studies in prokaryotic 
(Hanada et al., 1997; Harman and Kowalczykowski, 1998) and yeast model systems 
(Watt et al., 1996; Stewart et al., 1997) suggest that the fundamental defect in both BS 
and WS is one of recombinational repair.
In the following section, a brief overview of recombinational repair will be 
presented, together with an analysis of how specific defects in this mode of repair, can 
result in other disorders associated with predisposition toward cancer.
1.2 The 'recombinational repair' disorders
1.2.1 Recombination- principles
Genetic recombination is the molecular process by which new combinations of 
genetic material are generated (reviewed in Friedberg et al., 1995). Recombination 
functions to generate genetic diversity either through conjugational recombination in 
prokaryotes or meiosis in eukaryotes. It is essential for repair of damaged DNA, 
particularly of double strand breaks (DSBs). DSBs can arise as a result not only of 
damage (caused by ionising irradiation or free radicals) but also as intermediates in 
scheduled' DNA rearrangements (mating type switching in yeast or V(D)J recombination 
in mammalian cells). A failure to resolve such lesions can have catastrophic 
consequences to the cell, since even a single unrepaired DSB can be a lethal event 
(Frankenberg-Schwager and Frankenberg, 1990). Recombination interfaces or overlaps 
with nearly all aspects of DNA metabolism, a fact that until recently has been 
underplayed in the literature. Thus, one difficulty in assessing the various pathways 
involved is that a single protein can affect a multitude of processes, some in which its 
function is an absolute requirement and others where it is not essential but can still affect 
the outcome.
Four broad classes of recombination event have been proposed (Heyer and Kohli,
1994); (1) homologous recombination, which depends upon extensive sequence 
homology and can be defined according to the locations of the sequences combining; (2 ) 
site-specific recombination, including V(D)J rearrangements in lymphoid cells, where 
recombination occurs at specific sequences, sharing little or no homology; (3 ) 
transposition, in which DNA sequences are moved from one site in the genome to 
another in a random fashion; and (4) illegitimate recombination, in which neither 
significant sequence homology nor specific locations are involved, and which can result 
in insertions, deletions and other DNA rearrangements. Two basic mechanisms of 
recombination are homologous recombination involving strand exchange, and non- 
homologous recombination which involves 'end ling' of DNA. These are described 
briefly below, together with emerging evidence to suggest that defects in these two 
processes in humans can pre-dispose to the development of cancer.
1.2.2 Homologous recombination
The primary mechanism for the formation of heteroduplex DNA in homologous 
recombination involves strand exchange, and this is likely to be applicable to both
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prokaryotes and eukaryotes (reviewed in Eggleston and West, 1996). This type of 
recombination comprises several steps: (1) processing of a duplex molecule to form the 
substrate for strand exchange (that is, linear DNA with a single-stranded tail); (2) 
alignment of the homologous parental molecules; (3) strand invasion and the formation of 
a 4-stranded structure, known as a Holliday junction; (4) migration of the Holliday 
junction to extend the region of heteroduplex DNA; and (5) resolution of the interlinked 
molecules to give recombinant progeny. A diagrammatic representation of this basic 
process, together with the key players involved at each stage in prokaryotes is shown in 
Figure 1.1. It seems likely that the fundamental features of this mode of recombination 
are conserved in eukaryotes. In E.coli, three distinct pathways of homologous 
recombination can be defined at a genetic level: the RecBCD pathway, the RecF pathway 
and the RecE pathway (Dunderdale and West, 1994; West, 1994). Although previous 
studies, skewed toward an analysis of conjugal recombination, suggested that the 
RecBCD pathway was the primary pathway for homologous recombination in this 
organism, a more recent consensus is that the RecF pathway is just as important to the 
cell and plays a key role in post-replication gap repair (as discussed in section 1.3). In 
eukaryotes, homologous recombination that does not involve strand exchange and which 
involves proteins that participate in nucleotide excision repair (‘single strand annealing*) 
has been described (Haber, 1992).
1.2.3 RecA and RecA homologues
Central to each of the recombination pathways in E.coli is the RecA protein, which 
catalyses homologous pairing and strand exchange (Kowalczykowski and Eggleston, 
1994; Roca and Cox, 1997). This protein binds single-stranded DNA (ssDNA) with high 
affinity and stoichiometry of one RecA monomer per three nucleotides, to form helical 
nucleoprotein filaments in which the DNA is extended and underwound (Stasiak and 
Egelman, 1988). The RecA-bound filaments provide the structural framework for a 
homology search which involves the pairing with duplex DNA (Howard-Flanders et al., 
1984). In this structure, two homologous DNA molecules are brought in close proximity 
and ATP-dependent strand exchange occurs with a 5'-3' polarity relative to the ssDNA 
(Cox and Lehman, 1981).
The budding yeast RAD51 gene, a member of the RAD52 epistasis group, encodes a 
eukaryotic homologue of RecA (Aboussekhra et al., 1992; Basile et al., 1992; Shinohara
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et al., 1992). Like RecA, yeast Rad51 protein forms helical nucleoprotein filaments 
(Ogawa et al., 1993) and promotes homologous pairing and strand transfer reactions 
(Sung, 1994), although the polarity of strand transfer is opposite, being 3'-5' (Sung and 
Robersson, 1995). Transcription of the RAD51 gene is upregulated at the G 1/S cell cycle 
transition and also following exposure to DNA-damaging agents (Basile cl al., 1992). 
Deletion of RAD51, results in sensitivity to ionising radiation and to methyl methane 
sulfonate (MMS), and is associated with defects in meiosis or mating-type switching 
(Petes et al., 1991). Levels of spontaneous and radiation-induced mitotic recombination 
are reduced significantly in radSl mutants. Similar phenotypes are associated with 
defects in other RAD52-epistasis group genes, including RAD52,RAD54 and RAD57 
(Petes et al., 1991).
Other homologues of RecA have been identified in both the mouse (Morita et al.,
1993) and humans (Shinohara et al., 1993). Electron microscopic visualisation of human 
Rad51-DNA complexes shows that it forms RecA-like nucleoprotein filaments (Benson 
et al., 1994) and in vitro studies confirm that it catalyses ATP-dependent homologous 
pairing and strand transfer reactions (Baumann et al., 1996), albeit with an opposite 
polarity of strand transfer to the prokaryotic protein (Baumann and West, 1997). 
Mammalian Rad51 protein is upregulated at the G 1/S cell cycle ph^se transition 
(Yamamoto et al., 1996a) and is expressed at high levels in gonadal and lymphoid tissues 
(Shinohara et al., 1993). This latter finding is consistent with a role in meiosis and V(D)J 
recombination. A role in meiosis is further suggested by the identification of human 
Rad51 protein in discrete foci on spermatocytes during meiotic prophase I when 
chromosomes undergo synapsis (Barlow et al., 1997).
In mouse somatic cells, Rad51 is induced following treatment with DNA damaging 
agents (Haaf et al., 1995). This role of RecA-like proteins in mediating double strand 
break repair is emphasised by the recent finding that the genes XRCC2 and XRCC3, 
which complement the radiation-sensitivity of rodent cell mutants, both encode proteins 
with significant homology to RecA (Liu et al., 1998). In contrast to RecA or S.cerevisiae 
RadSl, mammalian RadSl appears to be essential. Targeted disruption of muiine RAD51 
gene leads to an embryonic lethal phenotype and it has not been possible to generate 
RAD51-/- ES cells (Lim and Hasty, 1996; Tsuzuki et al., 1996). This suggests that 
RAD51 may be required for cell viability in mammalian cells, perhaps through essential 
roles in cell proliferation and/or genomic maintenance. In this context, the interactions
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identified between human RadSl and Brcal and Brca2, both of which are defective in 
familial breast/ovarian cancer (reviewed in Zhang et al., 1998), may provide clues as to 
the nature of these essential functions.
1.2.4 Brcal and Brca2 - a role in recombination?
About 1 in 20 cases of breast cancer in women results from a hereditary 
predisposition to the disease (Stratton and Wooster, 1996). Two breast cancer 
susceptibility genes, BRCAl and BRCA2 have been cloned, which appear to be 
responsible for the majority of inherited breast cancer, but very few sporadic cases 
(Stratton, 1996). Women who inherit a defective BRCA gene have an 85% risk of breast 
cancer by the age 70 (Easton, 1997). BRCA genes act as tumour suppressors as the wild 
type gene is lost in the tumours of heterozygous carriers. Individuals who carry the 
defective genes are also at risk of other cancers, including ovary, prostate and pancreas.
Several lines of evidence have suggested a role for Brcal and Brca2 in 
recombinational repair of DNA damage. First, both proteins associate with Rad51 
protein. Brcal and Rad51 proteins co-immunoprecipitate and co-localise in discrete 
nuclear foci of mitotic cells. In human meiotic cells, Brcal and Rad51 proteins are 
associated with the unsynapsed elements of the synaptonemal complex (Scully et al., 
1997a). Brca2 and Rad51 interact in a 2-hybrid assay and their tissue expression pattern 
is similar (Sharan et al., 1997). Second, Rad51 and Brea 1/2 show co-ordinate cell cycle 
regulation (Rajan et al., 1996; Yamamoto et al., 1996a). Third, as with Rad51, both 
proteins appear to be involved in the cellular response to ionising irradiation (Scully et 
al., 1997a and 1997b; Thomas et al., 1997). Rad51/Brcal nuclear foci disperse upon 
DNA damage, concomitant with phosphorylation of the Brcal protein. Disruption of 
BRCA2, results in embryos that are hypersensitive to ionising irradiation, as observed in 
RAD51 null embryos and arrest at a similar stage in embryonic development (Lim and 
Hasty, 1996; Tsuzuki et al., 1996; Scully et al., 1997a). Indeed certain cancer cell lines 
derived from BRCA 2-defective individuals show marked sensitivity to ionising 
irradiation (Abbott et al., 1998).
A small number of recent studies have assessed the phenotype of cells homozygous 
for a defective murine BRCA2 gene, encoding a truncated form of the protein. These 
homozygotes show gross growth retardation, the development of thymic lymphomas, 
and cells derived from them show sensitivity to DNA damaging agents (Connor et al.,
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1997; Friedman et al., 1998; Patel et al., 1998). Most strikingly, such cells also 
demonstrate numerous spontaneous chromosomal anomalies, including chromatid breaks 
and the formation of triradials and quadriradials (Patel et al., 1998), features observed in 
RAD57-deficient embryos (Lim and Hasty, 1996).
1.2.5 Non-homologous recombination
Chromosomal breaks may be repaired by a process that requires little or no 
homology (reviewed in Chu, 1997; Tsukamoto and Ikeda, 1998). Non-homologous end 
joining (NHEJ) may be site-specific (as for V(D)J recombination) or non-specific (as for 
illegitimate recombinational repair of DSBs induced by DNA damaging agents). Both 
site-specific and non-specific NHEJ are likely to share siniilarities in their basic 
mechanism and in this regard may employ a similar protein machinery. In vertebrates, 
NHEJ appears to be the primary mode of repair for ionising irradiation-induced DSBs, 
whereas in budding yeast homologous recombination is the most prominent mode of 
repair (Friedberg et al., 1995). Thus, in the latter organism, studies of NHEJ usually 
require the disablement of RAD52-dependent homologous recombination functions.
The three major components necessary for NHEJ that appear to be conserved in all 
eukaryotes, are the Ku proteins, DNA ligase IV and the Rad50/Mrell complex. A 
diagrammatic representation of a model for the steps involved in NHEJ is presented in 
Figure 1.2. The Ku proteins (Ku70 and Ku80) bind to the ends of DSBs and promote 
their alignment and/or their ligation (Dvir et al., 1993; Gottlieb and Jackson, 1993; 
Boulton and Jackson 1996a and 1996b). They may also act to bind other components of 
the NHEJ machinery including, in vertebrates, the serine/threonine protein kinase DNA- 
PK catalytic subunit (Hartley et al., 1995). In S.cerevisiae^ loss of Ku70 or 80, results in 
an overall reduction in the frequency of joining of linearised plasmids with cohesive 
ends, and in those plasmids that are recovered, the joining is error-prone (Boulton and 
Jackson, 1996a and 1996b; Milne et al., 1996). Loss of either of the Ku proteins in 
budding yeast results in an increase in radiation sensitivity, but only when RAD52- 
dependent homologous rcuumbination is disabled (Boulton and Jackson, 1996a and b; 
Siede et al., 1996c). A number of ionising irradiation-sensitive rodent cell lines are 
complemented by expression of human genes encoding Ku proteins (including XRCC5 
andXRCCd), and these cell lines are also defective in V(D)J recombination (Tsukamoto 
and Ikeda, 1998).
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A second component of the NHEJ pathway are DNA ligases. These enzymes act to 
catalyse the joining of nicks in duplex DNA and the ends of DSBs during many aspects 
of DNA metabolism (Tomkinson and Levin, 1997). In S.cerevisiae, DNA ligase IV 
functions in Ku-dependent NHEJ, presumably at the final ligation step (Schar et al., 
1997; Teo and Jackson, 1997; Wilson et al., 1997). In humans, it is less clear which of 
the four DNA ligases has an important role in NHEJ, since they can all promote end- 
joining of DNA in vitro (Ramsden and Gellert, 1998). The finding that human DNA 
ligase rv  also interacts with Xrcc4, another participant in mammalian NHEJ, make it the 
most likely candidate (Critchlow et al., 1997; Grawunder et al., 1997). This is further 
suggested by the recent finding that S.cerevisiae DNA ligase IV interacts with an Xrcc4 
homologue which is also defective in NHEJ (Herrmann et al., 1998).
The Rad50 complex also appears to participate in the same NHEJ pathway although 
the precise biochemical functions of this complex are not well understood. In 
S.cerevisiae, this complex consists of Rad50p, Mrel Ip and Xrs2p, and 2-hybrid analyses 
indicate that the three proteins physically interact (Alani et al., 1990; Malone et al., 1990; 
Ajimura et al., 1993; Johzuka and Ogawa, 1995). Mutants defective in these proteins are 
defective in meiosis but remain proficient in mitotic homologous recombination. These 
proteins participate in the Ku-dependent repair of DSBs and consequently, rejoining 
efficiencies of linearised plasmids is reduced in the respective mutants (Scheistl et al., 
1994; Milne et al., 1996; Tsukamoto et al., 1997; Boulton and Jackson, 1998). This 
defect in NHEJ presumably underlies the sensitivity of the mutants to ionising irradiation. 
Human Mrel 1 and Rad50 homologues have also been identified and, as in yeast, appear 
to act together as a complex (Petrini et al., 1995; Dolganov et al., 1996). A possible 
human Xrs2 homologue, p95, has also been identified (see discussion below). The role 
of this complex in mediating NHEJ repair is supported by the finding that human Mrel 1 
and Rad50 co-localise in nuclear foci following treatment with agents that induce DNA 
DSBs (Maser et al., 1997). M rell associates with DSBs shortly following irradiation 
(Nelms et al., 1998). Attempts to generate null M REll-l- mutant ES cells show that 
M REll is essential for viability (Xiao and Weaver, 1997).
1.2.6 Human disorders with potential defects in non-homologous recombination.
Defects in NHEJ might result in the loss of genomic stability and the development of 
cancer. This is suggested by the finding that human Mrel 1/Rad50 proteins act together
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in a complex with another protein, p95, which is defective in Nijmegen Breakage 
syndrome (NBS). The protein p95 shows modest homology in the N-terminal region to 
budding yeast Xrs2 (Carney et al., 1998; Varon et al., 1998). NBS is a rare autosomal 
recessive disorder characterised by microcephaly, immunodeficiency and an increased 
risk of haematological malignancy (van der Burgt et al., 1996). At a cellular level, NBS 
shows increased sensitivity to ionising irradiation, as well as increased levels of 
spontaneous and induced levels of chromosomal fragility (Shiloh, 1997). Cells fail to 
induce p53 at the G 1/S checkpoint and show the phenomenon of radio-resistant DNA 
synthesis, due to lack of an S-phase checkpoint that normally slows the rate of DNA 
replication when cells are damaged (Jongmans et al., 1997; Sullivan et al., 1997). In 
common with Rad50 and Mrel 1, p95 accumulates with similar distribution in cell nuclei 
following irradiation (Carney et al., 1998).
Many researchers have been struck by the similar clinical and cellular phenotypes of 
NBS and another inherited human disorder associated with genomic instability, ataxia 
telangiectasia (AT) (Shiloh, 1997; Stumm et al., 1997). AT is an autosomal recessive 
disorder characterised by progressive cerebellar degeneration, telangiectasia, 
hnmunodeficiency and a predisposition to haematological malignancy. ATM, the gene 
mutated in AT encodes a 350 kDa protein with significant homology to the signal 
transduction molecule, phosphatidyl inositol (PI)-3 kinase and to the checkpoint proteins 
Mecl in budding yeast and Rad3, in fission yeast (Savitsky et al., 1995). At a cellular 
level NBS and AT are almost indistinguishable, in that they both show chromosomal 
instability, loss of checkpoints and sensitivity to ionising irradiation. Chromosomal 
instability in NBS cells is more marked, however (Shiloh, 1997). Fusion of AT and NBS 
cells fails to complement the chromosome instability, suggesting that p95 and ATM may 
act in the same pathway (Stumm et al., 1997). Furthermore, the formation of 
Rad50/Mrell foci in AT cells post-irradiation is diminished (Maser et al., 1997) and 
studies of joining proficiency of linearised plasmids suggest a defect in NHEJ (Runger et 
al., 1992).
One explanation for the pleiorropic effects associated with loss of ATM is that this 
protein acts to sense damage to cellular macromolecules and activates signal transduction 
pathways that induce DNA repair, cell cycle checkpoints or other patliways involved in 
limiting the effects of oxidative stress (reviewed in Shiloh, 1997; Taylor, 1998). The p95 
protein may form part of this signal transduction pathway leading to DNA repair and
9
activation of the cell cycle checkpoints. A key question to be answered is to what degree, 
if any, do either of these proteins participate in DNA repair. It is clear that not all the 
phenotypes of AT cells can be explained in terms of checkpoint deficiency. Thus, AT 
cells are sensitive to ionising irradiation even when cells are not cycling (reviewed in 
Jeggo et al., 1998). Furthermore, under non-cycling conditions the rejoining of DSBs is 
defective in AT cells. Whether AT or NBS cells are defective in NHEJ or in a distinctive 
repair pathway remains to be determined.
Another disorder associated with chromosomal instability is Fanconi's anaemia (FA). 
This disease is associated with progressive pancytopenia, growth retardation, skeletal 
malformations and predisposition to leukaemia (Auerbach et al., 1989). The most 
consistent cellular feature in FA is an increase in spontaneous chromosomal breakage, 
amplified following exposure to cross-linking agents (Liu et al., 1994; Friedberg et al.,
1995). At a molecular level, the main finding is one of deletional mutation (Papadopoulo 
et al., 1990; Bredberg et al., 1995). FA is an autosomal recessive disorder with 8 
complementation groups (Buchwald, 1995; Joenje et al., 1997). The genes for two of 
these groups, FAA (Lo Ten Foe et al., 1996; The FA/BC consortium, 1996) and FAC 
(Strathdee et al., 1992) have been cloned. Neither of the encoded proteins shares 
homology with other known proteins or contain any recognised motifs, suggesting that 
they act in a novel pathway unique to vertebrates. The FAA and FAC proteins form a 
complex that translocates to the nucleus (Kupfer et al., 1997) and both proteins are 
expressed in tissues with rapidly dividing cells (Krasnoshtein and Buchwald, 1996). The 
sensitivity of FA cells to DNA cross-linking agents has suggested that such cells may be 
defective in recombinational repair, since in prokaryotes and eukaryotes this mode of 
repair is invoked following treatment with the same agents (reviewed in Digweed and 
Sperling, 1996). Although no defect in homologous recombinational repair has been 
described (Thyagarajan and Campbell, 1997), other studies have implicated defects in 
NHEJ. Although the overall ligation frequency of linearised plasmids is the same as 
control cells, this occurs at the expense of an increase in deletions or other complex 
mutations (Runger et al., 1993; Escarceller et al., 1997 and 1998). No general defect in 
NHEJ can be proposed, however, since FA cells are not sensitive to ionising irradiation 
(Friedberg et al., 1995).
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Figure 1.1: Homologous recombination in E. colL RecBCD, RecJ, RecQ, and RecE proteins 
use their helicase and/or nuclease functions to generate regions of ssDNA that are recognised by 
RecA. Assembly of the RecA filament may be facilitated by RecF, RecO, RecR and SSB 
proteins. RecA forms helical nucleoprotein filaments and promotes interactions with other 
duplex DNA molecules, leading to homologous pairing and strand exchange. This recombination 
intermediate in which 2 DNA molecules are connected by a crossover, is referred to as a Holhday 
junction. Resolution of this structure by the action of Ruv ABC of RecG, results in the formation 
of nicked duplex products that are repaired by DNA ligase.
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Figure 1.2: A model.for DNA intermediates in non homologous end joining Non-homologous 
end joining (NHEJ) proceeds through a series of steps including synapsis of DNA ends and 
alignment by micro-homology pairing. Microhomology alignment could occur by unwinding of the 
DNA ends (as shown), or alternatively by strand invasion/displacement, or by exonuclease digestion 
of one of the strands on each end. Gap filling and ligation then complete the repair of the double 
strand break. Proteins thought to participate in NHEJ and the stage at which they act are indicated 
(see text for details).
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1.3 Human disorders associated with defects in RecQ family helicases.
So far, an attempt has been made to show how defects in highly conserved 
recombination pathways may result in genome instability and cancer-predisposition. In 
the following sections, two putative recombinational repair disorders. Bloom's syndrome 
(BS) and Werner's syndrome (WS) will be discussed in the context of information 
derived from prokaryotic and eukaryotic model systems. Both these inherited disorders 
result from defects in similar proteins that show a high degree homology to RecQ, a 
participant in the RecF pathway of recombination in E.coli (Nakayama et al., 1984: Ellis 
et al., 1995; Yu et al., 1996).
13,1 Bloom's syndrome: clinical phenotype
In 1954, a New York dermatologist, David Bloom, described the association of 
'congenital telangiectatic erythema resembling lupus erythematosus' in association with 
short stature in children (Bloom, 1954). Over the next decade, individuals with a similar 
constellation of features were studied and entered into what we now know as the 
‘Bloom's Registry*. By 1965, the predisposition to malignancy and its likely, autosomal 
recessive inheritance had been noted (German et al., 1965; German, 1969). Since that 
time, and until 1991, any individual with Bloom's syndrome was eligible for entry to the 
Bloom's register, allowing the prospective follow-up of a cohort of individuals and the 
accumulation of considerable clinical and experimental data. By 1991, the total number 
of individuals accrued to this database was 168 (German, 1997). The development of the 
Registry was the key determinant in the eventual identification of the BIM  gene, defects 
in which are responsible for this disorder.
The incidence of BS is extremely low in the general population, but occurs in about 
1 in 58,000 Ashkenazi Jews (German, 1979). No definitive data exists concerning any 
anomalies or cancer risk in heterozygous relatives of affected individuals. The main 
clinical features of Bloom's syndrome are growth retardation, a sun-sensitive facial 
erythema, immunodeficiency and a marked predisposition to malignancy of all types 
(German, 1993). At birth, individuals are noted to have a proportionately small body size 
and few attain full adult height. This is associated with a characteristic appearance which 
comprises dolichocephaly (long, thin cranium), malar and mandibular hypoplasia. The
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predominant skin lesion is a photo-sensitive rash affecting the face, dorsa of the hands 
and forearms. This is sometimes accompanied by patchy areas of both hyper- and hypo­
pigmentation (German, 1995). Patients present with repeated infections, primarily 
bacterial infections affecting the respiratory tract and this a major cause of mortality in 
affected individuals. All men with BS are infertile (small testes associated with a 
complete failure of spermatogenesis), whilst women with BS are subfertile. Other 
features reported in association with BS include persistent vomiting and diarrhoea in 
infancy, diabetes mellitus, a high-pitched voice, subnormal intelligence and a number of 
minor anatomical anomalies.
The feature which is of most interest to the scientific community is the proneness to 
cancer in BS individuals. By 1996, a total of , 100 cancers (arising in 71 persons) had 
been reported amongst the 168 individuals in the BS Registry (German, 1997). The mean 
age of death in BS is 23.8 years and the majority of deaths are due to.malignancy. More 
than 1 in 4 BS individuals who develop a malignancy go on to develop one or more 
further primaries. In general, the spectrum of cancers mirrors that of the general 
population although with a vastly increased incidence. In the first 2 decades of life, 
leukaemias and lymphomas predominate, and in the 3rd and 4th decades of life epithelial 
cancers become more conunon. The overall picture is of an increased risk, a normal 
spectrum of cancers and an age distribution which is skewed markedly to a younger age 
range, as compared to normal individuals. No significant differences in terms of cancer 
grade, cytogenetics or treatment responses are described. No excess treatment-related 
radiosensitivity has been reported.
1.3.2 Werner's syndrome: clinical phenotype
WS was first identified in 1904 by Otto Werner in his doctoral thesis Cataract in 
combination with scleroderma' (Werner, 1904). He reported 4 siblings with similar 
clinical findings; short stature; senile appearance; greying of the hair occurring in the 
2nd decade of life; cataracts occurring in the 3rd decade; scleroderma-like skin changes; 
and ûvâiiân failure. Further eharacterisation of the disorder by Oppenheimer and Kugel 
in 1934, Thannhausser in 1945 and by Epstein et al. in 1966 identified WS as a disorder 
associated with growth retardation, some features of accelerated ageing, canccr- 
predisposition and chromosomal instabihty.
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The inheritance of WS is autosomal recessive, and the frequency of homozygotes 
ranges from 1 to 25 per 10 ,^ with increases in incidence reported in Japan and Sardinia 
(reviewed in Thweatt and Goldstein, 1993). No definitive data exist in relation to the 
phenotype associated with heterozygotes. The first recognised and consistent feature of 
WS is a failure of the adolescent growth spurt, such that adults are short in stature. Skin 
anomalies are prominent and include scleroderma-like atrophic changes affecting the face 
or distal extremities and ulceration affecting the legs. Both females and males are 
subfertile. Features considered representative of progeria include premature onset of 
cataracts, greying of the hair, coronary and peripheral vascular disease, diabetes mellitiis 
and osteoporosis. The mean age of death is 47 years, and the most common cause is 
ischaemic heart disease (Epstein, 1966). Despite these features, WS cannot be really be 
classified as a disorder of premature ageing since there is no proportional advancement in 
time of all manifestations of ageing and secondly, no proportional advancement of all 
diseases or all causes of death. In particular, the absence of Alzeimher's disease suggests 
that the assignment of WS as an ageing disorder is imprecise. Furthermore, in contrast 
to normal ageing, there is a propensity to rare, non-epithelial cancers. A comprehensive 
review of 124 case reports of cancer in WS in the world literature, reveals a ratio of 
epithelial: non-epithelial cancers of 1:1, as compared to the usual 10:1 (Goto et al., 1996). 
Prominent amongst the non-epithelial tumours, are soft tissue sarcomas, osteosarcomas, 
myeloid disorders and benign meningiomas. As in BS, no consistent differences in the 
grade, of cancer, cytogenetics or treatment responses are reported. No excess treatment- 
related radiosensitivity-has been described. A comparison of the respective clinical 
phenotypes of WS and BS is shown in Table 1.1.
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Table 1.1: Comparison of the clinical features of Bloom's and Werner's syndromes
feature Bloom's syndrome Werner's syndrome
onset prenatal post -adolescent
features of ageing not prominent yes
skin facial erythema scleroderma-like
immunodeficiency yes no
fertility males infertile, 
females subfertile
subfertility
mean age at death 
(m^jor cause)
24 years (cancer) 47 years (cardiac disease)
cancer all types non-epithelial
1.3.3 Cellular phenotypes associated with Bloom’s and Werner’s syndromes
Cells derived from individuals with both BS and WS grow slowly, with a reduced 
rate of transit through S-phase (Hand and German, 1975; Gianelli et al., 1977; Ockey and 
Saffhill, 1986; Fujikawa-Yamamoto el al., 1987; Salk, 1982; Giesler et al., 1997). Newly 
synthesised DNA strands elongate more slowly in both cell types and this is associated 
with the presence of abnormal replication intermediates in BS cells (Lonn et al., 1990) 
and a decreased frequency of initiation events in WS cells (Hanaoka et al., 1985). WS 
cells also demonstrate premature replicative senescence in culture (Martin et al., 1970; 
Salk et al., 1981: Salk, 1982; Tollefsbol and Cohen, 1984), although this has not been 
studied in BS cells. In contrast to cells from other disorders associated with genome 
instability, both BS and WS cells are not particularly sensitive to DNA damaging agents
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(reviewed in Friedberg et al., 1995). Although there are a small number of reports 
suggesting sensitivity to UV or cross-linking agents in cells derived from affected 
individuals, these are the exception rather than the rule.
A gross level of spontaneous chromosomal instability is evident in both diseases. A 
dramatic representation of this is the large numbers of epithelial cells from BS 
individuals containing micronuclei, which are produced when aberrant chromosomes or 
chromosome fragments lag at anaphase and are surrounded at telophase by their own 
nuclear membrane (Rosin and German, 1985). At a cytogenetic level the nature of the 
genomic instability in the two disorders is distinctive.
BS stands out from other chromosome instability syndromes because of its unique 
tendency for increased exchanges between homologous chromosome segments. This is 
manifested as an increase in sister chromatid exchanges (SCEs) or interchanges between 
homologous chromosomes (quadriradials and telomere associations), both of which occur 
spontaneously and which are amplified following exposure to various DNA-damaging 
agents (Kuhn and Therman, 1986). The ten fold increase in the number of SCEs as 
compared to wild type cells when BS cells are incubated in the presence of 
bromodeoxyuridine is specific to this disorder. Single chromosome breaks and chromatid 
translocations between nonhomologous chromosomes are also increased. In WS, 
cytogenetic abnormalities include deletions, reciprocal translocations and inversions, an 
appearance termed ‘v^egated translocation mosaicism’ (Salk et al., 1985). A wide 
spectrum of break points is found in the WS karyotype, with specific clusters affecting 
lql2, 5ql2 and 6cen. WS cells do not demonstrate an elevated rate of SCEs.
The most elegant evidence that the cytological changes in BS described above reflect 
an increase in somatic recombination, has been the study of affected individuals who are 
heterozygous for the MN blood group (Kyoizumi et al., 1989; Langlois et al., 1989). 
Glycophorin A (GPA) is a cell surface erythrocyte protein which occurs in two forms, M 
and N, and is the product of codominantly expressed alleles. Using a flow cytometric 
approach to assess the cell surface expression of the M and N antigens, loss of 
heterozygosity was detected at a rate 50-fold greater than normal individuals, such that 
about 1 in 1000 erythroid cells in BS individuals were the progeny of cells that had been 
altered by a recombinational event between the GPA alleles. Hemizygous or partial loss 
variants were also markedly elevated (50-80 fold) in BS individuals. Although, this 
hemizygous variant could arise as a result of chromosomal breakage, comparisons with
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the frequencies of these events with other situations in which chromosome breaks are 
observed (for instance, in individuals exposed to ionising irradiation), suggest that 
additional mechanisms resulting in this genetic variant are involved in BS individuals 
(Langlois et al., 1987).
At a molecular level, no consistent representation of the events that lead to mutation 
in BS and WS individuals has yet emerged. In contrast to hereditary non-polyposis 
colonic cancer which is associated with a mismatch DNA repair defect, there is no 
increase in microsatellite instability in either disorder (Foucault et al., 1996; Brooks- 
Wilson et al., 1997). A marked increase in rates of mutation at the HPRT locus in BS and 
WS individuals appears to arise as a consequence of large deletions (Warren et al., 1981; 
Vijayalaxmi et al., 1983; Fukuchi et al., 1989; Tachibana et al., 1996). In an attempt to 
characterise the mechanism of this 'hyper-mutability' in more detail, plasmid products 
derived from normal, BS and WS cells following transfection of linearised plasmid DNA 
have been assessed. For BS cells, the efficiency of plasmid re-joining was reduced 1.3-3 
fold, and the spontaneous frequency of the mutations in the derived products was up to 
21-fold greater than normal controls. The type of mutations identified included deletions, 
insertions, point mutations or complex rearrangements at joining sites (Runger and 
Kraemer, 1989). In contrast, in WS the efficiency of plasmid rejoining is normal and 
although this ligation is error-prone as compared to wild type cells, the complexity of the 
mutations (deletions) was less marked than in BS (Runger et al., 1994).
No explanation currently exists to explain the immunodeficiency associated with BS. 
Abnormalities identified include low immunoglobulin levels, reduced in vitro 
proliferative responses to mitogen stimulation, depressed natural killer activity, 
impairment of B-cell differentiation and reduced helper T-cell function (Hutteroth et al., 
1975; Weemaes et al., 1979; Taniguchi et al., 1982; Ueno et al., 1985). However, in 
studies to date no abnormalities in either signal or coding joint formation of V(D)J 
recombination have been identified (Hsieh et al., 1993). Furthermore, BLM does not 
appear to be involved in the process of immunoglobulin hypermutation (Sack et al., 
1998).
1.3.4 The identification of BLM  and WRN genes.
The process that led up to the identification of the BLM gene involved at its ultimate 
stage, a completely novel strategy and is thus described in some detail. At an early
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stage, BS was believed to be a single gene disorder as evidenced by the absence of 
complementation in fusion experiments between cell lines derived from BS individuals of 
different ethnic backgrounds (Weksberg et al., 1988). The chromosomal location was 
identified by complementation analysis following microcell-mediated transfer of human 
chromosomes into a transformed BS fibroblast cell line, which showed that chromosome 
15 was able to correct the elevated SCE rate (McDaniel and Schultz, 1992). Analysis of 
affected persons whose parents are cousins (and thus, who are likely to have inherited an 
identical defective gene) allowed genetic mapping to a band 15q26.1 and tight linkage 
between the proto-oncogene FES and the putative BLM gene (German et al., 1994). 
Further linkage analysis indicated that BLM was just proximal to FES and to D15S127 (a 
CA repeat locus) and could be assigned to an interval no greater than 2cM (Ellis et al.,
1994).
Although it is likely that this standard positional cloning method approach would 
have allowed the eventual identification of BLM, a novel method that exploited an 
observation made nearly twenty years earlier was used. It had been noted that in certain 
individuals with BS, a small number of cells could be isolated with normal rates of SCE 
formation (German et al., 1977). This high SCE/low SCE mosaicism was identified only 
in individuals whose parents were not known to share a common ancestor. In multiple 
low SCE cells studied, polymorphic loci distal to BLM on 15q had become homozygous, 
whereas polymorphic loci proximal to BLM remained heterozygous. These observations, 
supported the hypothesis that low SCE cells arose through recombination between 
different ^/m alleles in persons who had inherited paternally and maternally derived blm 
alleles mutated at different sites (Ellis et al., 1995). This type of recombinational event in 
a precursor stem cell could thus give rise to a cell whose progeny had a functional wüd 
type gene and phenotypically a low SCE rate (Figure 1.3). Consistent with this model, 
certain low SCE cell lines demonstrated a reduction to homozygosity at loci distal but not 
proximal to the BLM locus. These observations and hypothesis led to a cloning method 
referred to as somatic crossover point (SCP) mapping (Ellis et al., 1995). In this strategy 
the aim was to identify the most proximal polymorphic locus that was constitutionally 
heterozygous but that had been reduced to homozygosity in the low SCE cells, and to 
identify the most distal polymorphic locus that remained constitutionally heterozygous in 
them. BLM would then be in the short interval defined by the reduced (distal) and 
unreduced (proximal) heterozygous markers. A schematic diagram of this SCP approach
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is shown in Figure 1.3. The candidate gene identified in this way was proven to be the 
disease-related gene, by a number of methods including single-stranded conformational 
polymorphism analysis of sequences generated by RT-PCR from patients and control 
RNA, which permitted identification of mutations in 10 individuals with BS (Ellis et al.,
1995). The BLM gene was predicted to encode a 1417 amino acid protein with 
significant homology to the RecQ family helicases.
Within a few months of this discovery, positional cloning identified the gene 
defective in WS. The WRN gene, located to 8pl2, was also found to encode a RecQ 
family helicase (Yu et al., 1996). Thus within a very short period of time, two distinct 
human disorders associated with gross chromosomal instability were found to result from 
defects in proteins from the same DNA helicase family.
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Figure 1.3: Intragenic somatic recombination in Bloom's syndrome. The high frequency of 
recombination in BS can generate a wild type BLM allele in compound heterozygotes, accounting 
for the minor population of lymphocytes with normal levels of sister chromatid exchange (SCE) 
observed in these individuals. I Each of 2 mutations in BLM (the yeliow rectangle), represented 
by the blue and red boxes, is at a different site in the gene. A/a and Bib are polymorphic 
microsatellite markers, located respectively proximal to and distal to the BLM locus. The 
centromere is represented by a grey circle. II Following homologous interchange between 
chromatids 2-2 and 3-3 at a point between the sites of mutation within BLM, a wild type gene is 
generated on chromatid 2-3, that corrects to normal the high SCE phenotype of BS cells. The 
distal marker b becomes associated with the wild type gene on chromatid 2-3. Ill By 
segregational events at mitosis, 2 pairs of daughter molecules are possible (only one of the 
possible pairs are shown). If chromosomes 2-3 and 44  co-segregate to the same daughter cell 
(on the right), the distal marker becomes homozygous bib and the proximal marker remains 
heteozygous A!a. This cell will have a low SCE phenotype.
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1.4 The RecQ subfamily of DNA helicases
1.4.1 DNA helicases
DNA helicases catalyse the disruption of hydrogen bonds that hold two strands of a 
DNA duplex together (Matson et al., 1994; Lohman and Bjomson, 1996). This NTP- 
driven process generates single-stranded DNA intermediates or templates for DNA 
repair, replication, recombination and transcription. The majority of helicases contain 7 
helicase 'signature' motifs. The first (la) and third motifs (H), corresponding to Walker 
boxes A and B respectively, bind to ATP. Motifs Ib and HI-VI are highly conserved and 
specific to helicases, although not all proteins with these motifs necessarily demonstrate 
helicase activity in vitro (Gorbalenya and Koonin, 1993). ; Their biological importance is 
emphasised by the finding of large numbers of helicases in most organisms whose 
genomes have been extensively studied. In budding yeast, there may be as many as 41 
helicases (Ellis, 1997).
DNA helicases can be categorised biochemically by their substrate preference, 
direction of unwinding, processivity and their interaction with other proteins or co­
factors. For example, some helicases act on blunt-ended duplexes, whereas others 
require ssDNA overhangs or fork-like structures. Using end-labelled substrates it is 
possible to ascertain the direction of helicase translocation through the duplex. 
Mechanistically, there are two broad groups of helicases (Matson et al., 1994): those 
requiring a 3’ flanking strand of ssDNA and those requiring a 5* flanking strand (known 
as 3*-5* and 5’-3’ polarity helicases respectively).
On the basis of sequence homology, there are five classes of helicase (Gorbalenya 
and Koonin, 1993). Most 3*-5* helicases are members of superfamilies I or H. These 
two families contain proteins which contain the seven conserved helicase motifs and a 
number of these proteins are thought to act as dimers. Superfamily m  represents 
helicases derived from DNA or RNA viruses, while superfamilies IV and V contain 5’-3* 
hexameric helicases related either to the E.coli replicative helicase DnaB or the bacterial 
transcription temiinator, Rho. The RecQ helicases form a subfamily of superfamily H.
Sequence analysis of helicases in superfamilies I and II indicate that the greatest 
variation is seen in regions between motifs la and H, and between IV and V, and at the N- 
or C-termini (Bird et al., 1998). This is consistent with a modular structure, in which 
insertions at the positions described above, could modify helicase activity. The structure
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of a small number of helicases have been resolved and demonstrate significant similarity 
in their pattern of folding, although the relative positions of the individual subdomains 
are different (Subramanya et al., 1996; Korolev et al., 1997). The nucleotide binding 
pocket is formed by several of the motifs conserved in superfamilies I and H, and is 
situated at the bottom of a cleft that runs between two domains.
A common feature in most superfamily I and II helicases, is the internal repeat of 
two RecA-like subdomains, suggesting that these domains may be the minimal structure 
necessary for helicase activity (Bird et al., 1998). This homology is likely to represent 
significant overlap in the mechanism of action for helicase and RecA proteins. Thus 
RecA destabilises a DNA duplex to enable invasion of a homologous strand, whereas 
helicases catalyse only the first step of : this reaction. Both sets of proteins couple the 
binding and hydrolysis of nucleotides to conformational changes that in turn alter the 
affinity of enzymes for different forms of DNA. Two models have been proposed to 
explain the molecular mechanism that results in unwinding. The ‘inchworm” model 
suggests that the helicase molecule translocates through the DNA in discrete steps 
coupled to the hydrolysis of ATP (Yarranton and Geftner, 1979). In this scenario, the 
helicase could conceivably act as a monomer. The ‘active rolling’ model proposes that 
helicases act by an alternation in the affinity of the enzyme for ss- or dsDNA that is 
controlled by the binding and subsequent hydrolysis of ATP (Wong and Lohman, 1992). 
This second model requires that the helicase acts as an oligomer and second, that a 
helicase subunit can bind ss- and dsDNA, but not both simultaneously.
1.4.2 The RecQ family
Since the isolation of E. coli RecQ in 1984 (Nakayama et al., 1984) there has been a 
steady increase in the identification of related family members, either through the direct 
cloning of genes defective in BS and WS, or more recently through searching the rapidly 
expanding genome databases. In the most recent estimate, there are at least 16 members 
of the RecQ family (see legend to Figure 1.4 for accession numbers). In general, it 
appears that the number of RecQ family helicases expressed in each organism is directly 
related to the complexity of that organism, such that prokaryotes and unicellular 
eukaryotes possess only a single RecQ helicase, whereas C. elegans possesses at least 
four, and H. sapiens has at least five. Attempts to classify members of this family on the 
basis of overall size, direct sequence comparison or phyllogenetic analyses have not
23
proven particularly useful to date. The ultimate aim should, of course, be to categorise 
individual members of this family on the basis of function.
In Figure 1.4, an alignment of 6 key members of the RecQ family is shown. Each 
protein is characterised by a central domain of -600 amino acids that contains the 7 so- 
called helicase signature motifs, including a putative ATP-binding sequence (Walker A 
box) in motif I, and a DExH-box in motif H. Amongst all of the proteins in this family, 
strong sequence similarity is restricted to this central domain both within and adjacent to 
the 7 helicase motifs. The 4 larger proteins, Sgslp, Rqhlp, WRN and BLM, also share 
an area of extended sequence homology C-terminal to the helicase domain. Although 
there is little primary sequence homology outside of these regions, the N- and C-terminal 
regions of the larger proteins appear to perform several roles. The N-terminal domain in 
each case includes blocks of sequence comprising multiple acidic amino acids that might 
be involved in protein and/or DNA interactions. Motifs homologous to the nuclease 
domains in RNaseD and certain proof-reading DNA polymerases have been identified in 
the N-terminal domain of WRN (Mushegian et al., 1997), suggesting that WRN protein 
may possess nuclease activity. The N-terminal domain of Sgslp has been shown to be 
important for binding to both topoisomerase m  (Gangloff et al., 1994) and topoisomerase 
n  (Watt et al., 1995)(see below). A nuclear localisation signal (NLS) sequence has been 
identified in the C-terminal domain of both WRN (a group of basic amino acids at 
residues 1370-1375, Matsumoto et al., 1997) and BLM (a bipartite NLS between residues 
1334-1349, Kaneko et al., 1997) (Figure 1.4).
To date, the spectrum of mutations identified in WS individuals are 4 nonsense 
(codons, R369X, R888X, Q1164X, R1304X), 1 frameshift (nucleotide, 1167delA), 3 
exon skipping (exons 20, 26 and 32) and one large deletion (>15kb). It is of interest that 
many of the WRN gene mutations identified in WS individuals (5 of the 9 mutations 
described) are predicted not to disrupt the helicase domain, but to truncate the protein 
resulting in loss of the NLS sequence (Yu et al., 1996; Goto et al., 1997; Yu et al., 1997). 
In the most recent analyses of cell lines derived from 35 non-Ashkenazi Jewish 
individuals with BS (Ellis et al., 1995; Dr. N. Ellis, personal couuuuoicalion), the 
spectrum of mutations identified were 5 missense (codons, Q672R, G891E, C901Y, 
C1055S, G1036T), 8 nonsense (codons, S186X, K272X, R364X, S595X, Q645X, 
Q700X, Q752X, R899X), 6 frameshift (nucleotides, 1610insA, 2042insG, 
228 IdelATCTGAinsTAGATTC, 2996delC, 32223delT, 3333delT), 2 exon-skipping
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(exon2, exonô) and 1 large ~750bp deletion (identified by Southern). Within this non- 
Ashkenazi Jew group, 8 unrelated individuals had the same mutation, evidence for small 
founder effects. A single frameshift mutation (228IdelATCTGAinsTAGATTC) 
accounts for the majority of BLM  mutations within the Ashkenazi Jewish group of 
individuals with BS. A screen of 1491 anonymous, unrelated Ashkenazi Jewish 
individuals with no known family history of BS found that the carrier rate was 1 in 107 
for this mutation (Straughen et al., 1998; Dr. N. Ellis, personal communication). The 
majority of the mutations described above for BS-affected individuals either severely 
truncate the BLM protein or cause amino acid substitutions in residues within or adjacent 
to the helicase motifs and are predicted therefore to eliminate helicase function (Ellis et 
al., 1997). The significance of the difference in mutational spectra between BLM  and 
WRN, and how this might relate to the different cellular phenotypes of WS or BS cells is 
not yet clear.
In an attempt to assign specific functions to each of the different RecQ family 
members, 3 general strategies have been deployed: (1) an assessment of the cellular 
phenotype associated with the absence of that protein; (2) a genetic approach to establish 
functional relationships with replication/repair/recombination pathways; (3) a 
biochemical assessment of the enzymatic activities of a purified family member. 
Summaries of the findings for each of these approaches (Nakayama et al., 1984; Gangloff 
et al., 1994; Watt et al., 1995; Hanada et al., 1997; Watt et al., 1996; Sinclair and 
Guarente, 1997; Stewart et al., 1997; Murray et al., 1997; Kuhn and Therman, 1986; 
Runger and Kraemer, 1989; Lonn et al., 1990; Giannelli et al., 1997; Friedberg et al., 
1995; Hoehn et al., 1975; Fukuchi et al., 1989; Hanaoka et al., 1985; Okada et al., 1998; 
Thweatt and Goldstein, 1993; Umezu and Nakayama, 1993; Harman and 
Kowalczykowski, 1998; Bennett et al., 1998; Karow et al., 1997; Gray et al., 1997; 
Suzuki et al., 1997; Shen et al., 1998) are shown in Tables 1.2 and 1.3. In comparing the 
various properties of each enzyme, it is important to make the following qualification. In 
each of the 5 cases where mutants exist, loss of a RecQ family helicase does not 
compromise cell viability, and therefore it is likely that other proteins can partially 
substitute or compensate for the loss of a RecQ helicase. This functional redundancy, 
which must in some cases involve enzymes with no structural similarity to RecQ 
helicases, has the potential to at least partially mask or distort the 'true' phenotypic effects 
of loss of a RecQ helicase.
25
number of 
amino acids
RecQ
Sgsl
R qhl
RECQL
BLM
WRN I  j I
610
1447
1328
649
1417
1432
RNase D acid block helicase D  homology NLS
Figure 1.4: Schematic representation of the structures of six members of the RecQ helicase 
family. The proteins shown are E. coli RecQ, S. cerevisiae Sgs 1, S. pombe Rqh 1, and H, sapiens 
RECQL, BLM and WRN, as indicated on the left. The size of each protein is shown on the right. 
Regions corresponding to RNase D motifs, blocks of acidic amino acids, helicase domains, 
extended regions of homology outside of the core helicase domain, and nuclear localisation 
sequences (NLS) are indicated and shown in the key below. Accession numbers for these and 
other RecQ family members are as follows; RecQ (A35776); Sgsl (L07870); Rqhl (Z54354); 
uncharacterized members in C. elegans (Z38112, U00052, U29097); and H. sapiens RECQL 
(L36140), BLM (U39817), WRN (L76937) and 2 other uncharacterized members (H I6879, 
Z15298).
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1.4.3 Are RecQ helicases involved in ‘replication fork repair’?
A significant amount of evidence, derived mainly from studies on bacterial and yeast 
model systems, suggests that RecQ family helicases may act upon DNA structures that 
arise during the DNA synthesis phase (Tables 1.2 and 1.3). DNA replication is 
potentially hazardous to the integrity of cellular DNA for numerous reasons. F or 
example, accumulating evidence indicates that replication fork progression is not always 
smooth but may be interrupted, for example, by the presence of lesions in the template 
(reviewed in Bieme and Michel, 1994; Friedberg et al., 1995; Kuzminov, 1995). This 
can have the effect either that a pre-existing single strand break in the DNA template is 
converted to a far more cytotoxic double strand break, or that the replication fork will 
stall and subsequently collapse. Alternative mechanisms by which this collapse could be 
precipitated include the collision of a replication fork either with a converging protein 
complex (a replication or transcription complex), or with an abnormal DNA structure 
(e.g. a cruciform). Collapse and disassembly of the fork may result in the formation of 
cytotoxic DNA strand breaks. Failure to resolve such lesions and to successfully re­
initiate replication would result in the loss of genetic information and the likely loss of 
cell viability. DNA structures that might exist at a stalled fork, such as single strand 
gaps in the lagging strand and the free 3' end of the leading strand, are also likely to be 
highly recombinogenic.
Cells have developed a number of strategies for dealing with the deleterious 
consequences of replication fork breakdown (for recent reviews, see Bierne and Michel, 
1994; Kuzminov, 1995). Lesions blocking replication fork progression can either be 
repaired directly, or be by-passed through the activity of a DNA polymerase equipped to 
catalyse translesion synthesis. Alternatively, extensive studies in prokaryotes and, more 
recently, in eukaryotes (Zhou and Rothstein, 1997; Merrill and Holm, 1998), suggest the 
involvement of genetic recombination functions in the 'repair' of DNA structural 
abnormalities arising during DNA replication. For example, single-stranded lesions that 
are converted to DNA DSBs at the replication fork could be repaired by a mechanism 
involving homologous recombination with the intact sister-chromatid. A second possible 
pathway for recombination-mediated replication fork repair is via post-replication gap 
filling (Kogoma, 1997; Cox, 1997). In this, replication re-initiates downstream of the site 
of fork blockage, leaving single-stranded gaps opposite the original lesion, which are 
subsequently filled by homologous recombination (Figure 1.5).
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In prokaryotes, post-replication gap filling is dependent upon the RecF pathway for 
genetic recombination. Indeed, a number of studies have shown functional connections 
between DNA replication and the RecF pathway. Thus, for example, the r^cF and recR 
genes are found within opérons encoding DNA synthesis genes (Flower and McHenry, 
1991). Certain forms of aberrant replication, including plasmid linear-multimer 
formation or rifampicin-resistant plasmid replication, have been shown to be RecF- 
dependent (Kusano et al., 1989; Magee and Kogoma, 1990). Moreover, loss of RecF 
pathway genes results in resistance to thymine starvation, a process that is also thought to 
result in abnormal replication (Nakayama et al., 1984). To explain these connections, 
Courcelle et al. (1997) have suggested that the replisome disengages from the template at 
a DNA lesion, and that RecF pathway proteins are required to subsequently ‘reassemble’ 
a replisome complex at the site of the replication fork following removal of the lesion by 
specific DNA repair enzymes. The precise means by which this re-initiation of 
replication at non-origin sites occurs is not clear, but seems to involve PriA-mediated 
priming of new DNA synthesis from sites of D-loops in the template. This would clearly 
permit replication to be re-initiated at the precise position where it faltered, an essential 
factor if loss or gain of genetic information is to be prevented.
Although recQ'is a member of the RecF pathway of recombination in E.coli, its 
precise function in relation to the processes described above has yet to be established. 
However, a recent detailed biochemical assessment of the catalytic activities of the RecQ 
protein provides firm evidence that RecQ, in association with RecA and SSB, can initiate 
homologous DNA pairing (Harman and Kowalczykowski, 1998), a finding consistent 
with much of the genetic data derived from studies of recQ mutants. In addition, RecQ 
exhibits a substrate 'promiscuity' in that it can unwind with similar efficiency a broad 
range of DNA substrates representative of structures generated during replication or 
recombination, including duplexes with blunt ends or 3' and 5' overhangs, 3- or 4-way 
DNA junctions and forked DNA structures (Harman and Kowalczykowski, 1998). Thus, 
the likely ability of RecQ to initiate recombination from internal nicks or small gaps (an 
ability not shared by the RecBCD enzyme, the major initiator of recombination in E.coli) 
make it an attractive candidate for dealing with structures generated at a stalled or 
collapsed replication forks. Consistent with this, in experimental systems designed to 
reproduce the effect of replication fork stalling in vivo (using plasmids carrying specific 
E.coli replication termination sites) an increase in the frequency of deletions arising via
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illegitimate recombination has been observed (Bieme et ah, 1997). Structurally similar 
deletions arise at an elevated frequency in recQ mutants (Hanada et al., 1997). It seems 
likely that the existence of a mechanism to resolve aberrant structures generated during 
the process of DNA replication is important in all cells, including those of higher 
eukaryotes.
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Figure 1.5: Post-replication gap repair. (A) A replication fork approaches a lesion (e.g. a 
pyrimidine dimer) on the template, leading to replication fork arrest and disassembly. (B) 
Replication reinitiates downstream of the blockade, leaving a gap opposite the lesion. (C) RecA 
(or one of its eukaryotic homologues) polymerises on single-stranded DNA at the gap, and 
promotes homologous pairing and strand exchange with the intact strand of the daughter duplex, 
forming a D-loop. (D) Extended strand exhange allows the 3’ end of the newly synthesised DNA 
to invade this structure, leading to the formation of a Holliday junction. The gap is then filled in 
by DNA synthesis. (E) Resolution of the Holliday junction and ligation completes the reaction. 
Removal of the lesion can then be catalyzed by the appropriate DNA repair pathway (i.e. 
nucleotide excision repair). Blue lines represent template DNA and red lines represent newly 
synthesised DNA.
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1.4.4 Evidence for replication abnormalities in the absence of RecQ family helicases 
in eukaryotes
There is emerging evidence from studies in yeasts that replication does not proceed 
normally in absence of a RecQ helicase. When fission yeast rqhl mutants are exposed to 
the DNA synthesis inhibitor, hydroxyurea (HU) they lose viability and exhibit a 'cut' 
(‘cell untimely torn’) phenotype in which the septum often bisects an undivided nucleus 
(Stewart et al., 1997). These mutant cells show a normal cell cycle checkpoint response 
to the initial insult, in that they show cell elongation, but no cell division. However rqhl 
mutants lose viability and initiate 'cuts' when the cells attempt to resume DNA replication 
following the removal of the HU. Thus, fission yeast cells are defective in the 'recovery' 
from S-phase arrest in the absence of a functional rqhl^ gene. Genetic studies also 
indicate that rqhl^ is necessary for viability in certain mutants showing defects in the 
elongation step of DNA synthesis (Murray et al., 1997). This implies that if replication 
fork progression is inhibited, Rqhlp is necessary in some way to facilitate the process of 
re-initiating DNA replication. The marked increase in levels of chromosome loss and 
recombination following exposure of rqhl mutants to HU (Stewart et al., 1997) is  
consistent with a failure to resolve lesions and/or aberrant structures arising at the sites 
of stalled replication forks.
Budding yeast mutants lacking SGSl, the homologue of rqhl^, were reported to be 
sensitive to HU while this thesis was in preparation (Yamagata et al., 1998). 
Furthermore, in the absence of HU, sgsl mutants show elevated rates both of mitotic 
recombination (both inter- and intra-chromosomal between repetitive sequences) and 
mitotic chromosome nondisjunction (Watt et al, 1995 and 1996). Sgslp also acts to 
suppress deletions arising through illegitimate recombination, in a similar manner to 
RecQ in E.coli (Yamagata et al., 1998). Taken together, these findings suggest that the 
RecQ-family helicases in prokaryotes and lower eukaryotes share similar fundamental 
functions.
It seems probable that the putative defects in replication described above, observed 
in the absence of RecQ helicase function in yeasts, are also evident in human cells. As 
stated earlier studies of fibroblasts derived from patients with WS and BS showed either 
retarded replication fork progression or the accumulation of abnormal replication 
intermediates (Giannelli et al., 1977; Hanaoka et al., 1985; Lonn et al., 1990). BS cells 
also show a marked elevation in the rate of sister-chromatid exchanges which arise in S-
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phase when cells are exposed to bromo-deoxyuridine (Kuhn and Therman, 1986). The 
finding that WS fibroblasts (Okada et al., 1998) show specific sensitivity to S-phase 
specific agents, such as the topoisomerase I inhibitor campothecin, suggests that this 
helicase functions primarily during the period in which the cell replicates its DNA. The 
recent finding that the formation of ‘replication foci’ in Xenopus, is dependent upon FFA- 
1 which shows a high degree of homology to the WRN protein, provides more direct 
evidence of a role in DNA replication (Yan et al., 1998).
1.4.5 Defects in RecQ helicases are associated with a reduction in life span.
Individuals with WS show many of the features of normal ageing, but display them 
several decades earlier in life than do unaffected individuals (Epstein et al., 1966). At 
this stage it is not clear how deficiency in a RecQ helicase leads to premature replicative 
senescence. Studies utilising sgsl mutants of budding yeast have suggested the possible 
role in the ageing process of a failure to suppress instability in DNA repeat sequences, 
particularly in the tandemly duplicated rDNA locus (Sinclair and Guarente, 1997). 
Guarente and colleagues have shown that there is a more rapid accumulation of extra- 
chromosomal rDNA circles (ERCs) in sgsl mutants than in wild-type cells, and that this 
chromosomal instability is associated with a 60% reduction in life span. This 
abnormality in controlling life span in sgsl mutants is associated with other features 
found in 'old' yeast cells, including sterility, nucleolar fragmentation and relocalisation of 
Sir proteins to the nucleolus. Immunolocalisation of Sgslp demonstrates that the protein 
is concentrated in the nucleolus, where it is proposed to act in the suppression of ERG 
formation. The number of ERCs in aged yeast cells was estimated to be between 500- 
1000 copies per cell and it has been hypothesised that the build up of ERCs directly 
results in the loss of viability by titrating out essential proteins necessary for replication 
or transcription. In this context, it is noteworthy that premature introduction of rDNA 
circles containing a weak replication origin into wild type cells, markedly reduces life 
span. Repeat sequence instability in sgsl mutants is partially RAZ)52-dependent (Watt et 
al., 1996), which implicates recombination functions in ERC formation. However, the 
nature of any putative recombinogenic structures arising at the rDNA locus are as yet not 
known. Since it is likely that ERC formation is RAD52-dependent, another key question 
to be addressed is whether deletion of RAD52 in an sgsl mutant improves life span.
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It is not clear whether a similar process can account for the replicative senescence in 
mammalian cells. Although the human WRN protein immunolocalises to the nucleolus, 
the murine homologue does not (Markinak et al., 1998), and there is no evidence that 
rDNA copy number increases in human cells undergoing replicative senescence.
1.5 Functional relationships between topoisomerases and RecQ family 
helicases
Topoisomerases catalyse the interconversion of topological isomers of DNA and are 
required for the resolution of torsional stress in the DNA and for the unlinking of 
topologically-intertwined molecules (Wang, 1996). For an excellent discussion of the 
potential roles of interactions between topoisomerases and helicases, which is beyond the 
scope of this introduction the reader is referred to Duguet (1997).
Interactions have been identified between the RecQ family helicases and 
topoisomerases in both human and budding yeast cells. For example, a reduction in the 
cellular level of topoisomerase I la  levels has been documented in cells derived from 
individuals with BS (Foucault et al., 1997). In budding yeast, deletion of SGSl results in 
a synergistic growth defect in combination with a topi mutation and a chromosome 
segregation defect that is epistatic to that of a top2-4 conditional mutation (Watt et al., 
1995; Lu et al., 1996). Moreover, both topoisomerase II and III are reported to interact 
physically with Sgsl protein (Gangloff et al., 1994; Watt et al., 1995). However, perhaps 
the most compelling evidence for a functional link between Sgslp and a topoisomerase is 
that deletion of SG Sl strongly suppresses the slow growth and hyper-recombination 
phenotype of top3 mutants (Gangloff et al., 1994). By understanding the function of 
topoisomerse III, it is reasonable to suppose that it will be possible to determine in greater 
detail the function of Sgslp and perhaps other protein members of the RecQ family.
In the following sections an overview of the topoisomerases and their biological 
functions will be presented together with a more detailed description of the 
topoisomerase III family. Current hypotheses regarding how this group of enzymes 
might act in concert with the RecQ family helicases will also be detailed.
1.5.1 Topology-definitions
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Topoisomerases are enzymes that catalyse the inter-conversion of topological 
isomers of DNA (Bates and Maxwell, 1993; Watt and Hickson, 1994; Wang, 1996). 
Topological isomers are those DNA molecules which differ only in their linking number, 
which is the number of times two strands cross each other when the DNA molecule is 
projected onto a plane. This is due to a combination of the degree of twist (the extent of 
coiling of the two DNA strands about the axis of the DNA helix) and writhe (the coiling 
of the helical axis in space). Within supercoiled DNA, further configurations can arise 
including catenation, which is the linking of two or DNA more molecules in which at 
least one strand of each duplex is in the form of a closed ring; and knotting which is the 
irreducible entanglement of a single DNA molecule.
Topoisomerases can be classified into two broad groups on the basis of their 
catalytic action (Wang, 1996). Type I topoisomerases produce transient single strand 
breaks, within a DNA duplex allowing the other DNA strand of the helix to pass through 
the break with subsequent religation of the primary strand. Type II topoisomerases 
introduce transient double strand breaks, enabling the passage of an intact DNA duplex 
through the break before it reseals. According to these abilities, type I topoisomerases 
can alter the linking number in steps of one, whereas type II topoisomerases alter the 
linking number in steps of two.
1.5.2 Topoisomerases-classification
A table summarising the features of the best studied topoisomerases is presented in 
Table 1.4 (Bates and Maxwell, 1993; Watt and Hickson, 1994; Wang, 1996). There are 
two groups of class I enzymes, type lA enzymes which are found in both prokaryotes and 
eukaryotes, and type IB topoisomerases found exclusively in eukaryotes. Type lA 
topoisomerases act as monomers, form a covalent link with the 5' phosphoryl end of cut 
DNA and with one exception are ATP-independent. This family consists of the 
topoisomerase III subfamily, E.coli topoisomerase I and ‘reverse gyrase’ subfamily. This 
latter group of enzymes are found in hyper-thermophilic archaebacteria and catalyse the 
ATP-dependent introduction of positive supercoils into DNA (see section 1.5.8 for a 
further discussion of their function).
Type IB topoisomerases also act as monomers and are ATP-independent, but differ 
from the type lA enzymes in that they bind from a covalent link to the 3' phosphoryl end 
of cut DNA. All eukaryotic type I topoisomerases are members of this group. These
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enzymes can relax both negative and positive supercoils and act primarily in replication 
and in transcription, where they act to limit excessive supercoiling which arises as 
proteins translocate through a DNA duplex.
Type II topoisomerases are ATP-dependent, function as dimers and form a covalent 
link with the 5' phosphoryl end of cut DNA. This group includes bacterial gyrase and 
topoisomerase IV, and all of the eukaryotic type II topoisomerases. These enzymes act 
either in controlling the level of supercoiling or as decatenases. This latter function is of 
most importance during the final stages of replication.
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Table 1.4 Summary of the classification and functions of the topoisomerases
Class name organism function
lA Topoisomerase I E.coli relaxes negative supercoils
Topoisomerase III E.coli genome stability/plasmid segregation
Topoisomerase III S.cerevisiae genome stability
Topoisomerase Ilia Human not known
Topoisomerase IIIp Human not known
reverse gyrase thermophilic
bacteria
induces positive supercoiling
IB Topoisomerase I S.cerevisiae relaxes negative and positive supercoils
Topoisomerase I Human relaxes negative and positive supercoils
II DNA gyrase E.coli induces negative supercoils
Topoisomerase IV E.coli chromosome segregation
Topoisomerase II S.cerevisiae chromosome segregation
Topoisomerase Ila Human not known
Topoisomerase lip Human not known
1.5.3 Biological functions of topoisomerases: an overview
Although at one level the topoisomerases have simple biochemical activities, their 
ability to influence nearly all aspects of DNA metabolism, make an assessment of their 
cellular functions more difficult. In the following brief overview the role of 
topoisomerases in two key areas will be discussed: their role in DNA replication and their 
involvement in maintaining genome stability. For an extensive review of the functions of 
the topoisomerases, see Wang, 1996 (and references therein).
Topoisomerases have important roles in both the initiation and elongation steps of 
DNA replication. In both cases, this function is dependent upon the ability of certain 
topoisomerases to modulate the level of DNA supercoiling. DNA supercoiling is a 
property of almost all DNA in the form of closed circular DNA. In eukaryotes, linear
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DNA is fixed at multiple sites to the nuclear matrix, and the domains between such 
attachment sites behave as closed circular molecules, since their ends are in fixed 
orientation relative to one another (Bates and Maxwell, 1993). Such closed circular 
molecules or closed domains are almost invariably supercoiled.
The role of topoisomerases in supercoiling homeostasis is relevant to the initiation 
step of DNA replication, since the binding of sequence specific proteins to 'origins of 
replication' (a necessary antecedent to the assembly of a replication complex), is 
stimulated by negative supercoiling of the DNA. For example, the binding of the E.coli 
initiation protein DnaA to oriC, the origin of replication, is more stable if oriC is located 
on negatively supercoiled DNA (Fuller and Komberg, 1983). In lower eukaryotes, the 
efficiency of the autonomously replicating sequence (ARS) to act as replication origins 
is also dependent upon the degree of supercoiling (Umek and Kowalski, 1988).
DNA replication involves the translocation of a replisome through the DNA duplex. 
This tracking process has the potential to generate positive supercoils ahead of the 
complex (Liu and Wang, 1987). Constraints upon the movement of the ends of the DNA 
molecule through anchoring to other proteins (Cook, 1991) or the viscosity of the nuclear 
milieu, also result in the formation of positive supercoils, since they cannot diffuse across 
the template. Topoisomerases can therefore act as 'swivelases' which relax positive 
supercoils and allow DNA chain elongation. In prokaryotes, this effect is achieved 
primarily by DNA gyrase which introduces negative supercoils to counteract the 
formation of positive supercoils. In eukaryotes either topoisomerase I or II activity is 
sufficient to fulfil this function. Loss of topoisomerase I in budding yeast results in a 
retardation of nascent chain elongation (Kim and Wang, 1989) and topoisomerase I is 
reported to preferentially associate with the replication fork (Wang and Liu, 1990).
At the terminal stages of DNA replication as two replication forks converge, the 
unwinding of the parental DNA strands between the two forks may precede their 
replication into two daughter helices. The product of replication may then be a pair of 
catenated DNA rings in the case of closed circular DNA, or catenated topological 
domains in the case of linear replicons (reviewed in Wang, 1996). In principle, catenated 
DNA molecules may be resolved by either type I or type II topoisomerases, but in the 
case of type I molecules, the reaction requires a nick, or single strand gap in at least one 
of the substrate DNAs. In prokaryotes, decatenation is achieved by topoisomerase IV and 
to a lesser extent, by gyrase and topoisomerase III (Hiasa et al., 1994; Hiasa and Marians,
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1994; Zechiedrich and Cozzarelli, 1995). In eukaryotes, there is substantial evidence also 
that type II topoisomerases are the predominant effectors of decatenation. In 
S.cerevisiae, shift of the conditional mutant top2-4, results in cellular progression through 
anaphase with entangled chromatids, leading to chromosome loss or breakage (Holm et 
al., 1985, 1989; Spell and Holm, 1994). This appears to affect primarily large 
chromosomes which were found to break in a 2 0 0kb region near the centromere, but 
smaller intertwined chromosomes appear to resolve without breakage, presumably 
through unwinding of the intertwinings off the ends of the chromosome arms. The role 
of topoisomerase II in chromosome segregation in higher eukaryotes has been confirmed 
by a large number of studies (reviewed in Wang, 1996). Thus, in mammalian cells, 
immunodepletion of topoisomerase II (Yang et al., 1987) or its inactivation by drugs 
(Roca et al., 1994) leads to inhibition of decatenation and chromosome separation.
Evidence supporting the role of topoisomerases in maintaining genome stability is 
mainly derived from studies in S.cerevisiae. Inactivation of any of the known three 
topoisomerases in this organism results in marked increases in mitotic homologous 
recombination. This is manifested primarily in loss of rDNA stability for topi and top2 
conditional mutants (Christman et al., 1989; Kim and Wang, 1989), whereas all repetitive 
sequences are affected by loss of topoisomerase III (Wallis et al., 1989; Gangloff et al., 
1994; Kim et al., 1995) (see 1.5.5). In cells of a topi A top2ts double mutant grown at the 
restrictive temperature, over half of the rDNA genes are present in the form of 
extrachromosomal rings (Kim and Wang, 1989). Expression of either TOPI or T0P2 in 
this mutant promotes re-integration of the rings back into the rDNA locus.
A number of mechanisms have been proposed to explain the loss of genomic 
stability when topoisomerases are inactivated (reviewed in Wang et al., 1990; Duguet, 
1997). The first is that hypernegative supercoiling, by promoting the inadvertent pairing 
of DNA molecules, may itself stimulate recombination, particularly in heavily transcribed 
regions such as rDNA. This seems unlikely as the hyper-recombination phenotype is 
observed in top i or top2 single mutants in which hyper-negative supercoiling is not 
evident. A second explanation is that topoisomerases may be involved directly in 
recombination, perhaps by acting to resolve plectonemic recombinational junctions, a 
process that is similar mechanistically to the separation of interwound parental strands 
during replication.
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Illegitimate recombination can be affected both negatively and positively by 
topoisomerase activity. Thus, on the one hand E.coli topoisomerase I appears to be 
necessary for illegitimate recombination events involving the formation of deletions that 
occur following perturbations of DNA replication (Zu and Scheistl, 1996; Bieme et al., 
1997). On the other hand, inactivation of E.coli topoisomerase III results in an increase 
in the spontaneous rates of deletion formation (Schofield et al., 1992). Treatment of 
eukaryotic cells with topoisomerase inhibitors, which act to stabilise covalent 
intermediates between DNA and the topoisomerases, results in chromosomal 
rearrangements, deletions, sister chromatid exchanges, quadriradials and an increase in 
integration events (Anderson and Berger, 1994). At a molecular level, there is good 
evidence that some of these events arise secondarily to non-homologous recombination 
(Bae et al., 1988 and 1991; Bodley et al., 1993; Aratani et al., 1996). However, since 
topoisomerase-inhibiting drugs also induce DNA damage, interpreting their effects and 
extrapolating them to topoisomerase function is difficult.
1.5.4 The topoisomerase III family
An alignment of the key members of this family is shown in Figure 1.6. Most of the 
information concerning this family of topoisomerases is derived from the bacterial or 
yeast enzymes. Where tested, these enzymes possess similar biochemical activities in 
vitro, although few direct comparisons have been made (DiGate and Marians, 1988; 
Hiasa and Marians, 1994; Zhang et al., 1995 and 1996; Kim and Wang, 1995; Hanai et 
al., 1996). However, it seems likely that their in vivo functions will differ at least in some 
respects, since in higher eukaryotes these enzymes are essential, whereas in prokaryotes 
and in S.cerevisiae these enzymes are not necessary for viability. At the time of writing, 
two new members to this family have been identified. An S.pombe sequence with a high 
degree of homology to budding yeast and mammalian topoisomerase III enzymes has 
recently become available, although the phenotype of the corresponding null mutant has 
not been reported. In humans, a putative T0P3p , predicted to encode an 753 residue 
protein, has also recently been identified in the immunoglobulin X locus at 2 2 q. 11-12 
(Kawasaki et al., 1997). The region of homology to other members of the topoisomerase 
III family extends throughout the first -600 amino acids. Like human topoisomerase 
Ilia , the predicted protein has a C-terminal domain but it shares no significant motifs or 
homologies to other proteins.
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Figure 1.6: Schematic representation of the structures of members of the topoisomerase III 
family. The proteins shown are E.coli topoisomerase III and topoisomerase I (the latter shown 
for comparison), and topoisomerase III enzymes of S.cerevisiae, S.pombe and H.sapiens, as 
indicated on the left. The size of each protein is shown on the right. Regions corresponding to 
areas of homology, weak homology or no homology are as indicated in the key below the 
diagram. Three black vertical bars in E .co li  topoisomerase I indicate the positions of 
tetracysteine motifs that may be involved in DNA binding. Alanine substitution at the highly 
conserved residues E (glutamine-9) and R (argininine-321), both of which are in close proximity 
to the active site tyrosine (Y-319), results in the loss of DNA relaxation activity of E.coli 
topoisomerase I.
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A comparison of the various properties of the topoisomerase III family is shown below. 
Table 1.5 A comparison of bacterial, yeast and human topoisomerase III enzymes
E, coli S.cerevisiae H . sapiens *
size 653 aa 656 aa 976 aa
DNA
binding
ssDNA ssDNA NTt
relaxation of 
supercoils
relaxes negative 
supercoils
relaxes negative
supercoils
(weak)
relaxes negative
supercoils
(weak)
decatenation yes NT NT
replication supports nascent 
chain elongation
NT NT
effect o f gene 
deletion
on genom e stability
deletional
mutations
instability of 
repetitive sequences
not known
* human topoisomerase I lia  
t NT - not tested
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1.5.5 E.coli topoisomerase III
E. coli topoisomerase III, although structurally similar to E.coli topoisomerase I, is 
biochemically and functionally distinct. It was originally purified as a superhelical DNA 
relaxation activity from cells containing a deletion of the gene {topA) encoding 
topoisomerase I (Srivenugopal et al., 1984). However, unlike topoisomerase I, 
topoisomerase III mediated relaxation of negatively supercoiled DNA is only detectable 
under extreme conditions such as high temperature, low salt and low Mg^ "^  (DiGate and 
Marians, 1988). In contrast, decatenation of paired plasmids or late stage replication 
intermediates is proficient under standard conditions (Hiasa and Marians, 1994; Hiasa et 
al., 1994). E. coli topoisomerase III is also able to support in vitro nascent DNA chain 
elongation, whereas topoisomerase I is inhibitory in this regard (Hiasa and Marians, 
1994). The finding that topoisomerase III can support chain elongation is of some 
interest, since it was originally thought to be dependent upon the ability of an enzyme to 
act as a ‘swivelase’, removing positive supercoils as they build up ahead of a replication 
fork. Two hypotheses have been put forward to explain this apparent paradox (Hiasa 
and Marians, 1994; Wang, 1996). One potential explanation is that topoisomerase III 
could catalyse the passage of one parental strand through another by acting on a single 
stranded region near the replication fork, thus reducing the degree of positive 
supercoiling. An alternative hypothesis is that positive supercoils can equilibrate across 
the DNA template, taking the form of catenanes behind the fork and positive coils ahead 
of the fork. Topoisomerase III could act on catenanes behind the replication fork and 
ensure its progression. Since topoisomerase III is partially redundant with gyrase and 
topoisomerase IV with respect to its ability to support in vitro replication (Hiasa and 
Marians, 1994), it is probable that this does not represent the major function of this 
enzyme. Consistent with this, the only cellular phenotype associated with loss of 
topoisomerase III activity is an excessive rate of spontaneous deletion formation between 
regions involving short homologies (Schofield et al., 1992) and it is not clear how this 
relates to any of the reported biochemical properties of this enzyme.
Although not necessary for viability, the recent finding that a large number of 
conjugative plasmids isolated from Gram positive and negative bacteria encode 
polypeptides with extensive sequence similarity to topoisomerase III (Li et al., 1997) is 
indicative of the biological importance of this topoisomerase subfamily. One of these, 
TraE protein derived from the plasmid RP4, exhibits biochemical activity identical to that
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of topoisomerase III. Based upon the observations described above, one possibility is 
that this group of plasmid-derived topoisomerase Ill-like proteins act to resolve plasmid 
DNA replication intermediates either during vegetative replication or in conjugative 
DNA transfer.
In view of the extensive sequence similarity between the type lA topoisomerases it is 
thought likely that they share common mechanisms of action at a biochemical level. At 
the time of writing, the crystal structure of none of the topoisomerase III enzymes has 
been determined. However, a 67 kDa fragment of E.coli topoisomerase I (comprising the 
N-terminal 596 residues) has been crystallised and its structure solved (Lima et al., 1994). 
The polypeptide folds into four distinct domains: domains I and IV form the ‘base’ of the 
fragment and domains III and II the ‘lid’; a pair of long strands connect the ‘lid’ to the 
‘base’, and the four domains and the connecting strands enclose a hole with an average 
diameter of 30 Â. The active site nucleophile Tyr-319 is located in domain III, at the 
junction between this domain and domains I an IV. This strategic location suggests that 
the DNA strand containing the phosphotyrosyl bond is bound to the enzyme across 
domain III and the base comprising I and IV. In order to provide room for the binding of 
a DNA strand, the lid (domains III and II) and the base (I and IV) must move away 
relative to each other from their positions, using the connecting strands as hinges. A 
diagrammatic representation of the proposed mode of action for type lA topoisomerases 
is presented in Figure 1.7. More recently, site-directed mutagenesis of residues 
conserved in all type IA topoisomerases has been reported (Chen and Wang, 1998). 
Alanine substitution at Glu-9 or Arg-321 (both of which are in close proximity to the 
active site tyrosine Y319) , both resulted in a loss of DNA relaxation activity in E.coli 
topoisomerase I.
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Figure 1.7: Model for type lA topoisomerase strand passage reaction (Lima et al., 1994).
Intermediate steps for a strand passage reaction resulting in the catenation/decatenation of double 
strand rings where one ring has a pre-existing single-stranded region. Type lA topoisomerases 
can cleave only ssDNA. In this reaction, the single stranded region is cleaved and the duplex 
portion of a different molecule is passed through the break. In the diagram shown, the 'passing' 
strand (P) can be either be internal or external (Pin or Pex) to the enzyme's central cavity, and is 
represented by the closed black circle. The single-stranded gated strand (G) can be either opened 
or closed (Gq or Gc) and is represented by the green tube. The enzyme (E) can also be either an 
open or closed state (Eq or Ec) and consists of a base (red rectangle) and a lid (blue arc). No 
directionality for this mechanism is known and all intermediates could proceed in either direction 
as indicated by the double arrows. A (Pex + EcGc). In this state neither the passing or gated 
strands are associated with the protein. The gated strand and the enzyme are in a closed state. B 
(Pex + EcGc). The gated strand interacts covalently with the enzyme (both in a closed state) and 
the passing strand is external to the enzyme. C (Pex +EqGo). The passing element is external to 
the protein and both the gated strand and the protein are open. Tyr-319 (yellow triangle) is shown 
covalently attached to the 5'-phosphoryl end of the gated strand. The 3 '-0H  end of the gated 
strand interacts non-covalently with the base of the enzyme. D (Pin + EgGg). The passing 
strand passes through the break in the gated strand and is now internal to the enzyme. E (Pin + 
EcGc). The passing strand is internal to the enzyme, but both the enzyme and the gated strand are 
closed. The gated strand interacts non-covalently with the base of the enzyme. F (Pin + EqGc). 
The passing strand can exit from the protein's central cavity as it is now in the open state. G 
(Pex + EqGc). The enzyme remains open and interacts non-covalently with the gated strand, 
whilst the passing strand exits the enzyme.
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1.5.6 S.cerevisiae topoisomerase III
The first eukaryotic type lA topoisomerase identified was budding yeast 
topoisomerase III (Wallis et al., 1989). S.cerevisiae top3 mutants show defective cell 
cycle progression such that cells appear to delay with a late S/G2 DNA morphology 
(Gangloff et al., 1994), which has been interpreted as evidence for a role in late 
replication as described below (Section 1.5.8). Diploids homozygous for top3 are unable 
to sporulate suggesting a role in meiosis, although at what stage during meiosis top3 cells 
are defective has not been defined. Like its prokaryotic counterpart, loss of yeast 
topoisomerase III activity results in a loss of genomic stability (Wallis et al., 1989; Bailis 
et al., 1992; Gangloff et al., 1994). Mutations in the T0P3 gene result in an increase in 
the frequency of i?AD52-dependent loss of a suppressor tRNA marker flanked by Ô 
sequences (short, repetitive sequences present in the yeast transposon Ty). The hyper­
recombination phenotype in top3 mutants is distinct from that observed in topl and 
toplts mutants, which affects stability only of the highly repetitive rDNA (Christman et 
al., 1989; Kim and Wang, 1989). In contrast, top3 mutants show increased 
recombination affecting all repetitive sequences studied, including 5 sequences, rDNA 
and unlinked homologous SAM  genes. In wild type cells, recombination at these loci 
occurs at a low frequency. It appears, however that in top3 mutants, not only is the 
overall frequency altered but that the mechanism of recombination is distinct. Thus, 
recombination in top3 mutants between the unlinked homologous SAMI and SAM2 genes 
was partially dependent upon the nucleotide excision repair gene, RADI. Since Rad Ip 
possesses exonuclease activity, it was proposed by the authors of this study, that this 
protein processes DNA lesions generated in the absence of topoisomerase III and 
facilitates their repair by RAD52-dependent recombination.
Biochemically, the yeast topoisomerase III enzyme resembles E.coli topoisomerase 
III, in that it partially relaxes negatively, but not positively supercoiled DNA , binds with 
strong preference to ssDNA and binds to sequences very similar to that of the E.coli 
enzyme (Kim and Wang, 1995). In vivo experiments, in which the other two yeast 
topoisomerases, I and II, are inactivated confirm that topoisomerase III has only weak 
activity in relation to the relaxation of negative supercoils (Wang, 1996). It appears 
unlikely therefore that a failure to modulate the degree of supercoiling in top3 mutants 
underlies their hyper-recombination phenotype.
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1.5.7 Mammalian topoisomerase III enzymes
Human TOP3a, encoding a 976 residue protein, is a single copy gene located on 
chromosome 17pl 1.2-12 (Hanai et al., 1996). This protein shows 44% identity and 61% 
similarity with yeast topoisomerase III over the first -  600 amino acids. However, in 
addition, the human enzyme has a C-terminal segment of over 300 amino acids with no 
counterpart in the yeast enzyme and which contains no significant motifs, but possesses 
weak homology with the C-terminal domain of E.coli topoisomerase I. At a biochemical 
level, human topoisomerase I lia  can partially relax highly negatively supercoiled DNA, 
although information regarding sequence recognition or the ability to support in vitro 
replication are as yet not available. TOP3a  mRNA is constitutively expressed in 
multiple normal tissues (Fritz et al., 1997).
Little is known, as yet, about the biological functions of mammalian topoisomerase 
I lia  in vivo. A murine T0P3a  has been identified which is highly expressed at the 
mRNA level in the testis (Seki et al., 1998). Targeted disruption of murine T0P3a  has 
recently been reported (Li and Wang, 1998). Heterozygous top3a'^/' mutant mice 
resembled phenotypically top3a'^/'^ litter mates. No viable top3a-/~ progeny were 
obtained. Examination of embryos or blastocysts cultured in vitro, indicated that 
implantation of top3'/~ embryos and the induction of decidualisation in the uterus could 
occur, but that viability was compromised at an early stage of development. This 
suggests that mammalian topoisomerase III performs an essential role, perhaps through a 
role in cell proliferation or genomic maintenance.
Indirect evidence regarding the functions of human topoisomerase III are derived 
from studies designed to identify genes able to complement the cellular AT phenotype. 
Expression of a truncated (amino acids 141-976) topoisomerase I lia  was able to partially 
correct the radiosensitivity, hyper-recombination and radio-resistant DNA synthesis 
phenotypes of an AT cell line (Meyn et al., 1993; Fritz et al., 1997). The effect was 
apparently related to a dominant negative phenomenon, since this effect was reproduced 
by an antisense construct, but not by expression of the full length gene. The 
interpretation of this finding is fraught with difficulty since there are a large number of 
unrelated genes which are able to complement the AT phenotype. Furthermore, it is 
difficult to distinguish between dominant negative effects that relate to the true functions 
of an overexpressed gene and artefactual effects of overexpression. Another potential 
clue to the role of topoisomerase III is that the T0P3a  gene is consistently deleted in
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individuals with Smith-Magenis syndrome (SMS) in which multiple congenital 
abnormalities/mental retardation are associated with an interstitial 4Mb deletion of 
chromosome 17pl 1.2 (Elsea et al., 1998). However, since the deletion is extremely 
large and likely to involve many other genes, and since the other TOPSa gene still 
remains intact, it seems extremely unlikely that partial loss of topoisomerase III activity 
has any role in the pathogenesis of this disorder.
1.5.8 Models to explain the interaction between Sgslp and topoisomerase III
A number of hypotheses have been put forward to explain the functional basis for the 
interaction between Sgslp and topoisomerase III. As discussed above, budding yeast 
topoisomerase III is a type lA topoisomerase, as are the hyperthermophilic 'reverse 
gyrases'. Many workers in the topoisomerase field have been attracted by the potential 
mechanistic similarity of an Sgsl/Top3 complex to the reverse gyrase enzyme found in 
hyperthermophilic archaebacteria. Reverse gyrase is composed of both a helicase-like 
domain and a type lA topoisomerase domain either in the same polypeptide or in the 
form of a heterodimeric complex (Confalonieri et al., 1993; Duguet, 1997). Movement 
of the helicase domain through the DNA duplex produces 2 waves of supercoiling, 
positive in front of and negative behind the translocating complex. Selective relaxation 
of the negatively supercoiled regions by topoisomerase III would, as a consequence, 
generate net positive supercoiling. In thermophiles, such an effect might act to prevent 
dénaturation of DNA during growth at elevated temperatures. However, attempts to 
generate positive supercoiling activity in vitro using a recombinant Sgslp fragment in the 
presence of topoisomerase III have so far proven unsuccessful (Bennet et al., 1998).
There are many alternative suggestions for the functional role of an association 
between a RecQ helicase and a topoisomerase. For example, a direct role for a helicase 
in conjunction with a topoisomerase in recombination has been suggested previously by 
others (Wang et al., 1990: Wang, 1996). Thus, depending upon the site of its activity, the 
helicase/topoisomerase complex could act either to disrupt inadvertently paired DNA 
strands, or to promote branch migration. Moreover, such a complex could act either as a 
'reformatase' to eliminate abnormal DNA structures, such as triple helices, or act to 
rapidly reform a plectonemically-wound double helix during branch migration of 
recombination junctions.
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An alternative and appealing possibility is that the RecQ helicase/topoisomerase 
complex acts to facilitate catalysis of the late stages of replication, as has been proposed 
previously (Gangloff et al., 1994; Watt et al., 1995). As two replication forks converge, a 
build up of positive supercoils and/or steric hindrance between the advancing replisomes 
could inhibit the final stages of DNA replication. Moreover, the priming of new lagging 
strand synthesis might not be possible under these circumstances. It has been proposed 
that Sgslp might unwind the unreplicated region between the advancing forks. This 
would have the effect of introducing intertwinings between the daughter DNA molecules, 
which would have to be resolved by the decatenation activity of a topoisomerase prior to 
anaphase. If replication of the partially single-stranded DNA molecules were completed 
prior to decatenation, then topoisomerase II (which uniquely can introduce double-strand 
breaks into DNA) would be the only enzyme capable of unlinking the resulting duplex 
catenanes (Watt et al., 1995). Alternatively, topoisomerase III, which is able efficiently 
to decatenate DNA molecules that contain single-stranded regions, could act on the DNA 
prior to the ‘filling-in’ of the small single-stranded gaps left at the sites of the converging 
forks (Gangloff et al., 1994). This might explain why Sgslp interacts with both 
topoisomerases II and III. Failure to resolve abnormal DNA structures that arise at the 
terminal stages of DNA replication could lead to DNA breaks and hence to aberrant 
recombination, as is observed in mutants deficient in either RecQ helicases or 
topoisomerases.
1.6 Conclusions
One form of genome instability particularly associated with cancer is chromosomal 
rearrangement. Rearrangement of DNA that results in amplification, deletion or altered 
expression of oncogenes or tumour suppressor genes occurs at a greatly increased rate in 
cancer cells, and may accelerate disease progression. Accordingly, defects in 
recombinational repair are likely to contribute to both tumour formation and progression. 
A better understanding of how this repair process contributes to the maintenance of 
genome stability in normal cells will hopefully lead ultimately to better treatments for 
cancers in which this process is defective.
In prokaryotes, the RecF pathway appears to have a key role in the recombinational 
repair of stalled replication forks. The only evidence that a similar pathway might exist
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in eukaryotes is the finding of homologues to RecQ helicase, an E.coli protein, which is 
aligned to the bacterial RecF pathway. The more recent finding that defects in RecQ 
family helicases in humans result in a predisposition to cancer underlines their biological 
significance. The interactions between the RecQ family helicases and the topoisomerases 
may provide important clues to how these proteins, acting in concert, influence genome 
stability.
In the following chapters, an attempt will be made to address to what degree the 
human BLM protein and the lower eukaryotic Sgslp share not only structural similarity, 
but also functional similarity. A primary aim of this initial work was to assess the 
validity or otherwise for using yeast as a model system for BS. The results of these 
experiments led directly to a study of the role of topoisomerase III in S.cerevisiae, in 
relation to the effect of this enzyme upon the cell cycle and the cellular response to DNA 
damage. In the final part of this thesis a model will be presented which uses information 
derived from this work, to explain the cellular roles of topoisomerase III and Sgslp.
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Chapter 2
Materials and Methods
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2.1 Chemicals
Unless otherwise stated, all chemicals used in this work were purchased from the 
Sigma Chemical Company. Bacterial and yeast media were supplied by ICRF Central 
Services, Clare Hall. Radioisotopes were provided by Amersham UK, Ltd.
2.2 Enzymes
Unless otherwise stated, all enzymes in this work were purchased from Boehringer 
Mannheim. Zymolyase-20T was obtained from AMS Biotechnology (Europe) Ltd. and 
Glusulase was purchased from DuPont.
2.3 Preparation and manipulation of DNA
2.3.1 Preparation of plasmid DNA
Plasmid DNA was prepared from E.coli saturated cultures using the alkaline lysis 
method as described by Sambrook et al. (1989). Alternatively, both small and large scale 
preparations of plasmid DNA were obtained using Promega 'Wizard' mini- or maxi-prep 
kits (which employ a silica-based resin to bind DNA) according to the manufacturer's 
instructions.
DNA to be sequenced was prepared by a modified alkaline lysis/PEG precipitation 
procedure. A single bacterial colony was inoculated into 4.5ml Terrific Broth [1.2% 
(w/v) bacto-tryptone, 2.4% (w/v) bacto-yeast extract, 0.4% (v/v) glycerol, 17mM 
KH2PO4 , 72mM K2HPO4] and grown with aeration at 37°C to saturation. Cells were 
then pelleted and resuspended in 200)11 of GTE buffer (50mM glucose, 25mM Tris-HCl, 
pH8.0, 10 mM EDTA, pH8.0). Lysis was achieved by the addition of 300|il of freshly 
prepared 0.2M NaOH/1% (w/v)SDS and then the contents mixed gently until the solution 
cleared. After incubation on ice for 5 minutes, the solution was neutralised by the 
addition of 300|il 3M potassium acetate, pH4.8, followed by mixing and a further 
incubation on ice. Cellular debris was removed by centrifugation in an Eppendorf 5415 
C bench top micro-centrifuge at 14,000rpm for 5 minutes and the supernatant transferred 
to a clean tube. RNase (DNase-free) was the added to a final concentration of 20|ig/ml 
and the solution incubated at 37°C for 20 minutes. Chloroform extraction was then 
performed twice (each time by adding an equivalent volume of chloroform), before
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precipitation of the DNA by adding an equal volume of isopropanol. Precipitated DNA 
was pelleted by centrifugation at 14,000rpm for 10 minutes and was then washed once 
with 500p.l of 70% ethanol. The pellet was then dissolved in 32pl of ddH20 and the 
DNA re-precipitated by the addition first of 8pi 4M NaCl, and then adding 40pl of 
autoclaved PEG solution [13% (w/v) PEG 8000]. The sample was then mixed and 
incubated on ice for 20 minutes, before pelleting the DNA by spinning at 14,000rpm at 
4°C. The supernatant was removed and the pellet washed with 500pl of 70% ethanol. 
The pellet was then resuspended in 20pl ddH20 and stored at -20°C.
DNA prepared for transfection was purified by ultracentrifugation on caesium 
chloride gradients. DNA generated by the alkaline lysis method (derived from 200- 
400ml volumes of saturated bacterial culture) was resuspended in 4.1ml TE containing 
40pg/ml ethidium bromide and 4.8g caesium chloride. Samples were then pre-cleared by 
the centrifugation at 2000rpm in a Beckman GPR centrifuge for 10 minutes. The 
supernatant was then loaded into Beckman ultracentrifugation tubes and ultracentrifuged 
at 80,000rpm for 3 hours at 20°C using a Vti80 rotor in a Beckman L8-M centrifuge. 
Using a 20G needle, the plasmid band was aspirated. All the above steps were then 
repeated to allow a second centrifugation under the same conditions. Following this, 
ethidium was extracted repeatedly with an equal volume of iso-amyl alcohol and the 
solution then diluted in 3 volumes of TE (lOmM Tris-HCl, pH8.0, ImM EDTA). 3 
volumes of ethanol were then added and the sample was left at -8Q0C for 15 minutes to 
precipitate the DNA. Samples were then centrifuged at 10,000rpm and the precipitated 
DNA washed once in 70% ethanol, before resuspending in lOOp.1 TE.
In all cases, DNA quality was assessed by measuring the OD26O and by running the 
products of the appropriate restriction digest on a 0.8-1.2% agarose gel.
2.3.2 Preparation of yeast genomic DNA
A single yeast colony was inoculated into 5-10 ml liquid YPD (see section 2.10) and 
grown to saturation. The cells were harvested by centrifugation at 3000rpm in a 
Beckman GPR centrifuge, room temperature for 5 minutes and then resuspended in 0.5ml 
solution A [1.2M sorbitol, 200mM Tris-HCl, pH7.5, 20mM EDTA, 0.1% (v/v) 2- 
mercaptoethanol and lOOpg/ml zymolyase 20-T] and cells allowed to spheroplast at 37°C 
for 20 minutes. Spheroplasts were pelleted by spinning for 2 minutes at 14,000rpm 
using a bench top microcentrifuge.
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In order to lyse the cells and remove RNA and protein, the cell pellet was gently 
resuspended in 50|l l 1 IM sorbitol and then 0.5 ml solution B [50mM Tris-HCl, pH7.5, 
lOOmM NaCl, lOOmM EDTA, 0.5% (w/v) SDS, 0.4mg/ml Proteinase K, 0.1 mg/ml 
RNase]. Following incubation at 65°C overnight, the preparation was gently extracted 
twice with phenol/chloroform [1:1 (v/v), pH 8.0] and the DNA precipitated by adding 
1ml ethanol. After gentle inversion, the DNA was pelleted by centrifugation at 
14,000rpm in a bench top microcentrifuge for 10 minutes. The DNA was washed with 
1ml 70% ethanol, dried and then resuspended in 200pl TE buffer.
2.3.3 Preparation of intact yeast chromosomal DNA
Intact yeast chromosomal DNA samples were prepared from log phase or arrested 
cells, as described previously (Louis and Haber, 1990). Briefly, 1 x 10  ^ cells derived 
from log phase or arrested cultures were pelleted and then washed in 1ml cold 50mM 
EDTA. Following centrifugation at 14,000rpm in a bench top microcentrifuge the pellet 
was resuspended in 200pl of 50mM EDTA and left on ice. For each sample, lOOpl 
SCE/zymolyase solution [IM sorbitol, O.IM sodium citrate, 0.05M EDTA, 5% (v/v) 2- 
mercaptoethanol and 3mg/ml zymolyase-20T] and 0.5 ml low melting point agarose 
solution [1% (w/v) low melting point agarose, 0.45M EDTA, O.IM Tris-HCl, pH8.0] 
were added simultaneously. The cells were gently mixed and then placed into an agarose 
plug mould. After setting, the plugs were put into clean 1.5ml eppendorf tubes and 
overlaid with 0.5ml of 0.45M EDTA, O.IM Tris-HCl, pH8.0, 5% (v/v) 2- 
mercaptoethanol. After incubation at 37°C for at least 4 hours, the above solution was 
removed and the plugs overlaid with 0.5ml of 1% (v/v) sarkosyl, 1 mg/ml proteinase K, 
0.1 mg/ml RNase, 0.4M EDTA and incubated at 37 ®C overnight. The plugs were then 
washed with cold 0.5M EDTA and then stored under 0.45M EDTA, O.IM Tris-HCl, 
pH8.0 at 4°C.
2.3.4 Polymerase chain reaction (PCR)
All polymerase chain reactions involving the generation of products used for 
subsequent cloning employed ExpancF^ High Fidelity PCR System (Boehringer 
Mannheim) according to the manufacturers instructions. This system is composed of 
thermostable Taq and Pwo polymerases. The latter enzyme possesses 3'-5' exonuclease 
activity which is reported to result in a higher fidelity of DNA synthesis than Taq alone
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(Barnes, 1994). In a standard reaction, 50-100 ng of template DNA and 20pmoles of 
each primer were used for a 50pl reaction. For each reaction, the optimal MgCl] 
concentration, annealing temperature, extension times and number of cycles was 
determined. Negative controls for PCR were reactions without template DNA. In all 
cases where DNA for cloning was being generated, the minimum number of cycles that 
generated a product visible on agarose gel electrophoresis was used. In order to generate 
a BLM  product, pooled PCR products derived from 5-10 individual reactions were used 
in order to reduce the number of cycles required. All oligonucleotides were generated by 
the ICRF Oligonucleotide Synthesis Service, Clare Hall and supplied deprotected and 
dried down. The side products of synthesis were removed by ethanol precipitation.
To generate a full length SGSl cDNA the 5' prim er 66436 (5'- 
GAGGAGGATCCAGGAHATGGTGACGAAGCCGTCACA-3’) and 3' primer 66435 
(5 -ATAAGAATGCGGCCGCTTACATCACTTTCTTCCTCTGTAGTG-3 ) were used. 
The 5' primer included a BamHl site (bold) and a yeast Kozak consensus (underlined) 
and the 3' primer included a Notl site (bold). Template DNA was cosmid 9646 (kindly 
donated by Dr. Ed Louis, Institute of Molecular Medicine, Oxford). Conditions for PCR 
were as follows; 1st step, 93°C (2minutes) for 1 cycle; 2nd step, 55°C (1 minute), 6 8°C 
(7 minutes) and 93°C (30 seconds) repeated for 5 cycles; and final step, 55°C (1 minute) 
followed by 6 8 °C (15 minutes) for 1 cycle.
A full length BLM cDNA was generated in 2 sections, a 5' 1.4 kb (Z) and a 3' 2.9kb 
(X/Y) with an overlapping unique EcoRl site. PCR(Z) was generated using the 5' primer 
FI (5 -AGAGGACTCGAGAGGATTATGGCTGCTGTTCCTCA-3 ) and 3’ primer R2 
(5 -TCCTAGGGTGGTAGTCAGTAAACA-3 ). The 5' primer included a X ho l site 
(bold) and a yeast Kozak consensus (underlined). Template DNA was a human B-cell 
cDNA library (kindly donated by Dr. D. Simmons, Institute of Molecular Medicine, 
Oxford). Conditions for PCR(Z) were as follows: 1st step, 93°C (2 minutes) for 1 cycle; 
2nd step, 55®C (1 minute), 6 8 °C (3 minutes) and 93°C (30 seconds) repeated for 32 
cycles; and final step, 55°C (1 minute) followed by 68°C (10 minutes) for 1 cycle.
PCR (X/Y) was generated using the 5' primer F3 (5'-ATA CAG GCC TGA TTC 
ACT -3') and the 3' primer R1 (5 -CTC GAG CAT TGA GAT TCG GTT GTT ATG 
AGA ATG-3'), and using the same template DNA. Conditions for PCR (X/Y) were as 
follows: 1st step, 93°C (2 minutes) for 1 cycle; 2nd step, 55°C (1 minute), 6 8 °C (5
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minutes) and 93°C (30 seconds) repeated for 18 cycles; and final step, 55°C (1 minute) 
followed by 6 8 ®C (15 minutes) for 1 cycle.
To generate a full length T O P  3 cDNA the 5' prim er 84735 (5'- 
GAGGAGGATCCACAATAATGAAAGTGCTATGTGTCGC-3') and the 3' primer 
84734(5'-ATAAGAATGCGGCCGCTTACATGGATGCCTTGACAC-3') were used. 
The 5' primer incorporated a BamHl site (bold) and the 3' primer incorporated a Notl site 
(bold). Template DNA was pRK500 (kindly donated by J.Wang) and the polymerase 
used was Taq. Conditions for PCR were as follows: 1st step, 94°C (2 minutes) for 1 
cycle; 2nd step, 55°C (1 minute), 72°C (5 minutes) and 94°C (30 seconds) repeated for 7 
cycles; and final step, 55°C (1 minute) followed by 72°C (5 minutes) for 1 cycle.
2.3.5 Restriction digest
DNA was digested with the appropriate restriction enzyme according to the 
manufacturers instructions assuming that 1 p.g of DNA is digested by 1 unit of enzyme at 
37°C (or other temperature depending on the enzyme utilised). DNA fragments 
generated by PCR were usually digested overnight, while other restriction digests were 
incubated for 1-4 hours.
2.3.6 Ligations
Standard ligation protocols were used in the generation of constructs detailed in 
Section 2.3.7 (Sambrook et al., 1989). Ligations were carried out using an insert: vector 
ratio of 10:1. DNA following treatment with restriction enzymes or PCR products were 
separated by agarose gel electrophoresis and/or purified using a GeneClean kit (BIO 101 
Inc.) according to the manufacturers instructions. Insert and vector DNA was then 
combined in a total volume of 10|Lil containing 20mM Tris-HCl, pH7.6, 5mM MgCl2, 
lOmM DTT, 50mg/ml BSA, ImM ATP (0.5mM for blunt end ligations) and 1 unit T4 
DNA ligase. Ligations were allowed to proceed for 1 hour at room temperature. 
Ligations of insert and the pCR-Script vector (Stratagene) were carried out according to 
the manufacturer's instructions. Controls, included in each ligation series, were: uncut 
vector, to confirm transformation efficiency; cut vector plus DNA ligase, to detect 
religation frequency; and cut vector alone, to confirm complete cutting and background 
religation. Ligation transformants were screened by colony PCR and subsequently by 
restriction digests of 'miniprep' DNA. For colony PCR, 5pi of saturated solution derived
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from individual ligation transformants was added to a 50pl PCR reaction. The conditions 
for PCR were as above except that the initial dénaturation of the 1st step was 94°C for 4 
minutes, and in the 2nd step, only 15 cycles were performed.
2.3.7 Plasmids
A list of plasmids used in this study for expression in yeast or mammalian cells is 
shown in Tables 2.1-2.3.
pJH626.T is a derivative of the pJH626 expression vector (Sikorski and Hieter, 
1989) in which the promoter for S. cerevisiae triose phosphate isomerase (a glycolytic 
enzyme with constitutive levels of expression) has been inserted between the EcoRl- 
Hindlll sites within the multiple cloning site region. This construct was generated by Dr. 
Charles Redwood (Institute of Molecular Medicine, Oxford).
A cDNA encoding the full length open reading frame of SG Sl was generated by 
PCR as described above and cloned into the pCR-Script SK(-k) vector (Stratagene). The 
cDNA was then inserted between the BamHl-Notl sites of pYES2 (to give pRKC2), 
pJH626.T (to give pRKC3) and pCDNA3 (to give pRKC4). The same cDNA was cloned 
between the Xhol-Notl sites of pREP3X to generate pRKC5.
Pooled 1.4 kb 5' (Z) and 2.9 kb 3' (X/Y) RLM cDNA PCR products were cloned into 
pCR-Script and plasmids derived from several of the resulting transformants sequenced. 
To generate pYES2, pJH626.T and pCDNA3 derivatives containing BLM , the strategy 
is set out in Section 3.1 was performed. This involved a 4-way ligation employing 
restriction digest products designed to exclude PCR-induced errors. The resulting 
constructs were pRKC15 (pYES2-REM), pRKC16 (pJH626.T-RLM) and pRK Cl? 
(pCDNA3-REM). To generate pRKC18 (pREP3X-RLM) a 3-way ligation was performed 
in which a X h o l-A vril 5' fragment of BLM (derived from a pCR-Script plasmid 
containing the 5' 1.4 kb BLM  per product) and an Avrll-Notl 3' fragment of BLM  
(derived from pRKC15) were inserted into the Xhol-Notl sites of pREP3X. A 
description of the modifications of pRKC15, to generate histidine-tagged BLM have been 
described previously (Karow et al., 1997). To confirm the BLM sequence, constructs 
were sequenced using ABI™  Dye Terminator Cycle Sequencing (Perkin Elmer 
Corporation).
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The full length TOPS cDNA was cloned into pTV.Blue (Invitrogen) to generate 
pRKC19. Construction of pRKC20, used for the one-step gene replacement of TOPS is 
described in Section 2.14.
Table 2.1 Mammalian expression vectors
name comment
pCDNA3 G418^, CMV promoter (Invitrogen)
pRKC4 pCDNA3, SGSl cloned between BamHl-Notl sites
pRKClV pCDNA3, BLM cloned between BamHl-Notl sites
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Table 2.2 S. cerevisiae expression vectors
name comment
pYES2 URA3, GALl promoter, multicopy (Invitrogen)
pJH626.T URA3, TPI promoter, single copy
pSE556 URA3, G ALI promoter, single copy (Navas et al., 
1996).
pJA98 pSE556 incorporating RAD53
pNKY2070 LEU2, PH05 promoter, multicopy (Kim and Wang, 
1992)
pRK500 pNKY2070 incorporating TOPS
pYCPlF16 TRPl, GALl promoter, multicopy 
(Foreman and Davis, 1994)
pRAD53HA pYCPlF6 incorporating HA-tagged RAD5S (de la 
Torre-Ruiz et al., 1998)
pRS426 URAS, multicopy (Sugimoto et al., 1997)
pDM198 pRS426 incorporating TELl
pRKC2 pYES2, SGSl cloned between BamHl-Notl sites
pRKC3 pJH626.T, SGSl cloned between BamHl-Notl sites
pRKC15 pYES2, BLM cloned between BamHl-Notl sites
pRKC16 pJH626.T, BLM cloned between BamHl-Notl sites
Table 2.3 S. pombe expression vectors
name comment
pREP3X LEU2, NMTl promoter
pRKC5 pREP3X, SGSl cloned between Xhol-Notl sites
pRKC18 pREP3X, BLM cloned between Xhol-Notl sites
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2.4 Preparation of RNA
The method employed the Qiagen 'RNeasy' kit which involves selective RNA 
binding (species > 200kb) to a silica gel. A number of modifications were made to the 
manufacturers instructions in order to increase the yield of RNA. 1 x 10  ^yeast cells were 
pelleted and frozen immediately on dry ice before storage at -80°C. Each pellet was 
allowed to thaw on ice, then resuspended in lOOjil lysis buffer RET and an equivalent 
volume of sterile, glass beads (diameter 0.2mm) added. The sample was then agitated in 
an homogeniser (Hybaid) for 45 seconds, before adding 500pl RLT buffer. All 
subsequent steps were performed at room temperature. To remove cellular debris, the 
sample was centrifuged at 14,000rpm for 2 minutes in an Eppendorf bench top 
microcentrifuge. The supernatant was then transferred to a new eppendorf containing 
500pl 70% ethanol and mixed. 500|il of this mixture was then added to an RNeasy spin 
column which was then spun for 15 seconds at 14,000rpm and the flow through 
discarded. This step was then repeated for the remaining mixture. 700pl of wash buffer 
RWl was then spun through the column as previously. Two washes with 500pl of buffer 
RPE were then performed. After the final wash, the column was spun again for 2 
minutes. The column was then placed in a new 1.5ml collection tube and 25pi RNase- 
free H2O added directly to the column membrane. The column was left at room 
temperature for 10 minutes, before spinning for 2 minutes at 14,000rpm. This step was 
then repeated. The final concentration was then determined by measuring the OD26O and 
samples were stored at -80°C. When working with RNA, precautions were taken to 
avoid RNase contamination. All solutions were made up with DEPC-treated H2O. 
Plastic disposable pipettes, freshly opened micropipette tips and eppendorfs were used. 
Electrophoresis apparatus and circulation pump tubing were all cleaned with 0.2% (v/v) 
Absolve (DuPont) before rinsing thoroughly in ddH2 0 . All working surfaces were 
cleaned with methanol.
2.5 Preparation of protein extracts
Total cellular yeast protein extracts were prepared using a TCA extraction technique 
(Fioani et al. 1994). Briefly, 1 x 10  ^ cells were pelleted and resuspended in 50pl 20% 
(v/v) trichloroacetic acid (TCA) and an equal volume of 0.2mm glass beads added. After
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vortexing for 3 minutes, the supernatant was then transferred to a new eppendorf. The 
remaining cell debris was resuspended in 5% (v/v) TCA and again the supernatant 
transferred. Precipitated protein was pelleted by spinning at 14,000rpm in a bench top 
centrifuge for 3 minutes. The supernatant was then removed and discarded and the 
protein pellet resuspended in lOOpl 1 x SDS loading buffer [60mM Tris-HCl, pH6 .8 , 1% 
(w/v) SDS, 5% (v/v) glycerol, 0.001% (w/v) bromophenol blue and 1% (v/v) 2- 
mercaptoethanol]. The pH of the protein sample was corrected by the addition of 2.5pl 
3M Tris-HCl, pH8.5 and then the samples boiled for 3 minutes. Protein concentrations 
were determined using the Bradford reaction (Sambrook et al., 1989), which was 
calibrated using a standard curve for human albumin.
Total protein from GM8505 Bloom's fibroblasts was prepared by collecting 1 x 10  ^
cells and resuspending the pellet in 200p.l 1 x SDS loading buffer. Samples were boiled 
for 5 minutes and the DNA sheared by passing the sample repeatedly through a 20G 
needle.
2.6 Electrophoretic techniques
2.6.1 Agarose gel electrophoresis
DNA samples were electrophoresed through 0.8-1.2% agarose gels in TAB buffer 
(40mM Tris-HCl, pH8.5, 2mM EDTA) to which 0.5pg/ml ethidium bromide was added 
and using a horizontal gel apparatus (Pharmacia). DNA samples containing 1/5 volume 
DNA sample buffer [30% (w/v) sucrose, lOOmM EDTA, 0.01% (w/v) bromophenol blue] 
were electrophoresed at 75mA until the dye had reached the desired distance. DNA was 
visualised by exposure to UV light from a high intensity, long range wavelength 
transmitter (Fotodyne). Photographs of gels were taken using an MP-4 Polaroid camera 
following the manufacturer's instructions. When DNA bands needed to be cut from gels, 
this was performed using a disposable scalpel under low intensity UV light.
RNA samples were electrophoresed through a 1.2% agarose gel in 20mM phosphate 
buffer (7mM Na2HP0 4 , 13 mM NaH2P0 4 , pH6 .6 ) using a horizontal gel apparatus 
(BioRad) with continuous buffer circulation. RNA samples made up to a total volume of 
5pl were mixed with 7.3pl glyoxylation buffer [10% (v/v) deionised glyoxal, 75% (v/v) 
deionised DMSG, 0.0IM phosphate buffer, pH 6 .6 ) and 4pl RNA loading buffer [50%
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(v/v) glycerol, 0.0IM phosphate buffer, pH 6 .6 , 0.4% (w/v) bromophenol blue]. Samples 
were then electrophoresed at 4V/cm for 4-6 hours.
2.6.2 Pulse field gel electrophoresis
Samples representing approximately 1 x 10  ^yeast cells were applied to a 1% agarose 
gel slab and chromosomes were separated using a Biorad contour-clamped homogenous 
electric field (CHEF) apparatus (CHEF-DRII). Separation was achieved in 24 hours at 
200V with initial and final switching times being 60 and 90 seconds, respectively. The 
running buffer used was 0.5 x TBE (44.5mM Tris, 44.5mM boric acid, ImM EDTA), 
which was maintained at a temperature of 11°C by rapid recirculation while running the 
gel at an ambient temperature of 4®C. The DNA was then transferred to nylon 
membranes and chromosome IV was detected with an HO gene probe, using standard 
protocols.
2.6.3 Polyacrylamide electrophoresis of proteins
This was performed according to standard protocols (Sambrook et al., 1989). 
Protein samples were heated at 95°C for 3 minutes in 1 X SDS loading buffer [60mM 
Tris-HCl, pH6 .8 , 1% (w/v) SDS, 5% (v/v) glycerol, 0.001% (w/v) bromophenol blue and 
1% (v/v) 2-mercaptoethanol]. SDS polyacrylamide gels were prepared using BioRad 
Mini-Protean vertical gel electrophoresis apparatus. The resolving gel (6.5-12% 
acrylamide, ratio to bis-acrylamide 37.5:1 to 150:1) was prepared in 375 mM Tris-HCl, 
pH8 .8 , 0.1% (w/v) SDS. The stacking gel (4% acrylamide, ratio to bisacrylamide 37.5:1) 
was made up in 125 mM Tris-HCl, pH6 .8 , 0.1% (w/v) SDS. Running buffer was 190mM 
glycine, 25mM Tris, 0.1% (w/v) SDS. Proteins were visualised by staining gels with 
0.1% (w/v) Coomassie blue, 50% (v/v) methanol, 7% (v/v) glacial acetic acid.
For analysis of Rad53, protein extracts were separated by SDS-PAGE using 6.5% 
acrylamide gels prepared using an 80:1 acrylamide:bisacrylamide ratio. For analysis of 
BLM protein, proteins were separated using a 10% gel with a 37.5:1 acrylamide:bis- 
acrylamide ratio.
2.7 Southern protocols
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Following the separation of DNA by electrophoresis, the agarose gel was exposed to 
UV light for 2-3 minutes, and immersed in denaturing solution (0.5M NaOH, 1.5M 
NaCl) for 30 minutes. The gel was then rinsed in ddH2 0  and immersed in neutralising 
solution (IM ammonium acetate, 0.02M NaOH) for 60 minutes. DNA was transferred 
overnight to Hybond N nylon membranes by capillary diffusion in 20 x SSC (3M NaCl, 
0.3M sodium citrate). The DNA was then cross-linked to the membrane using a UV 
Stratalinker 1800 (Stratagene).
Probes for Southern blotting were randomly labelled with a^^P dCTP using 'Ready- 
to-go' labelling beads (Pharmacia-Biotech), according to the manufacturers instructions. 
The HO cDNA was kindly provided by Dr. E. Louis, Institute of Molecular Medicine, 
Oxford.
Hybridisation was performed using a formamide-based buffer (Sambrook et al.,
1989). Blots were pre-hybridised in a Hybaid oven at 42°C for 6 hours in pre­
hybridisation buffer [50% deionised formamide, 10% (w/v) dextran sulphate, 0.2% (w/v) 
BSA, 0.2% (w/v) polyvinyl-pyrrolidine(MW 40,000), 0.2% (w/v) Ficoll (MW 400,000), 
0.1% (w/v) sodium pyrophosphate, 1% (w/v) SDS, 50mM Tris-HCl, pH7.5 and 
lOOpg/ml denatured salmon sperm DNA). Heat denatured probe was then added and the 
hybridisation allowed to continue overnight. Non-hybridised probe was removed by 
washing the membrane 3 times in low stringency buffer [2x SSC, 0.1% (w/v) SDS] at 
room temperature, followed by 2 washes in high stringency buffer [0.1 x SSC, 0.1% 
(w/v) SDS] at 65°C. X-ray films (BioMax, Kodak) were exposed to cling film-wrapped 
membranes for signal detection.
2.8 Northern protocols
Following the separation of RNA by electrophoresis, transfer of RNA to Hybond N 
nylon membranes was achieved by capillary diffusion overnight in 40 mM phosphate 
buffer (14mM Na2H P0 4 , 26mM NaH2P0 4 , pH6 .6 ). RNA was cross-linked to the 
membrane using a UV Stratalinker 1800 (Stratagene).
RNRl, RAD51, RAD16 and ACTl DNA probes were kindly donated by Dr. Noel 
Lowndes, ICRF. A 1.9kb TOPS DNA probe was generated using the strategy outlined in 
section 2.3.4. Random labelling of probes was performed as above. Hybridisation was
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performed as in section 2.7. Northern blots were quantitated (Phosphoimager; Molecular 
Dynamics Ltd.) and the values were normalised to an ACTl loading control.
2.9 Western protocols
Western transfer was performed according to the method of Towbin et al. (1979). 
Proteins were transferred to Hybond C super nitrocellulose membrane (Amersham) by 
electroblotting using a Trans-blot cell (BioRad). Transfer was performed at 60V for 2 
hours at 4°C in transfer buffer [48mM Tris, 39mM glycine, 20% (v/v) methanol, 0.037% 
(w/v) SDS].
A rabbit polyclonal serum to Rad53p (NL016; de la Torre-Ruiz et al., 1998) was 
used at a final dilution of 1:10,000 in 1% fat free milk in PBS containing 0.02% Tween- 
20, with a primary incubation period of 12 hours. For BLM detection, a-BLM (a rabbit 
polyclonal raised against the N-terminal domain of BLM, kindly donated by Prof. S. 
Jackson, Cambridge University) was used at a concentration of 1:1000. Horseradish 
peroxidase-linked secondary antibody (Sigma) was used at 1:10,000 with a 60 minute 
incubation period.
Chemiluminescent detection, which relies upon the oxidation of luminol by 
Horseradish Peroxidase was performed using an ECL kit (Amersham), according to the 
manufacturer's instructions.
2.10 Media for yeast studies
S.cerevisiae strains were grown at 30°C on YPD or the appropriate synthetic 
complete (SC), or dropout (SD), in the latter case omitting one or more nutritional 
supplements. YPD is 1% yeast extract, 2% bacto-peptone, 2% dextrose, 2.5% bacto-agar 
and 0.005% adenine hemisulphate (all w/v) and was supplied by the ICRF, Clare Hall. 
SC/SD media is (w/v) 0.67% yeast nitrogen base (without amino acids), 0.5% ammonium 
sulphate, 2 % glucose, 2 % bacto-agar plus the appropriate amount of complete or drop 
out mixture (BIO 101). Liquid YPD or SD media was prepared as above but without 
agar. In experiments designed to identify the effect of regulated expression of genes 
cloned downstream of the GALl promoter, the carbon source was substituted as 
appropriate. 5-FIuoro-orotic acid (FOA) media is (w/v) 0.67% yeast nitrogen base, 2%
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glucose, 2% bacto-agar, 0.1% FOA (added after autoclaving when media had cooled to 
50°C), the appropriate quantity of uracil drop out media and 50mg/l uracil. Hydroxyurea 
or methyl methane sulphonate containing media were made up as above except with the 
addition of drug (just prior to pouring in the case of solid media).
S.pombe minimal EMM minimal media (Moreno et al., 1991) was supplied by the 
ICRF, Clare Hall. The appropriate nutrients were added according to the genotype of the 
strain being grown. Phloxin B was added at a final concentration of lOpg/ml in viability 
experiments.
2.11 Human cell culture
Human SV40-transformed fibroblast MRC V, human cervical carcinoma HeLa S3 
and SV40-transformed BS-derived GM8505 cells were grown as monolayers in E4 
media, supplemented with 15% fetal bovine serum, 3mM glutamine and antibiotics 
(penicillin 100 units/ml, streptomycin 100 mg/ml and nystatin 50 units/ml). Cells were 
grown in Petri dishes at 37°C in a humidified atmosphere containing 5% CO2 . For 
passaging, cell monolayers were detached using 0.02% (w/v) EDTA in PBS A. All cells 
were tested for mycoplasma contamination and found to be negative.
2.12 E .coli bacterial strains
The following strain was used for transformations and for both small and large scale 
preparations of plasmid DNA:
DHlOp: F-, endAl, hsdR ll (r^", m^+), supEA4, thi-\, X-, recAl, gyrA96, relAl, A{arg¥- 
/flcZYA)U169, (l)80d/flcZAM15
2.13 Yeast strains
2.13.1 S.cerevisiae strains
All experiments were performed in the YPl strain background except where stated. The 
following strains were used:
YPl background:
RKCla, MATa leu2A his4-R ura3-52 lys2 ade2-101 top3::LEU2
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JMK22d, MATa leulA his4-R ura3-52 lys2 ade2-101 sgsl::LYS2 
RKClc, MATa leu2A his4-R ura3-52 lys2 ade2-101 sgsl::LYS2 top3::LEU2 
RKC Id, MATa leu2A his4-R ura3-52 lys2 ade2-101 
JMK90, MATa leu2A his4-R ura3-52 lys2 ade2-101 ku70:: G418^
JMK25 6B, MATa leu2A his4-R ura3-52 lys2 ade2-J01 rad51::LEU2 
M83, MATa leu2A his4-R ura3-52 lys2 ade2-101 rad52::LEU2 
M89, MATa leu2A his4-R ura3-52 lys2 ade2-101 rad54::LEU2 
JMK91, MATa leu2A his4-R um3-52 lys2 ade2-101 rad59:: G418^
6048b, M ATa leu2A HIS4 trpl-H ura3-52 lys2 ade2-101 srs2::LEU2 
Y 55 background:
RKC40, MATa his4-C Ieu2-R metl3-4 cyh2’^ lys2-d ura3-l adel-1 trpl-H  TRP5 CANl 
sgsl::LEU2
RKC41, MATa HIS4 Ieu2-R metl3-2 cyh2^ lys2-d ura3-l adel-1 TRPl trp5-l canE
sgsl::LEU2
A364a background:
RKC 31a, MATa ura3 his3 trpl leu2
RKC 31b, MATa ura3 his3 trpl leu2 top3::G418^
RKC 36d, MATa ura3 his3 trpl leul top3::G418^ rad9::HIS3
DLY 195, MATa ura3 his3 trpl leu2 rad9::HlS3 (Lydall and Weineit 1995)
RKC36e, MATa ura3 his3 trpl leu2 rad24::URA3 
RKC36f, MATa ura3 his3 trpl leu2 rad24::URA3 top3::G418^
RKC36g, MATa ura3 his3 trpl leu2 rad9::HlS3 rad24::URA3 top3::G418^
RKC37e, MATa ura3 his3 trpl leu2 radl7::URA3 
RKC37f, MATa ura3 his3 trpl leu2 radl7::URA3 top3::G418^
RKC37g, MATa ura3 his3 trpl leu2 radl7::URA3 rad9::HIS3 top3::G418^
RKC 12d, MATa ura3 his3 trpl leu2 sgsl::URA3
DLY264, MATa ura3 his3 trpl leu2 mec2-l::URA3 ( Paulovich and Hartwell, 1995) 
DLY 285, MATa ura3 his3 trpl leu2 mecl-1:: H1S3 (Paulovich and Hartwell, 1995) 
CG378 background:
RKC32/33a, MATa ade5 canl leu2-3,112 trp l-289 ura3-52 
RKC34/35c, MATa ade5 canl leu2-3,112 trpl-289 ura3-52 top3::G418^
CG378-R1, MATa ade5 canl leu2-3,112 trpl-289 ura3-52 rfa2-l (Santocanale et al., 
1995)
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CG378-R2, MATa adeS canl leu2-3,112 trpl-289 ura3-52 rfa2-2 (Santocanale et al., 
1995)
CY379, MATa adeS canl leu2-3,112 trpl-289 ura3-52 pri-M4 (Marini et al., 1997) 
RKC34d, MATa adeS canl leu2-3,112 trpl-289 ura3-52 rfa2-l top3::G418^
RKC35d, MATa ade5 canl leu2-3,112 trpl-289 ura3-52 rfa2-2 top3::G418^
RKC39d, MATa adeS canl leu2-3,112 trpl-289 ura3-52 pri-M4 top3::G418^
2.13.2 S.pombe strains
910a, leu l-32 ura4-D18 ade6-706 
910b, leu l-32 ura4-D18 ade6-706 hus2.22
2.14 Yeast strain construction
In both the A364a and the CG378 strains, TOP3 was disrupted using pRKC20. In 
this plasmid the full length open reading frame of TOP3 incorporating 5'BamHl and 
3'N otl sites was cloned into pT7. Blue (Invitrogen), and the coding sequence was 
disrupted by insertion of the KanMx;4 module (Wach et al., 1994) between the Hpal and 
BstXl sites (Figure 2.1). This disruption deletes the coding sequence for 289 amino 
acids including the active site tyrosine. The presence of stop codons in the KanMx4 
module in all 3 reading frames precludes the possibility that a Top3-KanMx fusion 
protein could be synthesised in vivo. The product of aBamHl and Notl digest was used 
for the transformation, and the resulting transformants were analysed by PCR using 
primers flanking the TOP3 gene and within KanMx4 module (Figure 2.1 and 2.2). 
Primers corresponding to the diagram in Figure 2.1 were:
A(5 ’ -GTCGG ATC AT AC AGGC ATGT-3 ’ ) ;
B ( 5 -CATCCTATGGAACTGCCTCGG-3 );
C (5 ' TTC AG A A AC A ACTCTGGCGC A-3 ' ) ;
D (5’-TAGTCGCGCGTGAATATGCTA-3’).
In the YPl background T0P3 was disrupted using Not /-digested plasmid pWJ258, 
kindly provided by Dr R. Rothstein. This disruption contains the LEU2 gene. 
Transformants were checked by Southern analysis and by PCR using primers flanking the
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T0P3 gene and within LEU2. The phenotype of top3A was also confirmed genetically in 
all backgrounds by the ability of an sgslA  mutation to rescue the slow growth of the 
top3A strains (Gangloff et ah, 1994).
SGSl, RAD 17 and RAD24 were deleted in the A364a background by Dr. J Kearsey 
(Institute of Molecular Medicine, Oxford) using a PCR based strategy (Wach et al., 1994) 
in which the entire open reading frames of the respective genes were disrupted by the 
KanMx.4 module. In each case deletions were checked by PCR as outlined above and by 
their respective phenotypes. In order to change the markers for these knockouts, linear 
DNA incorporating the entire open reading frame of URA3 flanked by 45bp of sequence 
homologous to the 5’ and 3’ ends of the G418^ was used to transform the various strains. 
The 5’primer,
(5’-ATC CCC GGG TTA ATT A AG GCG CGC CAG ATC TGT TTA GCT TGC 
CTC GCT TTT CAA TTC AAT TCA TC-3’) and the 3’primer, (5’-GTA TAG CGA 
CCA GCA TTC ACA TAC GAT TGA CGC ATG ATA TTA CTT AAA TCA TTA 
CGA CCG AG A T-3’) were used to generate this construct using the plasmid pFEPlO (a 
plasmid containing the URA3 gene, kindly donated by Dr. E. Louis, Institute of 
Molecular Medicine, Oxford), as template DNA. Conditions for PCR were as follows: 1st 
step, 94°C (2 minutes) for 1 cycle; 2nd step, 54°C (1 minute), 72°C (90 seconds) and 
94°C (30 seconds) repeated for 7 cycles; and final step, 54°C (1 minute) followed by 
72°C (5 minutes) for 1 cycle. The PCR product was used to transform the relevant yeast 
strains and correct placement of the markers was checked genetically by screening Ura+ 
transformants for a G418 sensitive phenotype.
The following strains were generated by Dr. J. Kearsey, Institute of Molecular 
Medicine: JMK22d, JMK25 6B, JMK90, JMK91. The following strains were obtained 
from Dr. E. Louis: M83, M89, 6048b. Other strains were obtained from the authors 
indicated. Strains 910a and 910b were obtained from Dr. A Carr (MRC Cell Mutation 
Unit, Sussex)
^Note that the T0P 3  deletion used in the A364a and CG378 strains was not complete. 
Dominant negative effects relating to the expression of a truncated N-terminal domain have 
not been excluded. This could be achieved by assessment of the top3A  phenotype in a 
heterozygous background.
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Figure 2.1: O ne-step gene d isruption . A null allele of the T0P 3  gene was generated by deleting 
the coding sequence for 289 amino acids (including the active site tyrosine) and insertion of the 
KanMx:4 module. Strains were transformed with this construct and G418"'" transformants were 
selected. The wild type T0P 3  gene was replaced with top3A::G 418^  by a double crossover. 
Primers A and D correspond to flanking sequences 5' and 3' to the T0P 3  gene, whereas primers B 
and C correspond to internal sequences of the KanMx:4 module.
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Figure 2.2: Confirmation of correct disruption of the T 0P 3  gene. In the A364a and CG378 
strains, TOP3 was disrupted using pRKC20. Wild type diploid G418+ transformants, were allowed 
to sporulate and genomic DNA prepared from the resulting putative wild type and top3A::G418^ 
segregants. In the above panels, results for 3 genotypes are shown: (1) wild type; (2) top3A::G418^\ 
and (3) radlOA::G418^. Molecular weight markers are shown on the left. In the top panel, PCR 
reactions using primers A and D (see Figure 2.1) for each of the 3 genotypes are shown. Disruption 
of the T0P3  gene results in a 3.0 kb product, whereas an undisrupted gene results in a 2.3 kb product. 
In the lower panels, PCR reactions using primers A and B (left) and C and D (right) are shown. 
Disruption of the T0P3  gene results in a 1.4 kb product for primers A and B, and a 0.9 kb product for 
primers C and D. No products are expected where the T0P3  gene remains intact.
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2.15 Tetrad analysis
During meiosis and sporulation in S.cerevisiae, genes on different chromosomes 
assort independently, and linked genes can be separated by recombination. Therefore 
meiosis and sporulation is a relatively straightforward way to create strains with different 
genotypes. For diploid construction, cells from each haploid isogenic parent with 
opposite mating types were mixed on the surface of a YPD plate and the mating allowed 
to proceed overnight at 30°C. The mating mixture was then replica plated to drop-out or 
minimal media to select for auxotrophic complementation. Alternatively, the mating 
mixture was plated out for single colonies and diploids selected by their inability to mate 
with either Mata or M ata trains.
Diploids constructed in this way were patched onto YPD plates and then after 
growth for 24 hours at 30°C, were replica plated to a sporulation medium [2% (w/v) 
potassium acetate, 0.22% (w/v) yeast extract, 0.05% (w/v) glucose, 2.5% (w/v) agar and 
0.09% complete amino acid mixture, pH7.0] or minimal sporulation medium [2% (w/v) 
potassium acetate, 2.5% (w/v) agar and the addition of those amino acids for which the 
strain is auxotrophic]. The sporulation plates were incubated for between 5-7 days at 
25°C. Tetrads were suspended in lOOpl sterile ddH20 to which 0.5|il glusulase had been 
added and was left at room temperature for 60 minutes. Dissection was performed using 
an Axioskop (Zeiss) dissecting microscope. Dissected tetrads were grown for 3-4 days at 
30°C or at the appropriate temperature for conditional strains.
2.16 Transformation and Transfection procedures
2.16.1 Yeast transformation
S. cerevisiae cells were grown to mid log phase in YPD (OD^oo 0.4-0.6) and 50 ml 
of cell culture were harvested by centrifugation at 3000rpm in a Beckman GPR 
centrifuge, room temperature for 5 minutes. The cells were washed once in sterile 
ddH2 0  and then washed again in 15 ml TE, pH 7.5, O.IM lithium acetate. The cells were 
then suspended in 0.5ml TE, pH 7.5, O.IM lithium acetate. For the transformation, 200|il 
of the above cell suspension was added to 5pi of lOmg/ml sheared salmon sperm DNA, 
and l-5pg of transforming DNA. 1ml of PEG solution [35% (w/v) PEG 4000, O.IM 
lithium acetate, TE, pH7.5 was added, mixed well and incubated with shaking at 30°C for
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30 minutes and then heat shocked at 42®C for 15 minutes. The cells were then pelleted 
by microcentrifugation, resuspended in sterile ddHiO and plated upon the appropriate 
selective plates. Transformants appeared generally after 3 days incubation at 30°C. 
Controls with no transforming DNA were run in parallel.
For transformation of S.pombe cells were grown to mid log phase in minimal media 
(OD600 0.3-0.5), cells from 50 ml harvested by centrifugation as above, and then washed 
once in cold sterile ddH2 0  and then washed again in cold in IM sorbitol. Cells were then 
resuspended in 200pi cold IM sorbitol. For the transformation, 40pl of the above cell 
suspension was added to lOOng of transforming DNA in a cuvette and left on ice for 5 
minutes. The cells were transformed with a Gene Puiser apparatus (Bio-Rad) set at 
1.5kV, 25 pF and 200Q parallel resistance. Cells were then plated out on the appropriate 
selective media. Transformants appeared generally after 5 days incubation at 30°C. 
Controls with no transforming DNA were run in parallel.
2.16.2 Preparation of competent E.coli
Cells were prepared according to the method of Sambrook et al. (1989). 400ml of 
Luria broth (LB) was inoculated with 1ml of saturated culture derived from a single 
E.coli colony and incubated at 37°C until mid log phase (ODeoo 0.4-0.5). The culture 
was then chilled on ice for 15 minutes and then centrifuged at 4000rpm in a Beckman 
GPR centrifuge, 4°C for 10 minutes. The pellet was then resuspended in 300ml of cold, 
sterile ddH20 and spun as previously. This step was repeated using 100ml of cold ddH20 
for resuspension, and then repeated again using 40 ml of ice cold 10% glycerol. 
Following a further centrifugation, the pellet was resuspended in 1ml 10% glycerol, 
aliquoted, snap frozen and then stored at -80°C. To assess the competency of the cells, 1- 
10 ng of plasmid DNA were used in a standard transformation reaction.
2.16.3 Transformation of plasmid DNA into E.coli
For electroporation of DNA into E.coli, the method was that described by Sambrook 
et al. (1989). Plasmid DNA (~10ng or 0.5 pi of a ligation reaction) was added to a 
cuvette (on ice) containing 50 pi of electrocompetent cells. The cells were transformed 
with a Gene Puiser apparatus (Bio-Rad) set at 2.5kV, 25pF and 200Q. parallel resistance. 
Immediately following transformation, 1ml of LB was added to the cuvette and the
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sample incubated at 37°C for 30 minutes, before spreading onto agar plates containing 
the appropriate antibiotic.
2.16.4 Transfection of human cells
Human cells were transfected either by electroporation or by DOTAP (Boehringer 
Mannheim). For electroporation, cell monolayers grown in 15cm Petri dishes to 50% 
confluence were detached by treatment with trypsin and then washed twice in 25ml ice- 
cold phosphate buffered sucrose (272mM sucrose, 7mM potassium phosphate buffer 
pH7.4, ImM MgCl2). Cells were then resuspended in the same buffer at 0.4 x 10  ^
cells/ml and 800pl aliquots incubated on ice in the presence of lOpg transfecting DNA in 
an electroporation cuvette. Samples were then electroporated using a Gene Puiser 
apparatus (BioRad) using 150-350kV, 25-125pF and 2000. Following electroporation 
the samples were left on ice for an additional 10 minutes, before being plated in 15 cm 
Petri dishes in F4/15% foetal bovine serum. After 24h 600pg/ml G418 was added. 
Transfectants appeared generally at around 14 days.
DOTAP is a liposome formulation of the cationic lipid DOTAP. Mixing of DOTAP 
with DNA results in the formation of stable complexes. These complexes adhere to the 
cell surface, fuse with the cell membrane and release the DNA into the cytoplasm. For 
DOTAP transfection, cells were grown to 40-45% confluence in 15cm Petri dishes in 
F4/15% foetal bovine serum. 15pg transfecting DNA in lOpl TF was made up to a total 
volume of 210|il with 170|il 20mM HFPFS buffer, pH7.4 and 45pl DOTAP transfection 
reagent. The mixture was then left at room temperature for 15 minutes, before addition 
to the Petri dish. Cells were then managed as described above.
2.17 Mitotic heteroallelic recombination
A freshly constructed diploid strain (RKC40 x RKC41) homozygous for sgslA, but 
heteroallelic for 2 recessive m etlS  alleles was transformed with pJH626.T, pRKC3 and 
pRKC 16 and transformants were selected on SD Ura- plates. Individual colonies from 
each set of transformants were then diluted in 100 pi sterile ddH2 0  and dilutions placed 
on SD -Met Ura and titred on SD-Ura plates. After 3 days the number of methionine 
prototrophs were scored and the frequency determined for each colony.
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Fluctuation analyses were performed as described by Lea and Coulson (1949) using 
the method of the median. The rate of heteroallelic recombination per cell per generation 
was calculated using the following formula: rate=0.4343(median frequency) divided by 
ln(number cfu/colony). This analysis was repeated 4 times with 11-19 independent 
colonies resuspended for each test of a given strain.
2.18 Flow Cytometric analyses
Cells were grown in YPD media, collected by centrifugation and resuspended in 
70% ethanol. Cells were then washed in 50 mM sodium citrate, pH7.0, and resuspended 
in the same buffer containing 0.25 mg/ml RNase A. The cells were sonicated and then 
incubated at 50°C for 60 minutes. Proteinase K was added to a final concentration of 1 
mg/ml and the cells were incubated at the same temperature for a further 60 minutes. 
The cells were then allowed to cool and propidium iodide was added to a concentration 
of 8 pg/ml. Samples were analysed using a Becton Dickinson FACScan machine 
incorporating LYSIS2 software. We confirmed that the peak shifting seen in flow 
cytometric analyses was a reflection of chromosomal DNA synthesis. The shift in the 
flow cytometric histograms from the G1 to the G2/M position was inhibited by a-factor, 
which induces a G1 arrest, and by HU, which inhibits DNA synthesis.
2.19 Cell cycle blockade and irradiation procedures
All experiments were performed in YPD. For cell cycle blockade experiments, 
cultures were grown to early log phase (OD G.3-0.4). G1 arrest was induced by adding 
a-factor to a final concentration of 20 pg/ml, and G2/M arrest was achieved by adding 
MBC to a final concentration of 200 pg/ml and DMSO to 1 %. After the appropriate 
time intervals, cells were checked microscopically and by flow cytometry to confirm the 
appropriate arrest phenotype. The method for UV-irradiation (254nm) has been 
described previously (Aboussekhra et al., 1996). Cell cycle delay during S-phase was 
analysed as described by Paulovich and Hartwell (1995).
2.20 Survival curves
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(i) HU A final concentration of 0.2 M HU was added to early log phase cells in YPD at 
30^C. Aliquots of cells were removed at timed intervals, washed once, sonicated briefly 
and dilutions at different concentrations were spread onto YPD agar plates. Colonies 
were counted after 72 hours growth at 30°C and the % survival determined, relative to 
the viable colony count prior to addition of HU.
(ii) MMS Cells were grown as above, before addition of MMS to concentrations of 
0.005 -0.03% for 60 minutes. The MMS was then inactivated by the addition of sodium 
thiosulphate to 5% and the % survival determined as above.
(iii) UV irradiation Cells were grown to log phase, diluted at different concentrations 
in dH20 and spread on YPD agar. Plates were irradiated at the indicated doses with 254 
nm UV light and after 72 hours growth at 30°C surviving colonies were counted. The % 
survival was compared to a non-irradiated control.
(iv) y-irradiation Cells were grown to log phase and then irradiated in suspension in 
15ml centrifuge tubes using a Gammacell 1000 ^^^Cs y-irradiator (Atomic Energy 
Corporation, Canada) at a dose rate of 3 Gy/minute at room temperature. Dilutions at 
different concentrations were spread onto YPD plates and colonies counted after 72 hours 
growth at 30°C. The % survival was determined relative to non-irradiated controls.
2.21 Analysis of cell morphology
Cells were fixed with 4% formaldehyde and microtubules were visualised as 
reported previously (Kilmartin and Adams, 1984). The anti-tubulin antibody was the 
mouse monoclonal TAT-1 used at 1.500 (kindly provided by Prof. K. Gull, University of 
Manchester), raised against Trypanosoma brucei a-tubulin (Woods et al., 1989) which 
cross-reacts with S.cerevisiae a-tubulin. The secondary antibody (1:250) was Cy3- 
conjugated rabbit anti-mouse IgG used at 1.250 (Sigma). Cellular DNA was stained 
using l|ig/ml DAPI. To determine and categorise cell morphologies, at least 200 cells 
were analysed for each sample. All samples were evaluated single blind.
2.22 Sister Chromatid Exchanges
Metaphase spreads were prepared from cells propagated through 2 rounds of DNA 
synthesis in the presence of lOpg/ml 5-bromodeoxyuridine. Chromosomes were stained
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with Hoechst 33258 and UV photolysis achieved by exposure to both long- and short­
wave UV light for 20 minutes at 50°C. Chromosomes were stained with Giemsa and 
exchanges scored single blind on a Zeiss Axiophot microscope. The SCE frequency was 
expressed as the number of individual strand exchanges per chromosome. Quantification 
of the frequency of SCE/chromosome was performed by P. North, Institute of Molecular 
Medicine, Oxford.
2.23 Statistical methods
Unless otherwise stated, statistical comparisons were performed using a chi-squared 
analysis (two-tailed). For mitotic heteroallelic recombination, statistical comparisons 
between different strains within an isogenic series were made by rank order (Wierdl et 
al., 1996). The frequencies for each colony of the 2 strains being compared were 
converted to rates using the median method equation described above and ranked 
together (equal numbers of colonies were used). A chi-squared analysis was performed to 
test whether one strain had significantly more colonies ranked in the top half of the rate 
values than the other strain. If the 2 strains had equal rates, then the expected of colonies 
in the upper half of the rank order for a given strain is 50% of the colonies. A chi- 
squared value (one-tailed) of >3.85 (p<0.05) indicates a significant deviation from the 
expected 50% and therefore a significant difference in rate between the strains.
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Chapter 3
Assessment of the ability of BLM to 
complement S.cerevisiae sgslA  mutants
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3.1 Introduction
If a human and yeast protein share not only structural, but also functional similarity, 
there are several advantages in using yeast as a model system for dissecting in detail the 
properties of the human protein. First, the entire genome of S.cerevisiae has now been 
sequenced (Goffeau et al., 1996). This is relevant to the study of BS, since in humans at 
least five (and quite possibly more) RecQ-family helicases exist, and this has the 
potential to mask or distort the effect of loss of function mutations in BLM. In budding 
yeast there is only one RecQ family helicase and thus the effect of loss of function 
mutations can be more readily assessed. Second, yeast cells grow rapidly with an 
average generation time of around 2 hours, significantly quicker than cultured 
mammalian cells. Indeed, both transformed and untransformed BS cell lines are 
exceptionally difficult to work with, since they demonstrate significantly prolonged 
generation times combined with a reduced plating efficiency. Third, yeast cells can be 
manipulated either as diploids or haploids and thus, in the latter case the effects of a 
recessive mutation(s) can be easily assessed. This contrasts with the difficulty in 
eliminating a wild type gene in mammalian cells. In yeast, genes can be easily deleted, 
mutated and reintroduced, overexpressed or tagged.
The experimental advantages of budding yeast are therefore being increasingly 
exploited to determine the function of genes mutated in human diseases. One example of 
this approach has been the study of the human ALD gene which is mutated in the 
neurodegenerative disease, adrenoleukodystrophy, a disorder characterised by defective 
p-oxidation of saturated very long chain amino acids which results in extensive neuronal 
demyelination (Mosser et al., 1993). The ALD  gene encodes an ABC transporter 
localised in the peroxisomal membrane. A structural homologue of this protein, Pat Ip, 
has been identified in S.cerevisiae and has been demonstrated to be involved in the 
import of activated long-chain fatty acids into peroxisomes (Hettema et al., 1996). Using 
a reversal of this strategy, identification of yeast genes has, on occasions, led directly to 
the discovery of human genes defective in human disease. For instance, the simple 
sequence repeat instability observed in yeast msh2 mutants (Strand et al., 1993) was 
found to resemble microsatellite instability in human hereditary non-polyposis colon 
cancer, and this led directly to the cloning of human MSH2 (Fishel et al., 1993) More
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recently, information derived from studies of yeast bubl mutants, which are defective in 
the spindle assembly checkpoint, accelerated the finding that in certain colorectal cancer 
cell lines showing high rates of aneuploidy, the human BUBl was mutated (Hoyt et ah, 
1991; Cahill et al., 1998).
It is now possible to use yeast to screen for drugs with potential effectiveness against 
human diseases (reviewed in Hartwell et al., 1997). For, example, yeast mutants 
defective in highly conserved DNA damage response pathways (such as mismatch 
repair) can be used as models of the human cancer cells, in order to screen directly for 
drugs or drug targets. In this way it may be possible to identify drugs with a therapeutic 
advantage by identifying agents that are more lethal to the mutant than to the wild type 
yeast cell. Many mutations in human cancers are loss of function mutations and thus, the 
proteins they encode do not themselves constitute a drug target. One approach that could 
circumvent this problem is 'synthetic lethal' screening which allows the identification of 
second site mutations that by themselves are not lethal, but in combination with the 
primary defect cause lethality. The gene products of these genes may constitute putative 
secondary drug targets, since their inactivation might be anticipated to kill cells with the 
primary defect. A more intricate approach appropriate to drug screening might involve 
the generation of hybrid yeast/human biochemical pathways. For example, in one study a 
yeast membrane bound chimeric yeast/mammalian G a  protein was used to couple the 
signal from a rat somatostatin receptor to a yeast reporter system (Price et al., 1995).
A significant number of human disease associated genes show significant sequence 
similarity to genes identified in the yeast Saccharomyces cerevisiae. In the most recent 
analysis, using the BLAST algorithm (Basic Local Alignment Search Tool), 74 out of 
250 human disease-associated genes match budding yeast genes (Altschul et al., 1990; 
Foury, 1997). A subgroup of these genes match an S.cerevisiae protein at least as 
significantly (BLAST p< c'^O) the human NFl (defective in neurofibromatosis type 1) 
and the yeast IRA2 gene (which encodes an inhibitory regulatory protein). This cut-off is 
used since, in this particular example, ectopic expression of the catalytic domain of 
human NFl complemented the yeast ira2 mutant. The finding of heterologous 
complementation combined with biochemical evidence of similar activity (Xu et al.,
1990), indicates that these proteins share significant functional properties.
The BLM gene product closely matches the proteins encoded by S.cerevisiae, SGSl, 
(BLAST p< e -105  ^ and in S.pombe rq h l  (BLAST p< A key question to be
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addressed therefore is to what degree the respective proteins share functional similarity. 
An initial experimental approach to this problem is to assess the ability of one gene to 
complement the cellular phenotype associated with defects in the other gene. This 
experimental strategy is outlined below.
3.2 Results
3.2.1 Cloning BLM
A  cDNA encoding the full length open reading frame of BLM was generated by the 
PCR using DNA from a human B-cell cDNA library as template. The strategy adopted is 
set out in Figure 3.1. The BLM cDNA was generated in 2 sections, a 5' 1.4kb PCR 
product incorporating a BamHl restriction site and yeast Kozak consensus sequence and 
a 3' 2.9kb fragment incorporating a Notl restriction site. In order to reduce the frequency 
of polymerase-induced errors a proof-reading enzyme was used and the conditions 
optimised to allow the fewest number of PCR cycles to generate a product. These 
products were then sequenced in order to screen for changes from the published 
nucleotide sequence. Two independent 2.9kb products with mutations predicted to alter 
the open reading frame were subsequently used: product (X) which had an A to G 
substitution at position 2482, which would have resulted in an alanine to threonine amino 
acid substitution at codon 827; and product (Y) which had an A to G substitution at 
position 4207, which would have resulted in a lysine to glutamic acid amino acid 
substitution at codon 1402 (see Figure 3.1). In order to circumvent these mutations, a 5' 
EcoRl -Hindlll fragment of product (Y) and a 3' //mJ/ZZ-AoGfragment of product (X) 
were used in the subsequent ligations.
The predicted amino acid sequence of the protein encoded by this cDNA was shown 
to be identical to the BLM sequence published by Ellis et al. (1995), although the 
nucleotide sequence contained 5 silent changes: T to C (position 621); A to C (position 
981); T to C (position 2286); G to A (position 3102); and C to A (position 3531). Four 
of these five changes, with the exception of the T to C change at position 2286, are likely 
to represent polymorphisms, as the same changes were identified in independently 
generated cDNAs. Examination of codon usage frequencies in different species 
indicated that the remaining silent mutation was unlikely to have any effect upon 
expression levels in either yeast or human cells. This cDNA was cloned into mammalian
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(pCDNA3), S.pombe (pREP.3X) and S.cerevisiae (pYES2 and pJH626.T) expression 
vectors.
In order to obtain recombinant BLM for protein purification, two modifications to 
the full length BLM  cDNA were made in work performed in conjunction with J. Karow, 
Institute of Molecular Medicine. First, a hexahistidine affinity tag was engineered at the 
3 ' end of the coding sequence to permit the expressed protein both to be detected by 
means of specific anti-histidine tag antibodies and to be purified on nickel-chelate resin. 
Second, the first five codons of the yeast T0P2 gene were placed immediately upstream 
of the complete BLM open reading frame. In previous studies it was shown that the 
presence of these yeast Top2p-derived amino acids improved the yield of expressed 
recombinant human proteins. The modified BLM cDNA was cloned downstream of the 
GALl promoter in the vector pYES2. The biochemical properties of the BLM protein 
derived from this construct have been published (Karow et al., 1997).
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BamHl ATG EcoRI EcoRI H indlll TAA Notl
X
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x d  Y
BamHl ATG EcoRI Hindlll TAA Notl
Figure: 3.1 Cloning BLM. The BLM  cDNA was generated in 2 sections, a 5' 1.4kb PCR product 
incorporating a BamHl restriction site and yeast Kozak consensus sequence and a 3' 2.9kb 
fragment incorporating a Notl  restriction site. Products were sequenced in order to screen for 
changes from the published nucleotide sequence. Two independent 2.9kb products with mutations 
predicted to alter the open reading frame were subsequently used: product (X) which had an A to 
G substitution at position 2482; and product (Y) which had an A to G substitution at position 
4207. Mutations are represented by thick black bars. In order to circumvent these mutations, a 5' 
EcoRI -Hindlll fragment of product (Y) and a 3' 7/mJ///-Aor7fragment of product (X) were used 
in the subsequent ligations.
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3.2.2 Complementation of the slow growth and elevated sister chromatid exchange 
phenotype of GM8505 Bloom’s fibroblasts by BLM,
Recombinant BLM protein derived from the above construct demonstrated DNA- 
dependent ATPase activity and ATP- and Mg2+-dependent helicase activity with a 3'-5' 
polarity for unwinding duplex DNA (Karow et al. 1997), features consistent with other 
members of the RecQ helicase family (Umezu and Nakayama, 1993; Gray et al., 1997; 
Suzuki et al., 1997; Bennett et al., 1998). Prior to heterologous complementation studies 
in yeast cells defective in RecQ homologues, confirmation that the BLM cDNA was 
functional and could complement a Bloom's syndrome fibroblast cell line was sought. 
The GM8505 cell line is an SV40-transformed fibroblast line derived from a patient 
with BS. This cell line demonstrates all the cardinal features of the BS cellular 
phenotype, including slow growth, poor plating efficiency and elevated rate of sister 
chromatid exchange in the presence of bromodeoxyuridine (McDaniel and Schultz, 
1992). This latter phenotype was shown previously to be corrected by microcell- 
mediated transfer of chromosome 15 which contains the BLM locus at 15q26.1 
(McDaniel and Schultz, 1992).
The unmodified BLM cDNA was positioned downstream of the CMV promoter in 
the vector pCDNA3 which also contains a G418^ reporter, to give pRKC17. GM8505 
cells were transfected with either pRKC17 or vector as a control. Selection for 
permanent transfectants was performed using G418 selection at 0.6 mg/ml. 2-3 weeks 
following transfection, single colonies were picked and propagated as independent 
cultures. Comparison of growth rates of 3 independent pRKC17 or vector transfectants 
demonstrated a mean 3-fold increase in the growth rate of GM8505 cells transfected with 
the BLM  cDNA (Figure 3.2). Transfection with the BLM cDNA also corrected the poor 
plating efficiency of the parental GM8505 cell line, as indicated by comparison of cell 
number at the first time point in Figure 3.2, in which an initial drop is observed in the 
vector transfectants. This effect upon plating efficiency was confirmed by staining 
colonies 7 days after a known number of cells were plated (Figure 3.3). Metaphase 
spreads from pooled BLM or vector GM8505 transfectants were then examined for sister 
chromatid exchanges in work performed by P. North, Institute of Molecular Medicine. 
The BLM transfectants showed a partial reduction in SCE frequency (0.72 
SCE/chromosome, n=2816 in 5LM transfectants, vs. 1.14 SCE/chromosome, n=2698 for 
the vector controls, p<0.0001). These results compare with correction of the elevated
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SCE phenotype in the same cell line from 2.12 SCE/chromosome in non-complemented 
cells to 0.50 SCE/chromosome in cells following minicell transfer of chromosome 15, 
which contains the BLM locus (McDaniel and Schultz, 1992). To confirm that the 
complementation of slow growth, poor plating efficiency and elevated SCE frequency 
was as a consequence of expression of the full length BLM protein, detection of the 
protein was tested by immunoblot analysis of extracts prepared from pRKC17 and vector 
transfectants in work performed by P. North, Institute of Molecular Medicine. 
Expression of the full length BLM protein was observed for 3 independent BLM 
clones, but not in the control transfectants (Figure 3.4). The GM8505 cell line is 
homozygous for a truncation mutation in BLM and no BLM protein can be detected (Dr. 
N. Ellis, Laboratory of Human Genetics, New York Blood Center, personal 
communication).
In a set of parallel experiments, an attempt was made to transfect GM8505 cells with 
SGSl cDNA which encodes the budding yeast structural homologue of the BLM protein. 
The full length SGSl cDNA was cloned into pCDNA3 to give pRKC4. No transfectants 
were obtained. In further experiments, alternative transfection methods including 
electroporation, differing quantities of transfecting DNA and other control fibroblast cell 
lines were adopted. In all experiments the vector control was transfected with high 
efficiency, but no SG Sl transformants were obtainable. Transformation of pRKC4 into 
E.coli conferred resistance to low dose kanamycin confirming that the G418B marker in 
this construct was intact. Attempts at transient expression of SGSl were not performed.
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Figure 3.2: Complementation of slow growth rate of GM8505 ceils by transfection with BLM.
Graph showing cell number (±SEM) against time, of 3 independent GM8505 clones, transfected with 
pRKC17 (BLM) or vector control. 1.5 x 10^ cells derived from log phase cultures of BLM  (O ) and 
control (□ )  transfectants, were grown under identical conditions. Note the initial fall in cell number 
in the control transfectants. Estimated mean generation times were -8 0  hours for the BLM 
transfectants and -240 hours for control transfectants.
pCDNAS pRKClV
GM8505
Figure 3.3: Complementation of poor plating efficiency of GM8505 cells by transfection 
with BLM. 5 x 1 0 ^  cells derived from log phase cultures of pRKC17 (BLM) transfectants and 
pCDNA3 (vector) controls were plated into 15cm petri dishes and grown for 7 days, before 
staining of adherent colonies with 400pg/ml crystal violet.
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Figure 3.4: Expression of full length BLM protein in GM8505 cells transfected with 
pRKClT. Protein extracts derived from GM8505 (G) cells were separated by SDS-PAGE, 
transferred to nylon and immunoblotted with an a-BLM  (upper panel) or a-M PPlO  (lower 
panel) antibody. Lanes 1-3 represent control transfectants and lanes 5-8 represent BLM  
transfectants. Lane 9 is a HeLa (H) positive control. MPPIO is a nuclear protein and was run as 
a loading control. Lanes 1-9 are as follows; (1) G, vector clone 1; (2) G, vector clone 2; (3) G, 
vector clone 3; (4) empty lane; (5) G, pRKC17 pooled clones; (6) G, pRKC17 clone 1; (7) G, 
pRKC17 clone 2; (8) G, pRKC17 clone 3; (9) HeLa positive control. BLM protein runs as a band 
-170 kDa with a second band visible at -100 kDa. This presumably represents a breakdown 
product of BLM as it is not observed in the GM8505 vector controls.
87
3.2.3 Assessment of ability of BLM  to complement fission yeast hus2.22 mutants.
Fission yeast Rqhlp is a structural homologue of the BLM protein, rqhl mutants are 
defective in the recovery from an S-phase arrest induced either by HU or by DNA 
damage (Stewart et al., 1997). Mutants demonstrate a loss of viability and a 'cut' (cell 
untimely torn) phenotype when replication is re-initiated following arrest. In this 
phenotype a septum bisects an undivided nucleus. The hus2.22 mutation (allelic to 
rqhl+) introduces a stop codon at amino acid position 790, eliminating the remaining 
580 amino acids which contain the last two conserved helicase motifs. The phenotype of 
hus2.22 mutants is identical to an rqhl null mutant.
In order to assess whether BLM could complement the phenotype of the hus2.22 
mutant, the full length cDNA was cloned downstream of the thiamine repressible NMT-1 
promoter in the S.pombe vector, pREP3X to give pRKC18. In this construct, gene 
expression is switched off in the presence of thiamine and switched on in its absence. 
pRKC 18 and a vector control were transformed into wild type and hus2.22 isogenic 
mutants. Plates containing -400 independent transformants were then replica plated to 4 
different types of selective media containing phloxin B: HU + thiamine; HU and no 
thiamine; no HU + thiamine; no HU and no thiamine. In the presence of HU, 
untransformed hus2.22 mutants grow poorly and colonies are a deep red colour, resulting 
from the failure of cells to extrude the phloxin B pigment consequent upon a loss of 
viability. In contrast, wild type cells in the presence of HU form larger colonies which 
are pink in colour. No differences were observed between hus2.22 BLM  and vector 
transformants in the presence of HU with or without thiamine. This suggests that BLM is 
unable to complement the HU- sensitive phenotype of hus2.22 mutants.
To confirm this in more detail, log phase cultures of B LM  or vector hus2.22 
transformants were grown either in the presence or absence of thiamine, exposed to HU 
or mock treated for 4 hours, and then released into media without HU, but again either in 
the presence or absence of thiamine. The end points determined were the percentage of 
'cuts' and viability. Results from 2 independent experiments are shown in Figure 3.5. No 
reduction in the HU-induced 'cut' phenotype or loss of viability of hus2.22 cells was 
evident under conditions in which full length BLM was expressed (Figure 3.6). In 
experiments performed in parallel, hus2.22 cells transformed with pRKC5 (a derivative 
of pREP3x in which the SGSl cDNA is cloned downstream of the AM7-7promoter), also 
failed to show complementation of the HU-sensitive phenotype. Isogenic wild type
controls did not demonstrate a 'cut' phenotype or loss of viability in the presence of HU. 
Sgsl protein expression, however, was not confirmed. No positive control was run in 
these experiments, because at the time they were performed only a partial sequence of 
r^ /ii+ w as available.
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Figure 3.5: Failure of B L M  to complement the phenotype of S.pombe hus2.22 mutants. hus2.22 
mutants transformed with pRKClS (BLM) , pRKC5 (SGSJ) or vector were grown in selective media, 
either under inducing (+) or repressed (-) conditions at 30°C. At t=0 cells were treated with lOmM 
HU or mock treated for 4 hours, and then released into fresh media either in the presence or absence 
of thiamine. After a further 4 hours, the % survival (A) in relation to the t=0 value, and % cells 
corresponding to a 'cut' phenotype (B) were determined. The % cells with a 'cut' phenotype was 
determined by scoring 1000 DAPI-stained cells single blind. The means (+ ranges) of 2 independent 
experiments are shown. In the absence of HU, survival was 100% and the % cuts were < 1%, for 
each set of transformants.
pREP.SX pRKClS
200
+ +
a-BLM
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Figure 3.6: Expression of full length BLM protein in hus2.22 mutants transformed with 
pRKClS Protein extracts derived from pRKClS (BLM) Or pREP.3X (vector) control hus2.22 
transformants were grown under inducing (+) or repressed (-) conditions at 30°C for 22 hours, 
under the same conditions of the experiment shown in Figure 3.5. As previously, a-BLM  
identified a 170 kDa band and a 100 kDa band, under inducing conditions.
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3.2.4 Assessment of the ability of BLM  to complement budding yeast sgsl mutants.
A number of potential end-points in assessing the ability of BLM to complement 
budding yeast sgsl mutants were available and these are described below.
3.2.4a Loss of budding yeast Sgslp in association with loss of another DNA helicase, 
Srs2, results in a synergistic growth defect.
SGSl is a non-essential gene, which suggests either that it serves a non-essential 
function or that other genes can compensate for its loss (Gangloff et al., 1994; Watt et al., 
1995). In E .co li, deletion of recQ in a recBC sbcB(C) background (which activates the 
RecF recombination pathway) is also compatible with viability (Mendonca et al., 1995). 
However, loss of both RecQ and another helicase, UvrD (Helicase II) in this genetic 
background is not compatible with survival (Mendonca et al., 1995). UvrD, like RecQ 
possesses 3'-5' helicase activity and is thought to initiate recombination events in the 
RecF pathway (Matson, 1986). Potential explanations for this lethality are that UvrD and 
RecQ are involved in alternate pathways essential for cell viability or that they act in the 
same pathway which is knocked out synergistically by the loss of both proteins.
In budding yeast, the helicase Srs2p shows a high degree of homology to UvrD and, 
like its putative counterpart in E.coli possesses 3'-5' helicase activity (Aboussekhra et al., 
1989; Rong and Klein, 1993). Mutants defective in Srs2p demonstrate a hyper­
recombination phenotype (Rong et al., 1991) and sensitivity to DNA damaging agents 
(Aboussekhra et al., 1989). The precise mechanism by which Srs2p helicase mediates the 
cellular response to DNA damage has, however, not been resolved.
Diploids heterozygous for sg sl A: :LYS2 and srs2A: :LEU2 were constructed 
(JMK22d X 6048b), allowed to sporulate and the resulting tetrads dissected. Combination 
of S.cerevisiae sgsl A and srs2A mutations resulted in a marked synergistic growth defect 
This synergistic growth effect was complemented by ectopic expression of a wild type 
SGSl cDNA from a single copy URA5-marked plasmid (pRKC3) and could be re­
induced by ‘chasing out’ the plasmid by the growth of transformants on FOA-containing 
plates (Figure 3.7, Table 3.1). In Table 3.1, the results show genotypes of segregants 
scored blind for colony size prior to confirmation of markers. Microcolonies were scored 
as non-viable and not counted. Complementation by SGSl was restricted to only half the 
potential sgslAsrs2A segregants, since the single copy plasmid, pRKCB, only segregates
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to approximately half of the spores during meiosis. Each of the 15 double mutants which 
were viable contained the f//M3-marked plasmid. The same effect is reproduced in other 
genetic backgrounds (Dr. J. Kearsey, Institute of Molecular Medicine, personal 
communication).
3.2.4.b BLM  fails to complement the synergistic growth defect of sgslAsrs2A  double 
mutants.
This genetic interaction provided a potential means by which to test for the ability of 
BLM to complement an sgslA-re\a.t&d phenotype. A diploid heterozygous for sgslA  
and srs2A was transformed with pRKC16 (a URA3 -marked single copy plasmid, in 
which the BLM cDNA was cloned downstream of the promoter for the constitutive 
glycolytic enzyme, triose phosphate isomerase). The resulting transformants were 
allowed to sporulate and the tetrads were then dissected. The resulting genotypes are 
shown in Table 3.1. Segregants were scored blind for colony size prior to confirmation 
of markers. Microcolonies were scored as non-viable. pRKC16 failed to complement 
the synergistic growth defect of sgslA  srs2A double mutants. Overexpression of BLM  
under inducing conditions from pRKC15 (a multicopy plasmid in which the BLM  cDNA 
is positioned downstream of the G A H  promoter) also failed to complement in this 
system (data not shown). As previously, expression of full length BLM was confirmed 
by immunoblot.
Table 3.1 Genotypes of segregants derived from diploid JMK22d x 6048b
genotype + vector
n=32 tetrads
+ SG Sl (pRKC3)
n=39 tetrads
+ BLM  (pRKC16)
n=50 tetrads
SCSI SRS2 29 32 35
sgslA SRS2 25 34 41
SOS I srs2A 26 34 46
sgslAsrs2A 2 15 2
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Figure 3.7: sgslAsrslA  demonstrate a synergistic growth defect. Diploids heterozygous for 
sgslA::LYS2  and srs2A::LEU2 were constructed (JMK22d x 6048b), allowed to sporulate and 
the resulting tetrads dissected. (A) A YPD plate showing colony sizes associated with each of the 
four resulting genotypes, after growth at 30°C for 3 days, is shown. (B) Transformation of the 
above diploid with a single copy I//?/ti-marked pRKC3 (SCSI)  before sporulation, was able to 
reverse the slow growth phenotype of the resulting sgslAsrs2A  double mutants. Chasing out 
pRKC3 on FOA (upper quarter of plate), reinduced the synergistic growth defect.
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3.2.4c Assessment of the effect of BLM  upon the hyper-recombination phenotype of 
sgsl A mutants
Cells derived from individuals with BS show hyper-recombination (reviewed in 
German, 1993). This is also the case for sgsl A cells, manifested as an increase in the 
frequency of interchromosomal homologous recombination, intrachromosomal excision 
recombination and ectopic recombination (Watt et al., 1996). In this latter study, the 
largest difference between sgsl A and wild type cells was a 13-fold difference in the rate 
of mitotic recombination between metl3-4 and metl3-2 heteroalleles in diploid cells. In 
order to test the ability of BLM to complement this phenotype, a diploid homozygous for 
sgsl A and heterozygous for the two met 13 alleles was constructed, and transformed with 
pRKC16 {BLM), pRKC3 (SGSl) and empty vector as a negative control. The rate of 
recombination is determined by scoring the frequency of methionine prototrophy, which 
could arise as a result of recombination (involving either crossover or gene conversion) 
or by back mutation. The overall strategy for this experiment is shown in Figure 3.8a.
To exclude the possibility that methionine prototrophy resulted from reversion of the 
met 13 allele, the rates for methionine prototroph formation of wild type and sgsl A 
haploid strains containing the metl3-4  recessive allele were determined. For 2 
independent estimations of the rate of reversion mutation at metl3, the wild type rate was
3.3 X 10"  ^ /cell/generation and the sgsl A rate was 3.0 x lO'^/cell/generation. Thus, the 
rate of reversion mutation for this recessive allele is not elevated in sg s l A haploid 
mutants. Assuming that the rate of reversion mutation is similar for a metl3-2 recessive 
allele, any differences observed between wild type and sgsl A diploid strains is likely to 
reflect differences in recombination rather than reversion mutation rates.
Four independent experiments (each involving 11 to 19 independent transformants 
for each plasmid) were performed to estimate the rate of heteroallelic recombination 
between met 13-4 and met 13-2 and the results are shown in Figure 3.8b. Ectopic 
expression of SGSl as a positive control, resulted in over a five fold reduction in the 
recombination rate as compared to the vector control. A smaller but consistent reduction 
was observed for the BLM transformants. This difference did not, however, reach 
statistical significance and time limitations did not permit additional experiments to 
confirm or refute this reduction.
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Figure 3.8: Effect of B L M  on the rate of heteroallelic recombination in sg s lA  mutants. 
Freshly constructed diploids (RKC40 x RKC41), homozygous for sgsl A and heterozygous for 
recessive metl3  alleles, were transformed with pRKC16 {BLM), pRKC3 {SGSl) or pJH626.T 
(vector) control. (A) Recombination between metl3-2  and m etl3-4  alleles (either by crossover 
or gene conversion) can generate a wild type MET13 gene and restore methionine prototrophy. 
The black crosses represent different mutations in the MET13 gene. (B) . In each experiment 11- 
19 independent Ura+ transformants were then resuspended in sterile ddH 20  and plated on SD 
Ura- Met- plates and titred on SD lira- plates. Median rates of recombination were then 
determined and the means (±SEM) of 4 independent experiments are shown.
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3.2.4d Expression of both SG Sl and BLM results in the re-induction of slow growth 
in an sgsl A top3A double mutant.
top3A mutants grow slowly, are defective in sporulation and demonstrate elevated 
rates of mitotic recombination. These phenotypes are suppressed by additional mutations 
in the SGSl gene (Gangloff et al., 1994). Ectopic expression of SGSl in an sgsl A top3A 
double mutant would therefore be expected to result in the re-induction of the slow 
growth phenotype. Evidence for heterologous complementation would also be obtained 
if this effect was reproduced by ectopic expression of BLM. To test this, wild type and 
isogenic sgsl A top3A  double mutants were transformed with pRKC2 (^GSl) and 
pRKC15 (BLM) in which the respective genes are cloned downstream of the GALl 
promoter, and empty vector as a control. Ten independent transformants from each were 
then spread on selective plates containing either glucose (repressed conditions) or 
galactose/raffinose (inducing conditions). Wild type SGSl or BLM transformants showed 
no differences from vector controls under inducing or repressed conditions. In contrast, 
SGSl or BLM  s g s l  A top3A transformants showed a consistent reduction in colony 
growth, as compared to the vector controls (Figure 3.9). This was confirmed by 
estimation of generation times (derived from serial determinations of cell number during 
log phase growth) of the respective transformants under inducing and non-inducing 
conditions (Table 3.2). Under inducing conditions, SGSl transformants demonstrated a 
nearly 4-fold increase in generation time as compared to vector controls, whereas BLM  
transformants showed a 1.5 fold increase.
Table 3.2 Generation times (±SEM) of sgsl A topSA transformants grown in SD -Ura 
media.
condition + vector -f- SGSl (pRKC2) + BLM (pRKC15)
2% glucose, n=5 2.80 ± 0.01 3.26+ 0.07 2.89+ 0.02
2 % galactose/
1% raffinose, n=9
3.62± 0.18 13.69+ 0.57 5.55+ 0.25
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Figure 3.9: Effect of BLM upon growth of sgslAtop3A  cells. Wild type and sgslAtopSA  cells 
were transformed with pRKC15 {BLM \  pRKC2 {SGSl) and pYES2 (vector) control. In each 
case the respective genes were cloned downstream of the GALl promoter. Independent 
transformants were plated onto selective media containing either 2% glucose or 2% galacose/1% 
raffinose and grown for 3 days at 30°C. Plates showing sgslAtop3A  transformants are shown. 
No effect of expression of SG Sl  or BLM  was observed in wild type cells. Expression of full 
length BLM protein under inducing conditions was confirmed as previously by immunoblot.
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3.3 Discussion
3.3.1 Complementation of the BS cellular phenotype
The potential advantage of introducing a wild type gene into a cell line containing a 
'knockout' mutation is that one can assess the phenotypes of cells that are otherwise 
isogenic. Results presented in this chapter demonstrate the partial correction of the slow 
growth, poor plating efficiency and elevated SCE rate of an SV40-transformed BS 
fibroblast cell line following transfection with the wild type BLM  cDNA under the 
regulation of the CMV promoter. The complementation of the BS cellular phenotype 
combined with the demonstration of DNA-dependent ATPase and helicase activities of 
the recombinant protein (Karow et al., 1997), have paved the way for combined studies in 
which the effects of BLM mutations upon helicase function in vitro can be compared 
with their effect upon the phenotype of BS or normal cell lines. Other studies ongoing 
include the evaluation of the response of BLM and vector transfectants to a variety of 
DNA damaging drugs or agents which inhibit DNA synthesis. In the longer term, 
regulatable expression of a wild type or mutated BLM gene, may provide a more 
powerful tool for dissecting the roles of the protein.
The failure to obtain complete correction of the SCE phenotype, in comparison with 
previous studies employing the minicell transfer of chromosome 15 into the same cell 
line (McDaniel and Schultz, 1992), probably reflect differences in the level and timing of 
mRNA expression. Similar results, confirming partial correction of the SCE phenotype 
in BS cells have recently been reported by others (Giesler et al., 1997). In this study, the 
authors reported that BLM transfection also resulted in an increase in the rate of S-phase 
transit as assessed by pulse labelling with bromodeoxyuridine.
The failure to obtain any permanent SGSl transfectants in either BS or normal cell 
lines, despite efficient control transfections performed in parallel was unexpected. 
Although this might represent a 'toxic' effect of Sgslp, perhaps secondary to unregulated 
helicase activity, it was anticipated that a proportion of permanent transfectants (with low 
or minimal levels of SGSl expression), might be viable. One way of addressing this 
might be to perform transient transfections or to use constructs that allow regulatable 
expression of SGSL
3.3.2 Synergy between sgsl A and srs2A
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The synergistic effects upon growth observed in sgslAsrs2A  double mutants could 
result either from an additive negative effect of the two mutations upon a single essential 
biological pathway, or from the inactivation of 2 different but functionally overlapping 
pathways. In both scenarios, and in the context of the similar biochemical activities of 
the respective proteins, it seems reasonable to postulate that both Sgslp and Srs2p act 
upon the same group of DNA structures and/or lesions.
A clue to the nature of these putative lesions might be extrapolated from the effects 
of different DNA damaging agents upon srs2 mutants. In S.cerevisiae, the cellular 
response to DNA damage is controlled by a set of genes which define three pathways 
(Game, 1993; Lawrence, 1994; Friedberg et al., 1995). Mutants defective in the RAD3 
excision repair group are primarily sensitive to UV irradiation which induces the 
formation of pyrimidine dimers and other photoproducts. RAD52 epistasis group mutants 
are defective in recombinational repair of double strand breaks and are sensitive to 
ionising irradiation, but less so to UV. The third set of genes form the more 
heterogeneous and complex RAD6 group and are sensitive to the lethal effects of both 
UV and y-rays. The RAD6 group appears to comprise 2 independent pathways, a major 
pathway mediating error-free post-replication repair, involving Polôp, PCNAp and 
Mms2p (Torres-Ramos et al., 1996; Giot et al., 1997; McDonald et al., 1997), and a 
secondary error-prone pathway, involving Rev3p, Rev7p and Rev Ip (Lawrence, 1994). 
It should be noted here that the mechanism for post-replication repair in eukaryotes is not 
known and its similarity or otherwise to post-replication repair in prokaryotes is not 
established. Double mutants deficient in both the RAD6 and RAD52 pathways 
demonstrate synergistic interactions (reviewed in Friedberg et al., 1995), suggesting that 
these two pathways are partly able to substitute for each other, and therefore share some 
common substrates.
Further evidence for this partial overlap derives from study of srs2 mutants which 
are sensitive to both UV and ionising irradiation, and which have complex relationships 
with both the RAD6 and RAD52 epistasis groups. Mutation or loss of Srs2p activity 
suppresses the radiation sensitivity of rad6 mutants (Aboussekhra et al., 1989), an effect 
which is dependent upon the presence of an intact RAD52 pathway (Scheistl et al., 1990). 
This led to the proposal that Srs2p plays some role in assigning DNA lesions or repair 
intermediates down a RADb-dependent post-replication repair pathway, and that in its 
absence lesions are channelled into recombination repair pathways. In this sense, Srs2p
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can be thought of as having 'anti-recombinogenic' activity. This is also illustrated by the 
fact srs2 mutants demonstrate a mitotic hyper-recombination phenotype (Rong et al., 
1991) and by the finding that overexpression of SRS2 in a wild type background confers 
sensitivity to ionising irradiation (Kaytor et al., 1995). Furthermore, srs2 mutations 
suppress the radiation sensitivity of partially defective mutants in the RAD52-dependent 
pathway (Milne et al., 1995). Counter to these anti-recombinogenic effects, Srs2p protein 
is reported to participate directly in recombinational repair of DSBs since srs2 mutants 
are defective in gene conversion involving long non-homologous 3' ends (Paques and 
Haber, 1997). This apparent contradiction mirrors findings for the Srs2 homologue in 
E.coli, UvrD. For example, biochemical studies show that, depending on the assay 
conditions, UvrD can either promote or inhibit RecA-mediated branch migration (Morel 
et al., 1993). Similarly, uvrD mutants not only stimulate recombination (Washburn and 
Kushner, 1991), but also have a positive role in the recombination pathway (Horii and 
Clark, 1973).
A number of hypotheses have been put forward to explain the phenotypes of srs2 
mutants (Friedberg et al., 1995; Chanet et al., 1996; Paques and Haber, 1997) . First, 
Srs2p could act to prevent inappropriate recombination during processes such as DNA 
replication which generate potential recombinogenic structures such as ssDNA gaps. 
Second, Srs2p could act directly to initiate repair of such structures by post-replication 
repair. Third, Srs2p could have a more direct role in recombination and depending upon 
the context, could either limit or promote the extension of recombination structures.
What does this information about Srs2p tell us about Sgslp? One potential 
explanation is that Sgslp is involved primarily in recombinational repair and thus, in the 
absence of both Sgslp and Srs2p, there is a failure to resolve structures either by post­
replication repair or by recombination. The exact nature of these putative structures, the 
process which generates them and the roles of either of these two proteins in resolving 
them remain to be determined.
3.3.3 BLM  partially complements the sgsl A phenotype
Failure to obtain heterologous complementation could occur for a number of reasons. 
First, although proteins from distinct organisms may be structurally similar, they may in 
fact not share functional similarity. For example, BLASTp data suggest that the closest 
yeast neighbour of the human CFTR protein, defective in cystic fibrosis (Riordan et al.,
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1989), is Ycflp (Szczypka et al., 1994). However, the closest human neighbour to 
Y Cflp is not CFTR, but another ABC transporter, MRP which is associated with 
multidrug resistance (Ze-Sheng et al., 1996). Both MRP and YCflp act as glutathione S- 
conjugate pumps and the MRP gene complements ycfl mutants. A second reason for 
failure to observe complementation, is that although two proteins may be functionally 
similar, the pathways in which they act or proteins with which they interact may be 
dissimilar. Third, the timing and levels of expression of many genes may be critical for 
their function and this may be difficult to achieve experimentally.
Expression of BLM in fission yeast failed to complement the effects of loss of Rqhlp 
activity. Other potential end points for assessing complementation, not published at the 
time these experiments were performed, would include the effect of BLM  upon the rates 
of recombination or chromosomal loss induced by HU in rqh l mutants. However, 
similar failure to obtain complementation by BLM, has been found by others (Dr. E. 
Stewart, Department of Genetics, Harvard Medical School, personal communication).
In budding yeast, there is no equivalent of the 'cut' phenotype seen in fission yeast 
and as demonstrated in Chapter 4, in the strain background employed for most 
experiments, sgsl A mutants do not show significant sensitivity to HU. BLM  expression 
did not correct the synergistic slow growth defect of the sgsl AsrslA  double mutant.
There was, however, evidence of partial complementation by BLM  for a subset of the 
phenotypes associated with sgsl A mutation. Deletion of SGSl results in a marked 
suppression of the slow growth and mitotic hyper-recombination phenotypes of a top3A 
mutant. Inducible ectopic expression of wild type SGSl in an sgslAtop3A background, 
but not in a wild type background, results in the re-induction of slow growth. Similarly, 
inducible expression of BLM  in an sgslA top3A  background, but not in a wild type 
background also induces a slow growth phenotype although not to the same extent as for 
SGSL  This partial complementation suggests not only that BLM and Sgslp share 
functional properties, but also that the genetics between topoisomerase III and RecQ 
family helicases may be highly conserved. While this thesis was in preparation, the 
ability of BLM to complement this subset of sgsl A phenotypes has been reported by 
others using strains in which BLM, under the control of the GAPDH promoter, was 
integrated into the SGSl locus. Furthermore, in this study BLM was found to partially 
complement both the elevated rate of illegitimate recombination and homologous 
recombination (between direct repeats) in sgsl A mutants. It seems likely, therefore, that
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the small but consistent reduction in the rate of heteroallelic recombination in BLM
sgsJA  transformants, measured in this study, does in fact correspond to a partial 
complementation effect.
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Chapter 4
An evaluation of the cell cycle defect in 
S.cerevisiae topSA mutants
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4.1 Introduction
DNA topoisomerases catalyse the interconversion of topological isomers of DNA 
and are required for the resolution of torsional stress in DNA and for the unlinking of 
topologically-intertwined molecules. Budding yeast expresses three topoisomerases, 
designated topoisomerases I, II and III, all of which are highly conserved in mammalian 
cells. The role of topoisomerase III in DNA metabolism has remained enigmatic, partly 
because this enzyme possesses only a very weak DNA relaxation activity on negatively 
supercoiled DNA and is thought, therefore, unlikely to participate in the maintenance of 
DNA supercoiling homeostasis (Kim and Wang, 1992; Wang, 1996). It has been 
suggested previously that this enzyme performs a non-essential role in the segregation of 
newly-replicated DNA, although there is no direct evidence to support this proposal 
(Wang, 1996). The bacterial topoisomerase III enzyme shows very similar catalytic 
properties in vitro to that of its eukaryotic counterparts and has been implicated in the 
unlinking of DNA strands during DNA replication to permit nascent chain elongation and 
the separation of daughter molecules (Hiasa and Marians, 1994). The slow growth 
phenotype of S.cerevisiae top3A mutants is associated with the accumulation of cells in 
late S/G2 phase of the cell cycle. Thus, one of the starting points in assessing the 
function of topoisomerase III was to address this defect in the cell cycle.
Cell duplication and division require an orderly and regulated transit through the cell 
cycle (reviewed in Murray and Hunt, 1993). The eukaryotic cell cycle consists of four 
phases: S phase, when DNA replication takes place; M phase, or mitosis, where 
chromosome segregation occurs; and the gap phases G1 (before DNA replication) and 
G2 (before mitosis). Progression through the cell cycle can easily be evaluated in 
S.cerevisiae since this organism divides by budding (Figure 4.1). Early in the cell cycle a 
small bud forms which increases progressively in size and eventually separates from the 
mother cell. Bud formation occurs just after START (see below) and is therefore a useful 
marker for this restriction point. In contrast to higher eukaryotes, the nuclear envelope 
does not break down during mitosis and microtubules are nucleated by spindle pole 
bodies rather than centrosomes. Another key difference is the formation of a pre-mitotic 
spindle during S-phase, the timing of which corresponds to the period of nuclear
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migration, when the nucleus approaches the canal between the mother cell and the bud 
(reviewed in Futcher, 1993).
Although the cell cycle can be viewed as representing discrete phases as described 
above, a more modern view is that cell cycle transitions are more complex involving 
regulation at a number of levels. These encompass changes in cyclin dependent kinase 
activity which in turn is regulated by proteolysis (reviewed in Nasmyth, 1996; King et al., 
1996; Osmani and Ye, 1997), and alterations at the level of the chromosome such that 
they are either competent or refractory for DNA replication (reviewed in Diffley, 1996; 
Stillman, 1996). The integration of these activities are essential in order to ensure first, 
the correct order of events, second, the completion of certain steps (such as DNA 
replication) prior to the initiation of others (such as mitosis) and third, to prevent the 
inappropriate repetition of processes that have already been completed.
Superimposed upon this regulatory network are a number of surveillance 
mechanisms which monitor the completion of individual processes and act either 
positively or negatively upon subsequent steps. A subset of these mechanisms can be 
regarded as ‘checkpoints’ which act to block cell cycle transitions. These are generally 
defined in terms of the response of cells to ‘extrinsic’ effects such as DNA damage or 
inhibition of DNA replication either in replication-defective mutants or following 
exposure to HU.
In S.cerevisiae the G2/M checkpoint induced by DNA damage is thought to be 
dependent upon proteins that act to sense abnormal DNA structures (for example Rad9p 
or Rad24p), ‘signal transducers’, (Meclp, a homologue of the protein ATM, and Rad53p) 
and ‘effectors’ of the cell cycle arrest (Pdslp) (Weinert and Hartwell, 1988; Weinert et 
al., 1994; Allen et al., 1994; Yamamoto et al., 1996b). Damaged cycling cells arrest with 
a large budded phenotype and a short spindle, suggesting an arrest in a G2 or metaphase 
state. In budding yeast, the arrest of cells at this point is mediated by Pdslp, which is 
required for preventing anaphase when DNA or spindles are damaged. Thus, in this 
organism the critical event postponed by the DNA damage checkpoint is sister chromatid 
separation. During the normal cell cycle Pdslp is targeted for degradation by a large 
protein complex, the anaphase promoting complex (APC), which promotes the 
ubiquitination of a number of proteins, including cyclins and Pdslp, that contain 
'destruction boxes' near their N-termini (Cohen-Fix et al., 1996; Osmani and Ye, 1997). 
Degradation of Pdslp, releases another protein, Esplp, which in turn appears to disrupt
105
cohesive forces between sister chromatids, allowing their separation (Ciosk et al., 1998). 
In the absence of Pdslp, cells exposed to DNA damage, progress inappropriately through 
anaphase and lose viability rapidly. In contrast to S. cerevisiae, other eukaryotes employ 
different strategies for inducing a block in cell cycle progression following DNA damage. 
In fission yeast, cells delay the onset of mitosis by inhibiting the activation of p3 4cdc2 
kinase. The onset of mitosis requires the activation and dephosphorylation of a tyrosine 
residue (Y15) of p3 4 cdc2 kinase (reviewed in Kitazono and Matsumoto, 1998). 
Experiments designed to induce inappropriate dephosphorylation of Y15 of cdc2p, also 
result in inappropriate progression though mitosis following DNA damage (Enoch and 
Nurse, 1990; Lundgren et al., 1991). A similar mechanism resulting in a G2 arrest is 
operational in higher eukaryotes, since expression of a p3 4 ^dc2 which 2 major 
phosphorylation sites have been mutated, results in a shorter delay in the onset of mitosis 
following damage, than in controls (Jin et al., 1996; Blasina et al., 1997).
Another checkpoint maintains the dependence of mitosis on the prior completion of 
DNA replication. There are two broad classes of yeast mutants that are defective in this 
checkpoint. The first class comprises mutants in the S.pombe rad/hus (Al-Khodairy and 
Carr, 1992; Jimenez et al., 1992; Al-Khodairy et al., 1994) and in the S.cerevisiae 
MEC1/RAD53 genes (Weinert et al., 1994). Instead of demonstrating a cell cycle arrest 
following inhibition of DNA replication, these mutants proceed inappropriately through 
mitosis. These mutants do not appear to be directly defective in replication or mitosis. 
This group of mutants also show a loss of checkpoint responses following DNA damage 
and thus, it is likely that the cellular response to DNA damage and replication block 
share, at least in some respects, a common framework. A second class of mutations are 
defective in the initiation of DNA replication and include the S.pombe cdclS, cut5/rad4 
and cdtl genes (Kelly et al., 1993; S aka et al., 1994; Hofmann and Beach, 1994) and the 
S.cerevisiae CDC6 genes (Piatti et al., 1995). These mutants are unable to synthesise 
DNA and are therefore not viable. However, instead of undergoing a cell cycle arrest 
like many other mutants defective in DNA replication, this class of mutants progress 
through mitosis with a haploid content of DNA. A single hypothesis which seeks to 
explain the phenotypes associated with the two distinct classes of mutant has been 
proposed (Humphrey and Enoch, 1995). It has been suggested that assembled replication 
complexes activate the checkpoint pathway, thus preventing mitosis while replication is 
ongoing. Thus, in the first class of mutants the surveillance mechanism which monitors
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this signal is impaired, and in the second class of mutants, no replication complexes are 
assembled and no inhibitory signal is generated. Consistent with this model is the finding 
that mutations in certain replication factors can also be associated with a failure to induce 
the appropriate cell cycle delay following DNA damage or inhibition of DNA replication 
(Navas et al., 1995; Sugimoto et al., 1997).
In the following sections, an attempt is made to identify the point in the S.cerevisiae 
cell cycle where topoisomerase III acts. Three approaches were adopted. In the first, an 
attempt was made to clarify the nature of the 'arrest' phenotype observed in top3A 
mutants. Second, the effects of perturbing DNA replication in the absence of 
topoisomerase III were examined. Finally, the cell cycle regulation of T0P3 mRNA 
expression was determined.
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Figure 4.1: Schematic representation of the organisation of the cell cycle of S.cerevisiae.
Nuclei are shown in blue, spindle pole bodies are represented by black circles and spindles by red 
bars. See text for details.
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4.2 Results
4.2.1 top3A cells demonstrate a checkpoint-dependent cell cycle delay at G2/M
The cell cycle transit time of S. cerevisiae top3A mutants is approximately double 
that of isogenic wild-type strains (Wallis et al., 1989). Previous microscopic studies of 
asynchronous top3A cultures revealed an accumulation of large budded cells (-70% of 
the total population) containing a single nucleus close to the neck of the mother cell 
(Gangloff et al., 1994), suggesting a delay in the cell cycle in late S/G2. In order to 
characterise this arrest phenotype in more detail, flow cytometric analyses were 
performed of wild type and top3A cells at timed intervals following release from a cell 
cycle arrest in G1 induced by the a-factor mating pheromone. It should be noted that 
because top3A  cells delay in late S/G2, it was not possible to obtain a completely 
synchronous G 1 population of mutant cells with a-factor within the time course of the 
experiment. Figure 4.2 shows that following release from an a-factor arrest, top3A cells 
progressed through S-phase at a rate similar to that of wild-type cells, but then delayed in 
the cell cycle at a point where they had a 2C content of DNA. Consistent with previous 
studies (Gangloff et al., 1994), therefore, the extended cell cycle time in top3A strains is 
at least in part accounted for by this late S/G2 delay. top3A cells showed a very broad 
cell size distribution (as measured by estimates of forward light scatter), which can affect 
the apparent DNA content of cells when measured by flow cytometry (Paulovich and 
Hartwell, 1995). In order to overcome this problem, contour plots of the flow cytometry 
data were employed because they reflect more accurately the DNA content of a 
synchronous population, and in all subsequent experiments such plots were evaluated 
alongside the more conventional histograms. Analysis of cell size using contour plots 
(Figure 4.3) indicated that top3A cells showed a marked and progressive increase in size 
during the extended delay at late S/G2. It should be noted that top3A cells emerged from 
an a-factor arrest about 1 0-20  minutes earlier than did wild type cells, as assessed 
microscopically by the appearance of small budded cells (data not shown). This possibly 
reflects the larger size of the G 1-arrested mutant cells, which would influence the rate at 
which cells pass the cell size restriction point before START (Pringle and Hartwell, 
1981). Moreover, top3A mutants showed the consistent presence of cells with a <1C 
content of DNA, suggesting an inherent abnormality in chromosome transmission (Figure 
4.2).
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It is not possible using flow cytometry to distinguish between late S-phase and 
G2/M cells and it is a possibility, therefore, that a residual level of non-replicated DNA 
exists in top3A cells that is sufficient to induce a late S-phase delay. To determine 
whether the late S/G2 arrested cells had completed DNA replication, intact chromosomes 
of log phase cells were separated by pulse field gel electrophoresis (Figure 4.4). In this 
assay, only fully replicated DNA enters the gel, whereas incompletely replicated DNA is 
retarded in the wells (Hennessy et al. 1991). As controls, wild type cells were treated 
with HU (blocks in S phase), a-factor (blocks in G l) or MBC (blocks in M). As 
expected, DNA from HU-treated cells failed to enter the gel, whereas the majority of the 
fully replicated DNA in a-factor- or MBC-treated cells entered the gel. In common with 
the findings for wild type cells, the majority of DNA from log phase top3A cells entered 
the gel (70.0% ± SEM 2.9 of total DNA for wild type cells vs. 82.3% ± 2.4 for top3A 
cells). This latter figure was consistently greater than the % of both large budded cells 
and cells with a 2C DNA content. Thus, top3A cells complete bulk DNA replication and 
arrest at a point in the cell cycle after completion of DNA replication, but prior to 
chromosome segregation.
The progressive increase in cell size when top3A mutants attain a 2C content of 
DNA would be consistent with activation of the G2/M DNA damage checkpoint. To 
analyse this, the RAD24 and RAD9 DNA damage checkpoint genes were deleted in a 
top3A background and the cell cycle distribution of the resulting double mutants was 
determined. As shown in Figure 4.5, asynchronous cells from the rad9A top3A and 
rad24Atop3A double mutants showed a marked reduction in the proportion of cells with a 
2C content of DNA. Thus the percentage of cells gated for a 2C content of DNA using 
the contour plots shown were 61.6% {top3A), 40.9% (top3Arad24A) and 40.3% 
(top3Arad9A). Analysis of contour plots indicated that the rad24Atop3A and rad9Atop3A 
cells with a 2C DNA content were of a more uniform size than was observed for a top3A 
single mutant population, suggesting that the double mutant cells were progressing more 
rapidly through G2/M. This suggests that the cell cycle delay in top3A cells is dependent 
upon RAD24 and RAD9 and, by inference, the G2/M checkpoint. Synchronisation 
experiments confirmed that deletion of RAD24 in a top3A background had the effect of 
shortening the G2/M phase and not of causing an additional delay in G l, which could 
have had a similar effect on the appearance of flow cytometric profiles (Figure 4.6). 
Thus, at 40 minutes following release from an a-factor arrest a significant proportion of
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the top3Arad24A cells have progressed into the next cell cycle, whereas the single top3A 
cells continue to be held up at G2/M. We have not excluded the possibility that deletion 
of RAD9 in a top3A background causes an additional problem in the Gl phase of the cell 
cycle. These results were confirmed in 2 independent strain backgrounds.
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F igure  4.2: Cell cycle in topSA m utants. Log phase cultures of wild type (RK C ld) and topSA 
(R K C la) cells were arrested in G l with aHfactor for 150 minutes, washed twice and then 
released into fresh, warmed medium. Flow cytometric analysis was performed at timed intervals. 
Peaks representing cells with a 1C and 2C content of DNA are indicated. Note the presence of a 
population of cells with a DNA content less than 1C in the topSA samples.
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Figure 4.3: Cell cycle changes in cell size and DNA content in top3A  mutants. Flow 
cytometric plots from the same experiment shown in Figure 4.2, in the form of contour plots with 
DNA content (y-axis) against forward light scatter (cell size; x-axis). Peak thresholds were set at 
15%.
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Figure 4.4: Bulk DNA replication is completed in top3A mutants. Intact chromosomal DNA fron 
log phase cultures of wild-type and topSA strains, or of wild-type cells arrested with HU, a-factoi 
or MBC, was separated by pulse field gel electrophoresis. After transfer to a nylon membrane, the 
DNA was probed with the HO gene, which reveals chromosome IV. The positions of the wells ant 
of chromosome IV which had migrated into the gel are indicated.
Ethidium bromide staining of the gel (not shown) demonstrated no differences in the staining 
of larger and smaller chromosomes.
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Figure 4.5: top3A cells demonstrate a RAD94RAD24-dependent cell cycle delay at G 2/M.
Flow cytometric contour plots from log phase cultures of RKC 31a (wild-type), RKCBlb (topSA), 
DLY195 (rad9A), RKC36e (rad24A), RKC36f (top3Arad24A) and RKC36d (top3Arad9A 
strains).
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Figure 4.6: Deletion of RAD24  in top3A  cells shortens the period of delay at G2/M. Log
phase cultures of top3A and top3Arad24A  cells were arrested in G l with a-factor and then 
released into fresh media. Flow cytometric contour plots at timed intervals post-release 
shown.
are
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4.2.2 The effect of SG Sl upon the viability of top3A mutants
One explanation for the cell cycle studies described above, is that in the absence of 
topoisomerase III, abnormal DNA structures are generated during replication, that 
induce a checkpoint-mediated delay at G2/M. Although, this accounts in part for the 
slow growth phenotype of top3A mutants, another factor is the poor viability of top3A 
cells such that they have a plating efficiency of only -25% (Figure 4.7). Deletion of 
SGSl in a top3A background results not only in a reversion to near wild type generation 
times (Gangloff et al., 1994), but also a marked improvement in cell viability. One 
possible interpretation of this is that in the absence of topoisomerase III, Sgslp is 
involved in generating DNA structures that are potentially cytotoxic during S-phase. If 
this is the case, then overexpression of Sgslp might be expected to exert a 'toxic' effect 
only during DNA replication. On this basis, we tested the effect of Sgslp 
overexpression (Sgsl^P) at different phases of the cell cycle in sgslAtopSA  cells. In 
preliminary results derived from 2 independent experiments, log phase cultures of 
sgslAtopSA  cells containing either pRKC2 {SGSl cloned downstream of GALl in a 
multicopy plasmid) or vector control were arrested either in G I with a-factor, or in M- 
phase with MBC. G1 arrested cells were then washed twice and either maintained in G1 
with a-factor or released into media without a-factor. M-phase arrested cells were 
washed twice and then released again into media containing MBC. For each of these 
conditions, the cells were split into 2 aliquots containing either inducing conditions 
(galactose/raffinose ) or repressed conditions (glucose). As shown in Figure 4.8, a 
marked reduction in cell viability was noted in those cells released from G1 into S-phase 
under inducing conditions. In contrast, holding cells in G1 or in M-phase fully or 
partially protected cells from loss of viability under inducing conditions. Protein 
expression was not determined in these experiments.
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Figure 4.7: Poor viability oïtop3A  mutants is suppressed by deletion of S G S l .  W ild type and 
sgsl A, top3A and sgslAtopSA  isogenic mutants were grown to log phase and a known number of 
cells plated onto YPD plates. The number of colony forming units for each strain were counted after 
3 days growth at 30°C and the percentage viability calculated. The mean viability (±SEM) of 3-6 
independent evaluations are shown.
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Figure 4.8: S G S l  overexpression induces a cell-cycle specific loss of viability. sgslAtopSA  
cells transformed with pRKC2 (SG Sl)  or pYES2 (vector control) were grown to log phase in 
selective media containing 2% glucose and then arrested in G 1 with a-factor or in M-phase with 
MBC for 2 hours. At t=0, G 1-arrested cells were then washed twice and then either maintained 
in G1 with a-factor (alpha) or released into media without a-factor (release) for 2 hours. At t=0, 
M-phase arrested cells were washed twice and then released into media containing MBC for 2 
hours. For each condition, cells were split into 2 aliquots containing 2% glucose (-) or 2% 
galactose/1% raffinose (4-). Mean (+ ranges) % survival in relation to t=0, from 2 independent 
experiments are shown. All values were corrected for vector control values. G1 and M-phase 
arrests were confirmed microscopically for the duration of the experiment. Expression of Sgslp 
was not confirmed in these experiments.
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4.2.3 top3A mutants lose viability rapidly when DNA replication is blocked by HU
There is substantial evidence supporting a role for topoisomerases during replication, 
acting both as swivelases and decatenases (Watt and Hickson, 1994; Wang, 1996). 
Furthermore, prokaryotic topoisomerase III possesses the ability to unlink DNA strands 
during replication in an in vitro system (Hiasa and Marians, 1994). One possible 
interpretation of the extended delay at G2/M in the absence of functional topoisomerase 
III is that abnormal DNA structures are generated during the process of DNA replication. 
This is in keeping with the similarities in flow cytometric profiles between top3A mutants 
and those of a number of replication-defective mutants, including cdcl7, cdc9 and cdc44 
(Weinert and Hartwell, 1993). In order to study this in more detail, we evaluated the 
effects on cell survival of inhibiting DNA synthesis with HU. Wild-type and top3A cells 
were released from an a-factor-induced G1 arrest into medium containing HU and % 
survival was quantified at timed intervals thereafter. Figure 4.9 shows that in a topSA 
cell population loss of survival occurred rapidly at a dose of HU (200mM) that was non­
toxic to wild-type cells, such that following a 2 hour exposure 75% of top3A cells had 
either lost viability or were committed to die. Release from a-factor arrest into medium 
lacking HU was not associated with any loss of survival. Significant loss of viability 
occurred at a point when top3A cells were still in early S-phase, as judged by analysis of 
their DNA content using flow cytometry (see Figure 4.13 below and confirmed using 
contour plots; data not shown). HU sensitivity of top3A mutants was confirmed in 3 
independent strain backgrounds.
Expression of a wild-type TOP3 gene in a top3A mutant fully suppressed both the 
slow growth phenotype in drug-free medium, and the sensitivity to HU (Figure 4.10). 
Previous work has shown that deletion of S G S l in a top3A genetic background 
suppresses the slow growth and mitotic hyper-recombination phenotype characteristic of 
these cells, and Sgslp has been shown to bind to topoisomerase III (Gangloff et al., 
1994). As shown in Figure 4.11, deletion of SGSl also almost completely corrected the 
HU sensitivity of top3Acç\\s. Indeed, top3A mutants could not be propagated on YPD 
plates containing as little as 2.5mM HU, whereas sgslAtop3A  double mutants formed 
colonies in the presence of 100 mM HU (data not shown). This genetic interaction 
between top3 and sgsl was confirmed in 2 independent strain backgrounds. This 
suggests that in the absence of topoisomerase III, Sgslp activity is maybe in some way 
dysregulated and that this contributes to the HU sensitive phenotype. To test this, the
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effect of Sgsl op in a wild type background was evaluated. In the preliminary experiment 
shown in Figure 4.12, Sgspop had a small effect upon the viability of wild type cells in 
the presence of HU. Expression of Sgslp in relation to the various conditions for this 
experiment was not determined.
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Figure 4.9: top3A cells lose viability when DNA replication is inhibited Log phase cultures of 
wild type (□ ) and top3 (O) cells were arrested in G1 and released into medium containing 0.2M 
HU. The mean % survival (±SEM) determined at timed intervals in 3 independent experiments is 
shown
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Figure 4.10: Complementation of the HU sensitivity oïtopSA  mutants by ectopic expression 
of wild type TOPS. Log dilutions of saturated cultures of top3A cells transformed with pRK500, 
which encodes wild type TOPS, or a vector-only control were plated onto YPD (upper panel) or 
YPD containing lOmM HU (lower panel).
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Figure 4.11: Deletion of SGSl suppresses the HU sensitivity of top3A mutants. Early log phase 
cultures in minimal media of wild-type (□ ), and isogenic sgsl  (■), sgs l  top3 ( • )  and top3  (O ) 
mutants were exposed to 0.2M HU at the times indicated and % survival was determined as 
compared to t=0. Data represent means (±SEM) from 4 independent experiments.
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Figure 4.12: SGSl overexpression confers HU sensitivity in wild type cells. Wild type cells 
transformed with pRKC2 (SGSl) or pYES2 (vector control) were grown to log phase in selective 
media containing 2% glucose. At t=0, cells were washed twice and resuspended in selective 
media containing 2% glucose plus 0.2M HU (□ ), 2% galactose/1% raffinose plus 0.2M HU (O) 
and 2% galactose/1% raffinose with no HU (■). At timed intervals %survival in relation to t=0 
was determined. The means (±SEM) of 5 experiments are shown for pRKC2 transformants are 
shown. In all cases and under each condition, % survival in vector controls was 100%. The % 
survival in cells released into media containing 2% glucose alone was 100% in each of the 
experiments. Note that the y-axis is linear. Expression of Sgslp was not confirmed in these 
experiments.
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4.2.4 top3A cells do not demonstrate an ‘arrest’ phenotype following exposure to HU
When DNA replication is blocked in wild-type budding yeast with HU, cells arrest 
with a uniform phenotype of a large-budded morphology containing a short, bar-like 
spindle and an undivided nucleus close to the bud neck. This arrest phenotype is 
dependent upon an intact checkpoint apparatus involving 'sensors' {P0L2, RFC5, 
D P B ll), ‘signal transducers’ {MECl, RAD53) and as yet undefined 'effectors' of the cell 
cycle arrest (Lydall and Weinert, 1996). The rapid kinetics of death in HU-treated topSA 
cells is similar to that observed previously in checkpoint-deficient mutants. These 
checkpoint mutants fail to show the uniform arrest phenotype seen in HU-treated wild 
type cells, and appear to progress through mitosis, as manifested by the presence of long 
anaphase-like spindles, with a near haploid content of DNA (Allen et al., 1994; Weinert 
et al., 1994; Navas et al., 1995; Araki et al., 1995; Sugimoto et al., 1997).
To investigate this aspect in top3A strains, wild type and top3A cqW cultures were 
arrested in G1 with a  factor and then released, one half into media containing HU and the 
other half into drug-free medium. Nuclear and cellular morphologies were then 
compared by DAPI/spindle staining at the 2 hour time point when both wild-type and 
top3A cells had an S-phase content of DNA (Figure 4.13). The most striking feature of 
HU-treated top3A cells was the apparent lack of the normal cell cycle arrest phenotype 
(despite evidence that replication was inhibited by HU) and a concomitant increase in the 
% of abnormal cells (Figures 4.14-16). Examples of abnormal nuclear morphologies in 
HU-treated top3A cells included DNA that was fragmented, positioned entirely within the 
bud, or completely absent (despite the presence of mitochondrial DNA staining). These 
qualitative observations were confirmed quantitatively by scoring the percentage of 
abnormal cells in the presence or absence of HU (Figure 4.17). Microtubule staining of 
top3A cells also demonstrated several abnormalities, including, loop- or spoke-shaped 
spindles, unusually thick microtubule or inappropriately long spindles. Thus, following a 
2 hour exposure to HU, 97% of wild type cells had arrested with a short spindle. In 
contrast, 23% of top3A cells had a partially elongated spindle.
The rapid loss of viability in the presence of HU, in association with marked 
abnormalities of nuclear and spindle morphology could suggest that the coupling of 
subsequent cell cycle events to the completion of DNA replication is dependent upon 
functional topoisomerase 111. One potential explanation for the loss of viability in HU- 
treated top3A cells is that they are entering a near haploid mitosis. However, if mitosis
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was inhibited by co-treating top3A cells with HU and the microtubule poison, MBC, 
there was no significant suppression of the loss of viability (Figure 4.18). Thus, 
commitment to death in HU-treated top3A  cells does not appear to require either 
cytokinesis or progression beyond the arrest point in M-phase induced by MBC, as has 
been reported recently for hypomorphic mutants of RAD53 or M ECl (Desany et al., 
1998).
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Figure 4.13: DNA content of wild type and topSA cells treated with HU. Flow cytometry 
histograms of wild type and top3A early log phase cultures that were arrested in G1 with a -fac to r 
and then released into medium containing either 0.2M HU or no drug as a control.
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Figure 4.14: Arrest phenotype observed in wild type cells following exposure to HU. Same 
experiment as in Figure 4.9. Representative photomicrographs of DAPI/tubulin staining of wild- 
type cells exposed to HU for 2 hours.
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Figure 4.15: Nuclear morphology oitopSA  cells exposed to HU. Same experiment as in Figure 
4.14. DAPI staining of top3A cells exposed to HU for 2 hours.
a-tubulin
topSA  + HU
Figure 4.16: Spindle morphology of top3A cells exposed to HU. Same experiment as in 
Figure 4.15. Spindle staining of topSA cells exposed to HU for 2 hours demonstrating the 
following abnormalities: elongated spindles (top left), loop-pattern (top right), radial pattern 
(bottom left) and thickened, irregular microtubule array (bottom right).
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Figure 4.17: Abnormalities in nuclear DNA staining in wild type and topSA cells following 
exposure to HU. Abnormalities in nuclear DNA staining were quantified in wild-type and top3A 
cells following exposure to 0.2M HU or mock treatment for 2 hours, by scoring at least 200 cells. 
All assessments were performed single blind and the mean percentage (±SEM) of 3 independent 
experiments are shown.
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Figure 4.18: Inhibition of mitosis does not reverse the HU sensitivity of topSA mutants Log
phase wild type (□ , ■  ) and topSA (O , # )  cells were arrested in G1 with a -fac to r, and then 
released at t=0 into media containing either 0.2M HU (open symbols) or 0.2M HU plus 200p,g/ml 
MBC (closed symbols). The mean % survival in relation to t=0 (±SEM) from three independent 
experiments is shown. Values for HU/MBC treated cells were adjusted according to values 
obtained when cells were released in parallel into media containing MBC alone. In this arm of 
the experiment, arrest at M-phase was maintained for at least 4 hours. Neither wild type nor 
top3A cells showed any significant sensitivity to MBC.
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4.2.5 Expression of the T0P3 gene is cell cycle regulated
Thus far, the data implicate topoisomerase III in an S-phase-specific role in response 
to DNA perturbations. Analysis of the pattern of T0P3 gene expression was therefore 
evaluated in order to provide further evidence for a cell cycle phase-specific role. For 
this, wild-type cells were arrested in G1 with a-factor and then released into fresh 
medium. RNA samples were prepared at timed intervals for Northern blot analysis, and 
cell cycle position was assessed in parallel by analysis of both budding index and DNA 
content using flow cytometry. In the representative experiment shown in Figure 4.19, 
synchrony was maintained until the middle of the second cycle. The level of T0P3 
mRNA peaked 20 minutes after release from a-factor arrest at a level 11-fold higher than 
that in the arrested cells. This time point coincided with onset in the decline of G1 cells, 
but was prior to the appearance of budded cells. In the second cycle, the peak in TOP3 
mRNA levels was coincident with the rise in the proportion of G1 cells. The estimated 
size of the T0P3 transcript was -2.5 kb. This pattern of transcription was confirmed in a 
second strain background, and the 2.5kb transcript was undetectable in RNA derived 
from top3A cells (data not shown). Thus, it appears that TOP3 transcripts are low in 
early G l, appear abruptly around START and decline during late S/G2.
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Figure 4.19: Cell cycle regulation of T0P 3  mRNA. Wild type cells (RKCld) were grown to 
early log phase, arrested in Gl as described in Figure 6 and then released into fresh warmed 
medium. Cells were removed at timed intervals for RNA extraction, measurement of budding 
index and flow cytometric analysis of DNA content. (A) Levels of the T O P 3 and A C T / 
transcripts at timed intervals prior to and following release from Gl arrest. (B) The percentage of 
budded cells (O ) and cells gated with a Gl content of DNA ( □ )  plotted relative to TOPS 
transcript levels (■), quantified from the data in panel (A). The maximal transcript level is given 
an arbitrary value of 100%. Note that cells lose synchrony at about the mid-point of the 2nd 
cycle.
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4.3 Discussion
4.3.1 top3A  strains are defective in cell cycle progression in the absence of DNA 
damaging agents or HU
Previous work has shown that the slower doubling time of top3A strains is a result of 
an accumulation of cells in the late S/G2 phase of the cell cycle. I have shown here that 
these cells have completed bulk DNA replication and are arrested at the G2/M DNA 
damage checkpoint. The most economical explanation for these findings is that some 
form of abnormal DNA structure and/or DNA lesion is generated during DNA replication 
and that while this is not sufficient to prevent completion of bulk DNA synthesis, it 
nevertheless is recognised by the G2/M DNA damage checkpoint machinery as 
abnormal.
A major challenge is now to identify the abnormal DNA structures that might occur 
during progression through S-phase in these mutants. It is known that aberrant 
replicative structures resembling recombination intermediates or late Cairns-type 
structures can be observed on 2 -dimensional gels following drug-mediated inactivation of 
topoisomerase I or II in budding yeast (Levac and Moss, 1996). However, DNA samples 
derived from asynchronous cultures of wild-type and top3A strains exhibit no consistent 
differences on 2-dimensional gels, even if replication is perturbed by either DNA damage 
(with 0.01% MMS) or 50mM HU (Dr. J. Kearsey, Institute of Molecular Medicine, 
personal communication). I conclude that any putative abnormal replication intermediates 
that might arise in top3A strains either fall outside the group of structures detectable by 
this method, or are accumulated at levels below the detection limit.
Preliminary evidence suggests that Sgslp is implicated in generating these putative 
abnormal structures. Thus, in an sgslAtop3A  mutant, ectopic expression of Sgslp 
appears to be particularly deleterious in cells progressing though S-phase. Relative 
protection was afforded to cells overexpressing Sgslp, but which were held either in Gl 
or in M-phase. I have not excluded the possibility that cells lose viability at other points 
in the cell cycle i.e. in G2 at a point prior to the M-phase block induced by MBC. 
Despite the obvious qualifications regarding the difficulty in interpreting the deleterious 
effects of overexpressing proteins, it will be of some interest to assess the effect of 
Sgslop upon replicative intermediates detected in 2D gels, since this might give some 
insight into the nature of abnormal DNA structures present in top3A mutants.
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It has been proposed that topoisomerase III in conjunction with Sgslp has a role in 
the terminal stages of DNA replication (Gangloff et al., 1994; Watt et al., 1995). As 2 
replication forks converge, a build up of positive supercoils between the two advancing 
replisomes could inhibit the final stages of DNA replication. It has been suggested that 
Sgslp might unwind the unreplicated region between the advancing forks, which would 
have the effect of introducing intertwinings between the daughter DNA molecules. This 
would then require the action of topoisomerase II or III to decatenate the daughter 
molecules prior to anaphase. Three findings suggest that this model does not fully 
explain the role of topoisomerase III. First, the cell cycle regulation of the TOPS 
transcript suggests that topoisomerase III protein is required at a much earlier stage in the 
cell cycle. Second, the sensitivity of topSA mutants to the effect of HU which blocks 
cells at early S-phase, suggest that its role in replication is likely to be earlier than that 
predicted by the model. Third, in data not shown, overexpression of topoisomerase II, 
which might be expected to suppress any defect in decatenation of daughter molecules at 
the terminal stages of replication, had no effect upon the growth rate or viability of topSA 
mutants.
4.3.2 tops A strains are hypersensitive to HU
Hydroxyurea is an S-phase specific toxin that acts through inhibition of 
ribonucleotide reductase (reviewed in Elledge et al., 1993). Wild type yeast cells treated 
with HU arrest in S-phase for approximately 2 hours, but then adapt to the presence of 
HU by inducing expression of ribonucleotide reductase subunits, permitting continued 
DNA synthesis. The HU-sensitive mutants of budding and fission yeast that have been 
identified to date fall into 2 distinct classes depending upon the kinetics of cell death 
induced by this agent. One class of mutants, which includes those defective in P0L2, 
RFC5, MECl and RAD53 in S. cerevisiae, fail to arrest adequately in the presence of HU 
and progress into an aberrant mitosis with unreplicated DNA (Allen et al., 1994; Weinert 
et al., 1994; Navas et al., 1995; Sugimoto et al., 1997). By definition, this class are 
defective in the S/M checkpoint that monitors whether DNA replication is complete 
before committing the cells to a mitosis, and these mutants show rapid death kinetics 
when treated with HU. To date, mutations of this class in S. cerevisiae have all been 
shown to reside in essential genes. Recent evidence suggests that the loss of viability in 
rad53 or mecl mutants following transient inhibition of DNA synthesis is not the result
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of inappropriate anaphase, but rather a failure to complete chromosomal replication 
(Desany et al., 1998). The second class of HU-sensitive mutants, exemplified by rqhl 
mutants of fission yeast, arrest normally in the presence of HU, but lose viability during 
the subsequent ‘recovery’ period when cell cycle progression is re-initiated after a period 
of adaptation (Stewart et al., 1997; Davey et al., 1998).
One interpretation of the data presented in this study is that top3 strains are 
representative of the first class of HU-sensitive mutants in that they lose viability rapidly 
upon exposure to HU and do not show the normal S/M checkpoint arrest in S-phase. 
This interpretation is subject to the following two qualifications. First, the viability of 
top3A mutants is low and thus, it is difficult to interpret whether the morphological 
abnormalities observed are occurring in cells already committed to die prior to exposure 
to HU or cells which only lose viability in the presence of HU. Second, top3A cells, in 
the absence of HU, demonstrate a delay in G2/M transition and thus, the kinetics of 
spindle elongation following release from a Gl arrest are different from wild type cells. 
In this context, it was not possible to demonstrate a progressive and inappropriate 
increase in the percentage of cells with anaphase-like spindles in top3A cells exposed to 
HU (data not shown). In conclusion, top3A cells exposed to HU, show rapid loss of 
viability associated with nuclear fragmentation and abnormal spindle morphology. It is 
not possible however, to state definitively whether these effects relate to loss of the S/M 
checkpoint or as a consequence of a defect in some other process, such as DNA repair.
top3A mutants are genuinely hypersensitive to HU in that they cannot be propagated 
on solid medium containing as little as 2.5 mM HU. To my knowledge, based both upon 
published reports and upon my own studies of various S/M checkpoint-deficient mutants, 
top3A strains are substantially more sensitive to HU than any of the previously described 
checkpoint-deficient mutants of budding yeast. Since many of the previously described 
HU-sensitive mutants, including rad53 and mecl, are apparently completely defective in 
the S/M checkpoint, it is difficult to reconcile the extreme sensitivity of top3A mutants 
simply with loss of this checkpoint. I would suggest that top3A mutants are defective in a 
process such as the processing of DNA lesions in preparation for their repair, that acts to 
maintain viability during or following exposure to HU. Consistent with this, loss of 
recombinational repair functions is also associated with extreme sensitivity to HU (Allen 
et al., 1994). Transient inhibition of DNA synthesis in rad53 and mecl mutants leads to
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a subsequent failure to complete chromosomal replication as assessed by pulse field gel 
electrophoresis (Desany et al., 1998). It will be important to test this in top3A mutants.
4.3.3 TOP3 is a putative new member of the SCB box-containing family of genes
The proposal that topoisomerase III has a role in S-phase is supported by the data 
showing that TOP3 transcript levels are cell cycle regulated, arising in Gl and declining 
in late S/G2. A number of genes are transcribed exclusively in the late Gl phase or at the 
Gl/S boundary, including the Gl cyclins and certain genes required for DNA synthesis ( 
reviewed in Schwob and Nasmyth, 1996). These late G 1-activated genes can be 
classified into 2 groups on the basis of cA-acting sequences found within their promoter 
sequences. The first group of genes includes the DNA metabolism genes (e.g. RFA 1-3, 
POLI-3, DBF4) and the CLB5 and CLB6 cyclin genes, and the promoter region of these 
genes contains an element similar to the Mlul cell cycle box (MCB element). The 
second group of genes, including CLNl, CLN2 and HCS26, contain a promoter motif 
termed the SCB element, which acts as a late G 1-specific upstream activating sequence 
and binds the Swi4/Swi6 complex (Ogas et al, 1991). Following S-phase, transcription of 
both of these groups of genes is down-regulated. In this context, I have identified a 
potential SCB element in the 5’ flanking region of TOP3 (CGCGAAA, at positions -130 
to -124 from the ATG start codon), suggesting that TOP3 is a new member of the group 
of genes regulated by the Swi4/Swi6 complex. While this finding would be consistent 
with the Gl activation of TOP3 gene expression, it should be noted that the minimal 
promoter region and positions of any potential transcription start sites in the T0P3 gene 
have yet to be characterised.
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Chapter 5
The role of S. cerevisiae topoisomerase III in 
mediating checkpoint responses to DNA 
damage and replication blockade.
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5.1 Introduction
Cells respond to DNA damage or to an inhibition of DNA replication by delaying 
cell cycle progression in order to resolve the resulting abnormal DNA structures. These 
cell cycle ‘checkpoint’ pathways are highly conserved in different eukaryotic species and 
act to preserve both genome integrity and cell viability (reviewed by Hartwell and 
Weinert, 1989; Carr, 1995; Paulovich et al., 1997). A major function of checkpoint 
pathways is to ensure that cells do not enter mitosis with non-replicated DNA, or enter S- 
phase or mitosis with a damaged genome. The first indication these pathways were under 
genetic control came from the observation that certain mutants of the budding yeast S. 
cerevisiae could be identified that failed to delay mitosis even when chromosomal 
damage remained unrepaired (Weinert and Hartwell, 1988). It is now clear from the 
results of many studies that checkpoint pathways are dependent upon the actions of 
numerous gene products (reviewed by Paulovich et al., 1997).
The genetic and biochemical composition of a particular checkpoint pathway is 
determined, at least in part, by the point in the cell cycle at which the perturbation of 
DNA structure/function occurs (Figure 5.1). Entry into S-phase is inhibited if cells incur 
DNA damage in G l, such as through UV irradiation, and this Gl/S DNA damage 
checkpoint is dependent upon the RAD9, RAD 17, RAD24, MECl, MEC3, DDCl and 
RAD53 (also called MEC2/SAD1/SPK1) genes in S. cerevisiae (Siede et al., 1993; Allen 
et al., 1994; Siede et al., 1994; Longhese et al., 1996; Siede et al., 1996a and 1996b; 
Longhese et al., 1997). These genes, in conjunction with PDSl, are also required for the 
G2/M checkpoint, which acts to inhibit entry into anaphase when DNA damage has not 
been repaired (Weinert et al., 1994; Yamamoto et al., 1996). Two additional checkpoints 
have been identified in budding yeast that function either to slow the rate of progression 
through S-phase in the presence of DNA damage, the intra-S checkpoint (Paulovich and 
Hartwell, 1995), or to inhibit entry into anaphase when DNA replication is blocked in 
response to inhibition of nucleotide biosynthesis by hydroxyurea (HU), the S/M 
checkpoint (Weinert et al., 1994). A common mechanism underlying both of these S- 
phase checkpoints is suggested by recent studies, indicating that inhibition of DNA 
synthesis or DNA damage, leads to a M ECHRAD53 -dependent inhibition of late 
replication origin firing (Santocanale and Diffley, 1998; Shirahige et al., 1998). The
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majority of the Gl/S and G2/M checkpoint genes play a minor or no role, at least in 
budding yeast, in the intra-S and S/M checkpoints (Paulovich et ah, 1997a and 1997b), 
with the notable exception of MECl and RAD53, which are both essential genes and are 
required for checkpoint pathways that operate in all phases of the cell cycle (Allen et ah, 
1994; Weinert et ah, 1994; Siede et ah, 1996b). In addition to the ‘dedicated’ checkpoint 
genes that play a role in S-phase, there are certain gene products that function in S-phase 
as part of the DNA replication machinery, whilst additionally performing some, as yet 
unidentified, role in checkpoint surveillance of the genome. These include Pole (DNA 
polymerase e) and D bpllp  (Pole-interacting factor), which act in the S/M checkpoint 
(Navas et ah, 1995; Araki et ah, 1995), and Prilp (the catalytic subunit of DNA primase), 
which acts in the intra-S checkpoint (Marini et ah, 1997).
In addition to subdividing checkpoints on the basis of the phase of the cell cycle in 
which they act, it is possible to categorise individual checkpoint proteins on the basis of 
whether they function in a DNA damage/abnormal structure ‘sensory’ role, as ‘signal 
transducers’, or as ‘targets’ of the signalling cascade (Lydall and Weinert, 1996). Thus, 
loss of a DNA damage sensor, such as Rad9p, Rad24p or Pole, causes a failure to 
transduce the signal required for arrest of the cell cycle (Navas et ah, 1995; Kiser and 
Weinert, 1996). Part of the signal transduction cascade that is absent in this class of 
mutants is the MEC7-dependent phosphorylation of Rad53p (Navas et ah, 1996; Sun et 
ah, 1996; de la Torre-Ruiz et ah, 1998). As a result of this defect in signalling, other 
features of the checkpoint response are absent, including transcriptional upregulation of 
DNA damage response genes such as RNRl, RAD51 and RAD 16 (de la Torre-Ruiz et ah, 
1998). Loss of factors acting downstream of the MEC7-dependent signalling cascade 
would not be expected to show deficiency in Rad53p phosphorylation, but instead might 
be blocked at a subsequent step in the checkpoint pathway, such as prior to induction of 
cell cycle arrest. Although considerable progress has been made in identifying 
checkpoint sensors and signal transducers, our knowledge of the targets of these factors, 
particularly those acting in S-phase, is still very limited.
In the previous chapter, I demonstrated that top3A mutants were HU-sensitive, 
although there is no definitive evidence for an associated loss of the S/M checkpoint. In 
the following sections, an attempt is made to assess the integrity of other cell cycle 
checkpoints in top3A mutants and to assess the relationship of topoisomerase III with 
components of the checkpoint apparatus.
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Figure 5.1: Model of cell cycle checkpoint responses in S.cerevisiae See text for details 
(Navas et af, 1996)
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5.2 Results
5.2.1 tops A cells are sensitive to DNA damaging agents
A number of checkpoint mutants are defective in the arrest of the cell cycle in 
response not only to inhibition of DNA replication, but also to DNA damage, probably 
reflecting some overlap in the cellular checkpoint response to a variety of different 
abnormal DNA structures (Lydall and Weinert, 1996). The sensitivity or otherwise of 
topSA mutants to DNA damaging agents was therefore tested. topSA cells were found to 
be sensitive to the DNA damaging agents MMS (Figure 5.2) and UV-light (Figure 5.3) 
and to a lesser extent (approximately 2.5-fold) to ionising radiation (Figure 5.4). These 
results were confirmed in 3 independent strain backgrounds. As was the case for HU- 
treatment, the sensitivity of topSA strains to DNA damaging agents was substantially 
suppressed by deletion of SGSl or by ectopic expression of a wild type TOPS gene 
(Figure 5.5).
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Figure 5.2: Sensitivity of topSA ceils to MMS. Strains RKCld (wild type, □) JMK22d (sgsl, 
■), RKClc (sgsltop3. • )  and RKCla (top3, O) were grown to early log phase in YPD and then 
at t=0 were exposed to MMS at the concentrations indicated for 60 minutes and % surviva 
determined in relation to t=0. The means (±SEM) of 3 independent experiments are shown.
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Figure 5.3: Sensitivity of top3A cells to UV. Strains RK Cld (wild type, □ )  JMK22d (sgsl, 
■ ), R K C lc (sgsltopS, # )  and R K C la (top3, O ) were grown to early log phase in YPD and 
exposed to UV at the doses indicated. % survival was determined in relation to a non-irradiated 
control. The means (±SEM) of 3 independent experiments are shown.
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Figure 5.4: Sensitivity of top3A cells to y-rays. Strains RKCld (wild type, □ )  JMK22d (sgsl, 
■ ), R K C lc {sgsltopS, # )  and R K C la {top3, O ) were grown to early log phase in YPD and 
exposed to y-rays at the doses indicated. Survival was determined in relation to a non-irradiated 
control. The means (±SEM) of 3 independent experiments are shown.
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Figure 5.5: Complementation of the MMS and UV sensitivity of top3A mutants by ectopic 
expression of wild type T0P3. Log dilutions of saturated cultures of top3A cells transformed 
with pRK500, which encodes wild type T0P3,  or a vector-only control were plated onto YPD 
(upper panel) or YPD containing 0.01% MMS (middle panel) or YPD, followed by UV 
irradiation at 60J/m^ (lower panel)
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5.2.2 top3A cells are defective in the intra-S checkpoint, but not in the G 1/S or G2/M 
DNA damage checkpoints
The intra-S checkpoint acts to slow the rate of DNA synthesis when DNA is 
damaged during S-phase and is dependent upon the products of a number of genes 
(Paulovich and Hartwell, 1995). The data in Figure 5.6 shows that when top3A cells 
were released from an a-factor-induced G1 arrest into medium containing 0.03% MMS, 
most cells achieved a 2C content of DNA after approximately 60-90 minutes, whereas 
wild-type cells similarly treated progressed through S-phase much more slowly, such that 
at 240 minutes the majority of cells still had a < 2C content of DNA. Consistent with a 
failure to invoke the intra-S checkpoint, the viability of top3A cells at the 60 minute time 
point was only <0.2% compared with 86.5% for wild-type cells. In the absence of MMS, 
top3A cells entered S-phase more rapidly than wild-type cells when the a-factor was 
removed (see earlier discussion in section 3.2.1) and the majority of cells have a 2C 
content of DNA at the 60 minute time point. In contrast, wild type cells attain a 2C 
content of DNA at 90 minute time point. This difference however cannot account for the 
dramatic disparity in the rates of S-phase progression in the presence of MMS. It should 
be noted that there is a partial delay in the rate of S-phase progression in top3A mutants 
in the presence of MMS and this is observed in other mutants defective in this checkpoint 
(Paulovich and Hartwell, 1995; Sugimoto et al., 1997; Paulovich et al., 1997b).
In contrast to the above results, cell cycle checkpoint responses to DNA damage 
occurring outside of S-phase were apparently unaffected by deletion of T0P3. Figure 5.7 
shows that when a-factor arrested top3A cells were UV-irradiated and then released into 
fresh medium, they showed a marked delay in the rate of progression through the G 1/S 
phase transition, as compared to non-irradiated controls. Indeed, the extent of the delay 
in top3A mutants appeared to be somewhat greater than that apparent in irradiated wild- 
type cells. Thus, while top3 mutants are proficient in the Gl/S checkpoint, it is possible 
that topoisomerase III plays some role in G 1, as supported by the finding that only partial 
protection was afforded to MMS-treated top3A mutants by maintaining them in G1 with 
a-factor (Figure 5.8).
The data presented in chapter 3 indicate that top3A cells delay at a Rad9p/Rad24p- 
mediated G2/M checkpoint in the absence of exogenously-added DNA damaging agents. 
When cells arrested in G2/M with MBC were then UV-irradiated, the extent of 
subsequent delay in the cell cycle following removal of MBC was comparable in wild-
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type and top3A cells (Figure 5.9), confirming that the G2/M DNA damage checkpoint is
intact in top3A mutants.
Budding yeast cells arrest in mitosis in response to spindle depolymerisation 
(Clayton et a., 1979). Mutants defective in this spindle-assembly checkpoint, such as 
madl or bubl, continue through mitosis without a spindle in the presence of microtubule 
poisons and die rapidly (Li and Murray, 1991; Hoyt et al., 1991). However, top3A cells 
were not sensitive to MBC, indicating that this checkpoint is also intact (Figure 5.10).
^Note that the possibility that the changes in DNA content of top3A mutants may reflect 
changes in the content of mitochondrial DNA. This could be excluded by assessing the effect 
of T0P3  deletion in strains containing no mitochondrial DNA.
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Figure 5.6: top3A  cells are defective in the intra-S checkpoint. To assess the intra-S
checkpoint, wild type and top3A cells were grown in YPD to early log phase and then arrested in 
G1 with a-factor for 150 minutes. Cells were then washed twice with fresh warmed media and 
released into media containing either 0.03% MMS (+) or no drug (-) as a control. DNA content 
was assessed by flow cytometry and contour plots with DNA content (y-axis) against cell size (x- 
axis) are shown. Thresholds were set at 15%. Similar results were obtained in each of 4 
experiments performed.
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Figure 5.7: topSA cells are proficient in the Gl/S checkpoint. Wild type and top3A cells were 
grown in YPD to early log phase and then arrested in G1 with a-factor for 150 minutes, and then 
irradiated with 80 J/m^ UV light (+) or mock treated (-), before washing twice and releasing into 
fresh medium. Similar results were obtained from 4 independent experiments.
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Figure 5.8: Effect of exposure to MMS in celis held in G1 with a-factor. Wild type ( □ ,  ■ ) 
and top3A (O , • )  cells were arrested in G 1 as above and then released into YPD containing 
either 0.005% MMS alone (open symbols) or 0.005% MMS plus 20pg/ml a-factor (closed 
symbols) and % survival was determined at the time points indicated. The effectiveness of the a- 
factor block in each case was assessed microscopically and by flow cytometry. The means 
(±SEM) of 3 inidependent experiments are shown.
148
wild type top 3 A
2C
1C
log
0
+  tim e (m inutes)
2C
"f" tim e (m inutes)
^  30 30
^  90
i
i f
150 150
■«3
Figure 5.9: top3A cells are proficient in the G2/M DNA damage checkpoint. Wild type and 
top3A cells were grown in YPD to early log phase and arrested in G2/M with MBC 200pg/ml for 
2 hours, and then irradiated with 80 J/m^ UV light (+) or mock treated (-), before washing twice 
and releasing into fresh medium. Similar results were obtained in 2 independent experiments.
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Figure 5.10: Sensitivity of wildtype a n d c e l l s  to the spindle poison, M BC. Log phase 
wild type ( □ )  and top3A (O) cells were exposed at t=0 to MBC at 200pg/ml and the % survival 
in relation to t=0 determined at the times indicated. The means (±SEM) of 3 independent 
experiments are shown. Note that a positive control was not run in this experiment.
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5.2.3 Rad53p phosphorylation and transcriptional upregulation of DNA damage 
response genes occurs in top3A cells
Checkpoint proteins can be categorised on the basis of whether they function as 
‘sensors’ of abnormal DNA structure, ‘signal transducers’, or ‘targets’ of the signalling 
apparatus (Lydall and Weinert, 1996). Loss of sensory function might be expected to 
result in an absence of all downstream responses following DNA damage or replication 
inhibition, including a failure both to phosphorylate Rad53p and to show transcriptional 
upregulation of DNA damage response genes. In contrast, loss of a target function would 
be predicted to result in the variable loss of transcriptional induction or cell cycle arrest 
(depending upon the point at which the protein acts), but would show intact 
phosphorylation of Rad53p.
In order to position topoisomerase III function in relation to this broad outline of the 
checkpoint pathway, an assessment was made of Rad53 phosphorylation and 
transcriptional induction of DNA damage response genes in wild-type and top3A cells 
following release from a G1 arrest into medium containing HU or MMS. Figure 5.11 
shows that phosphorylation of Rad53p (as indicated by the appearance of a slower 
migrating species on SDS-PAGE) occurred in top3A cells following DNA damage or 
inhibition of DNA replication. Furthermore, even in the absence of drug treatment, 
extracts from top3A cells showed a small fraction of Rad53p that migrated as a lower 
mobility form (indicated by the arrow marked with an asterisk in Figure 5.11). This 
aberrant phosphorylation in the absence of extrinsic damage suggests that abnormal 
structures exist in top3A cells that result in a degree of constitutive activation of the 
checkpoint pathway. Quantification of the immunoreactive Rad53 protein suggested that 
there was a clear attenuation in the extent of Rad53 phosphorylation following HU or 
MMS treatment in top3A cells as compared to wild-type cells. Thus, for topSA cells the 
maximal % of total Rad53p that existed in the phosphorylated form was 59.4% after HU 
treatment (91.4% for wild type cells), and 54.7% after MMS treatment (87.9% for wild 
type). Furthermore, the proportion of Rad53p that was fully phosphorylated following 
HU or MMS treatment in top3A cells was substantially less than in wild type cells.
Since transcriptional responses to DNA damage/replication block are at least 
partially dependent upon an intact Rad53-dependent pathway (Allen et al., 1994), we 
examined whether transcriptional upregulation of genes, including RNRl, RAD51, and 
RAD 16 occurred in top3A mutants. In the presence of either HU or MMS, ih t RNRl
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transcriptional responses was broadly similar (Figures 5.12 and 5.13). In both wild type 
and top3A cells the RAD51 transcript is upregulated following HU/MMS although this is 
less easy to interpret since the baseline level of transcription in G1 was 2.5 fold higher in 
top3A cells. RAD 16 transcript levels were evaluated since this transcript is not cell cycle 
regulated. In wild type cells MMS exposure results in a 2.5 fold induction in RAD16 
transcript levels although HU exposure has no effect. In untreated top3A cells the RAD16 
transcript levels increase 2 -fold following release from the G 1 arrest and there appears to 
be no significant induction over and above this following DNA damage or replication 
block. This data, together with the finding of aberrant Rad53 phosphorylation in 
untreated cells, would be consistent with the hypothesis that top3A cells accumulate DNA 
lesions, resulting in RAD 16 expression through the Rad53p-dependent pathway, which is 
proficient in these cells. This hypothesis is not supported, however, by the finding of 
attenuated levels of Rad53p phosphorylation following DNA damage or HU-treatment.
A number of checkpoint mutants defective in sensory {pol2, rfc5) or signal 
transduction {mecl) functions show partial rescue of their respective phenotypes by over­
expression of either Rad53p or Tel Ip, since these proteins probably function downstream 
of M eclp (Navas et al., 1996; Sanchez et al., 1996; Sugimoto et al., 1997). However, 
overexpression of neither RAD 53 (Figure 5.14) nor TELl (not shown) had any 
significant effect on the HU or DNA damage sensitivity of top3A cells.
152
control + HU + MMS
time (min): 0 50 100 150 50 100 150 50 100 150
Racl53 I Wild type
Rad53 [
Figure 5.11: Rad53 phosphorylation in top3A mutants. Wild type and top3A cells were 
grown in YPD to early log phase and then arrested in G1 with a-factor for 150 minutes. Cells 
were then released into YPD (control), or into YPD containing either 0.2M HU or 0.03% MMS. 
Protein extracts derived from cells removed at timed intervals were then separated by SDS- 
PAGE, transferred to nylon and immunoblotted with an a-Rad53 antibody. A representative 
Western blot for extracts from wild-type (upper panel) and top3A (lower panel) cells is shown. 
Arrows on the left label the positions of non-phosphorylated (lowermost arrow in each panel) and 
phosphorylated (uppermost arrow) forms of Rad53. The arrow marked with an asterisk defines 
the position of the additional, lower mobility form of Rad53 seen in top3A cells in the absence of 
drug treatments.
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Figure 5.12: Transcriptional induction following DNA damage or inhibition of replication 
in top3A cells. Wild type and top3A ceils were grown in YPD to early log phase and then 
arrested in G1 as described m Figure 5.11. Cells were then released into YPD (control) or into 
YPD containing either 0.2M HU or 0.03% MMS. Cells were removed at timed intervals for 
RNA extraction and representative Northern blots hybridised with either an R N R i  or an ACT!  
control probe are shown. Fold induction of the RNRl  transcript (as indicated to the right of each 
data set) in the presence of either HU or MMS was determined by dividing the maximal transcript 
level observed in each case by the transcript level seen in the absence of dmg treatment (corrected 
in all cases for ACT I mRNA levels).
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Figure 5.13: Transcriptional induction following DNA damage or inhibition of replication 
in tops A cells. Wild type and topSA cells were grown in YPD to early log phase and then arrested 
in G1 as described in Figure 5.11. Cells were then released into YPD (control), or into YPD 
containing either 0.2M HU or 0.03% MMS. Cells were removed at timed intervals for RNA 
extraction and Northern blots hybridised with RN Rl, RAD51, RAD16 or A C T l.  Transcript 
levels were corrected in all cases in relation to the loading control. Graphs showing the fold 
increase for each of the transcripts following treatment with 0.2M HU (□ ), 0.03% MMS (■) or 
mock treatment (O ) are shown. In each case the fold increase was determined in relation to the 
wild type G1 value. Wild type responses are shown on the left and topSA responses on the right.
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Figure 5.14 : Rad53p overexpression does not reverse the HU sensitivity oitopSA  cells Wild 
type and top3A cells were transformed with single copy pRAD53 (in which RAD53  is cloned 
downstream of the GALl promoter) or vector control, and the resulting transformants spread onto 
selective plates containing either 2% glucose or 2% galactose/1 % raffinose, with and without 
lOmM HU. Plates showing colony growth in the presence or absence of HU under inducing 
conditions are shown. Similar negative results were obtained when cells were exposed to MMS 
or UV. Similar negative results were obtained following overexpression of RAD53, also under 
the contol of the GALl  promoter, from a multicopy plasmid. Overexpression of Rad53p was 
confirmed by immunoblot.
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5.2.4 Effect of DNA damage or inhibition of replication upon TOPS  mRNA 
expression
As described above, both prokaryotic and eukaryotic cells upregulate the 
transcription of DNA repair genes following DNA damage or inhibition of DNA 
replication (Friedberg et al., 1995; Kiser and Weinert, 1996). In order to assess whether 
TOPS transcript levels are similarly upregulated, wild type cells were arrested in G1 and 
then released into YPD containing HU, MMS or no drug control. RNA samples were 
prepared at timed intervals for Northern blot analysis. There was an 3-fold increase in 
the level of TOPS mRNA when cells were exposed to MMS, but no significant increases 
following exposure to HU and UV (Figure 5.15). Controls showed increases in RNRl 
expression following exposure to both agents.
In budding yeast a number of genes whose transcription is upregulated by DNA 
damage have so-called 'damage response elements' (DREs) in their 5' regions (Sancar, 
1985; Siede and Friedberg, 1992; Zheng et al., 1993; Kiser and Weinert, 1996). A search 
for potential DREs in the 5' sequence upstream of the ORE for TOPS revealed potential 
DREs at positions (relative to the translation initiation codon) -46 to -64 (similarity to an 
element in the PH Rl promoter) and -817 to -831 (similar to the D REl element in the 
RAD2 promoter and another closely related element in the RAD5S promoter). An 
alignment of these putative DREs is shown in Figure 5.16.
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Figure 5.15: Transcriptional induction of T0P3  following DNA damage or inhibition of
replication. Wild type cells were grown in YPD to early log phase, arrested in G1 and then released 
into YPD containing (1) 0.2M HU, (2) 0.03% MMS or (3) no drug (control). Cells were removed at 
timed intervals for RNA extraction and a Northern blot hybridised with either a TOP3 or an ACTl  
probe. Transcript levels were corrected in all cases in relation to the loading control. Graph showing 
the fold increase for the TOP3 transcript following treatment with 0.2M HU (□ ), 0.03% MMS (■) 
or mock treatment (O ) is shown. In each case the fold increase was determined in relation to the G1 
value.
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Figure 5.16: Potential damage response elements in the 5' region upstream of the T0P3  
translation initiation codon. Two possible sites with sequence similarity to previously 
identified damage response elements, PHRl and DREl,  are shown. Figures to the left correspond 
to the position of the first nucleotide of each element in relation to the translation initiation codon 
of the respective genes. The nucleotide sequence with similarity to PHRl  identified in the T0P3  
5’ region is in reverse orientation to the reported element.
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5.2.5 Genetic interactions between top3 and other checkpoint-deficient mutants
The M E C l and RAD53 genes encode essential proteins involved in the signal 
transduction pathway that is activated during S-phase by inhibition of DNA replication, 
and during all phases of the cell cycle by DNA damage (Allen et al., 1994: Weinert et al., 
1994; Siede et al., 1996b). Combination of a topSA mutation in the A364a strain with 
conditional alleles of MECl (mecl-1) and RAD53 (mec2-l) resulted in synthetic lethality 
(either microcolonies that could not be propagated or no visible colony) after sporulation 
of the appropriate heterozygous diploids at the permissive temperature (Tables 5.1).
In an effort to characterise genetic interactions between top3A and other mutations 
that disable potential targets of the Mecl/Rad53 signal transduction pathway, the effect 
of combining deletion of T0P3 with conditional mutations in RFA2, which encodes the 
34 kDa subunit of single-stranded DNA binding protein, and PRIl, which encodes the 
large subunit of DNA primase, were examined. Rfa2p has roles in both DNA replication 
and DNA repair, and is one of the very few established ‘targets’ for the checkpoint kinase 
cascade operating in S-phase. In budding yeast, Rfa2p is phosphorylated in response to 
DNA replication block or DNA damage, and this phosphorylation is dependent upon 
MECl, but not RAD53 (Brush et al., 1996). Combination of top3A with either of two 
independent rfa2 alleles (rfa2-l and rfa2-2) resulted in synthetic lethality (Tables 5.1 and 
5.2, Figures 5.17 and 5.18), either at the permissive temperature for top3A rfa2-l double 
mutants (25®C, n=20 tetrads dissected) or at the semi-permissive temperature for top3A 
rfa2-2 double mutants (30°C, n=20). Similarly, combination of a top3A mutation with 
the pril-M4  mutation, which itself leads to a defect in S-phase checkpoint responses to 
DNA damage (Marini et al., 1997), resulted in synthetic lethality at the permissive 
temperature for the pril-M4 strain (25°C, n=20).
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Table 5.1
Genotypes of segregants following sporulation of diploid heterozygous for 
jc^and top3A ^
genotype m ecl-1
n=35
m ec2-l
n=25
rfa2 -l
n= 20
pri-M 4
n= 2 0
T0P3 X 32 19 17 26
T 0P 3x 14 27 21 12
top3 X 36 13 23 10
top3 X 0 0 0 0
1 where % is the recessive allele indicated at the top of each column and where X  is the 
respective wild type allele-
 ^all germinations were performed at 25®C'
Table 5.2
Survival of segregants of diploid heterozygous for rfa2-2 and top3A at different 
temperatures^
genotype 250C, n=20 3Q0C, n=20
T0P3 RFA2 18 18
T O f /yü2-2 16 16
top3 RFA2 17 17
top3 rfa2-2 19 0
1 segregants were germinated at 25°C and then spread onto 2 plates, and then allowed to 
grow at either 25°C or 30°C for 3 days.
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Figure 5.17: Synthetic lethality of top3A and rfa2-l  m utations. CG378 diploids heterozygous 
for top3A::G418^ and rfa2-l were constructed, allowed to sporulate and tetrads dissected onto 
YPD plates. Spores were then allowed to germinate at 25°C for 3 days. Ten tetrads, each 
arranged vertically, are shown. Genotypes shown in the table below are as follows; {\)T0P3  
RFA2-, (2) T 0 P 3  rfa2-l ; (3)top3 RFA2\ and (4) top3 rfa2-l. No segregants with a type (4) 
genotype were recovered. In each case, where there is no macroscopic colony, between 10-50 
cells were evident on microscopic examination, confirming that germination had taken place, but 
that subsequent vegetative growth was defective. Genotypes were assigned by screening 
segregants for the ability to grow in the presence of G418 or at 36°C. Since, both top3A and 
rfa2-l cells are unable to grow at 36°C, G418-resistant segregants were mated to wild type cells 
and the resulting diploids dissected. Cells derived from the inital cross were assigned a top3 
RFA2 genotype if no segregants from the second cross that were both G418-sensitive and 
temperature-sensitive were recovered.
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wild type rfa2-2
top3Arfa2-2 top 3 A
wild type rfci2-2
top3Arfci2-2 top 3 A
25°C 30°C
Figure 5.18: Synthetic lethality of top3A  and rfa2-2 mutations. CG378 wild type, rfa2-2, 
top3A and top3A rfa2-2 cells were spread on YPD plates and incubated at the permissive (25°C) 
or semi-permissive (30°C) temperature for 3 days.
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5.2.6 Genetic interactions between top3 and mutations affecting checkpoints outside 
S-phase.
In the absence of extrinsic damage or inhibitors of replication, synchronous top3 
cells demonstrate a RAZ)24//MD9-dependent delay at the G2/M checkpoint. Bulk DNA 
replication as assessed by pulse field gel electrophoresis of intact chromosomal DNA is 
complete. One explanation put forward in Chapter 4 is that during DNA replication 
abnormal structures or lesions are generated in top3 cells that are not sufficient to prevent 
the completion of bulk DNA synthesis, but nevertheless are recognised by the G2/M 
damage checkpoint machinery as abnormal.
One prediction of this hypothesis is that loss of the G2/M checkpoint would have 
deleterious consequences upon the viability of top3 cells. In order to address this, a 
series of double mutants were constructed in which the G2/M checkpoint genes RAD9, 
RAD 17 and RAD24 were deleted in a top3A background (A364a strain). Unexpectedly, 
loss of the G2/M checkpoint in a top3A mutant did not reduce viability significantly 
(Figure 5.19). Since deletion of RAD9 or RAD24 singly, does not completely abolish the 
G2/M checkpoint (Aboussekhra et al., 1996), a triple mutant in which both these genes 
were deleted in a top3A  background was constructed. Deletion of both these genes 
abolishes the G2/M checkpoint almost completely (Aboussekhra et al., 1996; de la Torre- 
Ruiz et al., 1998). Viability in this triple mutant was not compromised as compared to 
the top3A single mutant. This suggests that any DNA lesions generated prior to the 
induction of the checkpoint-mediated delay in the cell cycle are not repaired to any great 
extent during the delay period.
Another unexpected finding was that deletion of either RAD 17 or RAD24, but not 
RAD9, resulted in an increase in viability of top3A cells. RAD9 forms part a distinct 
epistasis group from the other G2/M checkpoint genes including RADI 7, RAD24, MEC3 
and DDCl. Members of the latter group, as opposed to RAD9, appear to have a role in a 
meiotic checkpoint (Lydall et al., 1996). Furthermore, it has been suggested that whereas 
Radl7p and Rad24p promote exonuclease activity in response to certain damage, this 
activity is antagonised by Rad9p. Since loss of RAD9 or RAD 17/24 in a top3A 
background resulted in equivalent reductions in the cell cycle delay at G2/M, it seems 
likely that this difference reflects differences in the activities of Rad9p and Rad24p that 
are independent of their checkpoint role.
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Consistent with this, assessment of survival following UV irradiation suggested that
TOPS had an epistatic relationship with RAD17/24 but a synergistic relationship with
^ 0 9  (Ftgures 5.20. 5.21 and 5.22). The classical interpretation of epistasis data in
A repair ts that mutations which when combined do not lead to increased radiation
sensitivity compared to the most sensitive single mutant act in the same pathway
utations which do increase radiation sensitivity when combined act in different
pathways. In the latter case, if the effect is synergistic it is likely that the respective gene 
products compete for the same subset of lesions.
In summary, loss of the G2/M checkpoint in a ropSA does not compromise viability
Loss of Rad24p/17p activity actually improves overall viability of a ,op3A mutant and
the respective mutants show epistatic relationships in relation to DNA damage. It should
be noted that the effect of RAD24 deletion upon topSA viability was specific to the A364a
background and was not reproduced in 2 other strain backgrounds tested. In no
background tested was there any significant additional loss of viability following deletion 
of RAD9 or RAD24 in a topSA background.
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Figure 5.19: Viability of top3A cells following loss of RAD9 and ÆAD24 genes. Cells derived 
from log phase cultures of isogenic mutants in the A364a background were counted and a known 
number of cells plated onto YPD. The number of colony forming units was determined after 3 days 
growth at 30®C. The means (±SEM) of 3-6 independent experiments are shown.
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Figure 5.20: Effect of R A D 24  upon UV sensitivity of top3A mutants. Log phase cultures of 
A364a wild-type (□ ) , top3A (O), rad24A (■ ) and top3Arad24A (# ) strains were plated onto YPD, 
exposed to UV, and % survival determined in relation to non-irradiated controls. Mean (±SEM) % 
survival from 4 independent experiments are shown.
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Figure 5.21: Effect of R A D I 7 upon UV sensitivity of top3A mutants. Log phase cultures of 
A364a wild-type (□ ) ,  topSA (O), radlVA (■) and top3Aradl7A  (# )  strains were plated onto 
YPD, exposed to UV and % survival determined in relation to non-irradiated controls. Mean 
(+SEM) % survival from 4 independent experiments are shown.
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Figure 5.22: Effect of RAD9  upon UV sensitivity of top3A cells. Log phase cultures of A364a 
wild-type (□ ) , top3A (O), rad9A  (■) and top3Arad9A ( • )  strains were plated onto YPD, 
exposed to UV and % survival determined in relation to non-irradiated controls. Mean (±SEM) 
% survival from 4 independent experiments are shown.
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5.2.7 Genetic interactions between top3 mutants and genes which influence 
recombinational repair.
Loss of each of the 3 topoisomerases in budding yeast results in mitotic hyper­
recombination (Christman et al., 1989; Kim and Wang, 1989; Wallis et al., 1989; 
Gangloff et al., 1994; Kim et al., 1995). In top3 mutants this is characterised by RAD52- 
dependent recombination between repetitive sequences, including the rDNA (Wallis et 
al., 1989; Gangloff et al., 1994). A potential role in recombinational repair is suggested 
by the sensitivity of top3 mutants to ionising irradiation. The above results also 
suggested a link to recombination, since rad24 mutants show an epistatic relationship not 
only to top3 mutants but also to rad52 in relation to sensitivity to UV irradiation 
(Eckardt-Schupp et al., 1997). It has been proposed that Rad24p is involved in the 
formation of single stranded substrates for the recombinational repair machinery (Lydall 
and Weinert, 1995).
Loss of any of the genes of the RAD52 epistasis group in a top3A background (YPl 
strain) resulted in an improvement in viability as compared to the top3A single mutant 
(Figure 5.23). This compared with little effect upon viability following loss of KU70, a 
gene with a role in the non-homologous end-joining of double strand breaks. 
Comparison of the various isogenic mutants suggests that TOP3 showed an epistatic 
relationship to RAD52 in relation to their sensitivity to ionising irradiation (Figure 5.24), 
although this latter result should be interpreted cautiously since top3A mutants are only 
mildly sensitive to ionising irradiation. The effect of RAD52 deletion upon top3A 
viability was reproducible in another independent strain background.
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Figure 5.23: Viability of top3A cells following loss of genes involved in recombinational
repair. Cells derived from log phase cultures of isogenic mutants in the YPl background were
counted and a known number of cells plated onto YPD. The number of colony forming units was
determined after 3 days growth at 30°C. The means (±SEM) of 3-6 independent experiments are 
shown.
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Figure 5.24: Effect otRADSZ upon 7-ray sensitivity ottopSà cells. Log phase cultures of YPl 
wild-type (□), top3A (O), radSlA (m)and top3àrad52A (• )  strains were exposed to y-rays at the 
indicated doses and % survival determined in relation to non-irradiated controls. Means (±SEM) 
of 3 independent experiments are shown.
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5.3 Discussion
5.3.1 The role of topoisomerase ID in S-phase checkpoint responses
In the previous chapter, evidence was presented demonstrating that untreated top3A 
cells delay at G2/M. In the presence of HU top3A cells lose viability rapidly and this is 
associated with the finding of cells with fragmented nuclei. Although this latter finding 
would be consistent with the loss of the S/M checkpoint, it is difficult to interpret 
morphological changes in cells that already have disturbed cell cycle kinetics. In this 
chapter, we have shown that top3 cells are defective in the intra-S checkpoint but other 
checkpoints outside S-phase are intact.
While there are many examples of mutants that show abnormal responses within S- 
phase to inhibition of DNA replication or .DNA damage, it would appear that no 
previously described mutant exhibits the same range of phenotypic characteristics as 
those of a top3A mutant. Amongst the previously described mutants that lack both the 
intra-S and the S/M checkpoints Qi&.mecl-l,mec2-l ( an allele of RAD53) and rfcS-l 
(defective in a subunit of Replication Factor C), all of which are conditional mutations in 
essential genes (Allen et al., 1994; Weinert et al., 1994; Paulovich and Hartwell, 1995; 
Sugimoto et al., 1997). However, mecl-1 andmec2-l mutants are defective in all 
checkpoint responses, including those operating outside of S-phase, and rfc5-l mutants 
are defective in transcriptional induction of DNA damage response genes and 
phosphorylation of RadSSp in response to DNA damage or replication blockade. To my 
knowledge, only one mutant has been identified to date that shows intact transcriptional 
responses to DNA damage, but nevertheless fails to inhibit progression through S-phase 
in the presence of DNA damage. This is the partially dominant, conditional mutation 
(pri-M4) in the PRIl gene, encoding the catalytic subunit of DNA primase (Marini et 
al., 1997). However, tills mutation does not confer HU sensitivity, unlike deletion of 
T0P3. Thus, deletion of TOP3 is distinctive in that it neither affects checkpoints 
operating outside of S-phase, nor the ability to upregulate transcription of DNA damage 
response genes (at least in the case of RNRl).
It has not been possible to determine whether topoisomerase HI acts upstream of 
Rad53p in a 'sensing' role or whether it acts downstream as an effector of cell cycle delay. 
Against topoisomerase HI acting downstream is the reduction in the degree of Rad53p 
phosphorylation following DNA damage or replication block. However, the failure to
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observe any effect of overexpressing either RAD53 or TELl upon either HU or MMS 
sensitivity of top3A cells is in contrast to the reported effects of overexpression in pol2 
(Navas et al., 1996) or rfc-5 (Sugimoto et al., 1997) mutants. Although transcriptional 
responses appear to be intact, such upregulation is not necessarily dependent upon 
Rad53p (de la Torre Ruiz et al., 1998). Thus, at present, two models can be envisaged. 
In the first topoisomerase III acts upstream of Rad53p as a sensor of abnormal structures. 
In this case the integrity of the transcriptional responses is dependent upon redundancy in 
this sensory mechanism. In the second model, topoisomerase IQ acts downstream of 
Rad53p as an effector of the cell cycle delay. In this scenario, the attenuation in the 
degree of Rad53p phosphorylation reflects the loss of viability of top3A cells in the 
presence of HU or MMS. This is discussed in more detail in Chapter 6 .
5.3.2 topSA strains are sensitive to several classes of DNA damaging agents
Mutations in a wide variety of genes encoding DNA repair enzymes or checkpoint 
proteins confer sensitivity to DNA damaging agents (Friedberg et al., 1995). Thus, for 
example, mutation of nucleotide excision repair genes leads to sensitivity to UV light, 
while mutation of recombinational repair genes confers sensitivity to ionising radiation 
and MMS, but not to UV light. top3A mutants are unusual in being sensitive to all three 
of these classes of agent, indicating that the protein probably does not play a dedicated 
role in any single pathway for the repair of specific DNA lesions, but instead operates 
more generally in cellular responses to DNA damage. To my knowledge, this represents 
the first evidence in eukaryotes that a topoisomerase can protect ceUs from the cytotoxic 
effects of DNA damaging agents. In one report, mutation of prokaryotic topoisomerase I 
was. associated with UV sensitivity and this has been interpreted as evidence that proteins 
involved in nucleotide excision repair are influenced by the superhelical density of DNA 
(Stemglanz et al., .1993; Pedrini and Ciarrochi, 1983). Since yeast topoisomerase m  does 
not appear to play any significant role in supercoiling homeostasis (Wang, 1996), this 
hypothesis is unlikely to apply to top3A mutants.
The iipreg;iilation of the TOPS transcript following treatment of wild type cells with 
MMS, but not HU, may indicate that it has some role in the direct processing of DNA 
lesions resulting from this agent. This result should be viewed with some caution, 
however, since the TOPS transcript is cell cycle regulated and treatment with MMS 
perturbs the cell cycle. Experiments that assess TOPS transcript and topoisomerase IQ
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protein levels following MMS-exposure of cells held at different points in the cell cycle 
will need to be performed. The role of the putative DREs identified in the 5' region 
upstream of the translation initiation codon of the TOPS gene has also not been 
determined. Transcription initiation sites and the stability or otherwise of the 
topoisomerase IQ protein are, however, not known. The significance of these sites, 
together with the role of a putative SCB box (described in Section 4.3.3), will need to be 
evaluated by assessing the effect of mutation of the various elements.
5.3.3 The relationship of TOPS to other genes that mediate S-phase checkpoint 
responses
Given the intact nature of DNA damage checkpoint responses occurring in G1 and 
G2, but a failure to invoke the intra-S DNA damage checkpoint, it would appear that 
DNA damage arising during S-phase presents the most serious threat to topSA mutants. 
Consistent with this is the finding that combination of topSA with mutants that are 
defective in S-phase checkpoint responses {mecl-1, mec2-l, pri-M4)) or in targets of this 
response {rfa2-l, rfa2-2), resulted in a synthetic lethal phenotype. In contrast, 
combination of topSA with deletions affecting genes which influence specifically G1 and 
G2/M checkpoints, did not result in a lethal effect. The difficulty in interpreting this 
information is that each of the S-phase checkpoint genes, with the exception of TOPS, is 
an essential gene. Loss of an essential function in cells which are already compromised 
does not necessarily imply that the topSA mutation and the other S-phase checkpoint 
mutations act synergistically to knock out an essential checkpoint pathway. Thus, the 
lethality of combined of topSA and pri-M4 mutations may simply reflect a failure to 
replicate DNA. However, in data not shown, topSA mutations when combined with a 
hypomorphic mutation {pol2-12) in another essential S-phase specific gene, P0L2 , was 
not associated with synthetic lethality. Although these latter mutants are reported to be 
defective in the S/M checkpoint (Navas et al., 1995), I was not able to reproduce this in 
the A364a background.
I have not excluded the possibility that abnormal DNA struetures are generated 
outside of S-phase that require the action of topoisomerase IQ. The protracted delay of 
topSA cells in the G1 phase following UV-irradiation, the failure to completely reverse 
the MMS sensitivity of these cells by maintaining them in G1 during drug exposure, and 
the presence of a minor fraction of phosphorylated Rad53p in undamaged G1-arrested
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cells, is consistent with a possible role for topoisomerase HI in the G1 phase of the cell 
cycle. In the absence of DNA damage, however, the rate of progression through the G 1/S 
transition is not prolonged. The nature of any role for topoisomerase III in G 1 remains to 
be determined.
5.3.4 Identification of other potential suppressors of the top3A phenotype
Genetic suppression of mutants defective in a cellular process can occur in two ways 
(Murray and Hunt, 1993). Mutational suppression results from a compensatory 
mutational change that re-establishes function. Dosage suppression infers that an 
increased concentration of an interacting component might stabilise a complex or 
promote a reaction by over-riding any block.' W e have identified two groups of genes, 
which when deleted, suppress the loss of liability of mutants. The first includes 
members of the RAD24 epistasis group and the second, members of the RAD52 epistasis 
group.
The effect of Rad24p or Radl7p appear to be independent of their role in the G2 
checkpoint, since deletion of Rad9p does not suppress the low viability of topSA 
mutants. In this context, there is some evidence that Rad24p and Radl7p have roles in 
DNA repair. For example, Rad24p shows sequence similarity to subunits of replication 
factor C (RFC) (Griffiths et al., 1995). RFC is a five-subunit protein complex that has 
roles in both DNA replication and repair (Waga and Stillman; 1994; Aboussekhra et al., 
1995; McAlear et al., 1996). The similarity of Rad24p to these subunits resides in 
domains H, HI and Vm, and suggests that Rad24p has some RFCftype functions. Like 
certain rfc mutants, rad24A mutants show a moderate degree of HU sensitivity (Lydall 
and Weinert, 1997). Furthermore, overexpression of Rad24p strongly reduces the growth 
rate of yeast strains defective in DNA repair/replication proteins including RFC Ip, DNA 
pola and DNA polS. More indirect evidence of a role in DNA repair derives from 
studies that suggest that Radl7p has significant homology with human RADI which 
possesses 3' to 5' exonuclease activity (Parker et al., 1998). Taken together, these results 
suggest that in the absence of topoisomerase IQ, Radl7p and Rad24p possess DNA 
processing functions that are deleterious to cell viability. This effect was only observed 
in the A364a background and not 2 other backgrounds tested, a finding in keeping with 
those of others studying the effects of Rad24p overexpression (Lydall and Weinert, 
1997). The reason for this is not known. In no background, however, did loss of the
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RAD24 or RAD9 genes confer any significant loss of viability. This might indicate that a 
substantial fraction of the DNA lesions that led to the induction of the G2/M checkpoint 
are either irreparable, at least in G2/M, or can be tolerated in subsequent cell cycles.
Deletion of genes in the RAD52 epistasis group conferred a similar improvement in 
viability in top3A mutants as that following deletion of RAD24. Thus, recombinational 
processing of abnormal DNA structures present in the absence of topoisomerase m  are 
damaging to the cell. Furthermore, in work performed while this thesis was in 
preparation, deletion of RAD52 has been found to suppress the HU and UV sensitivity of 
top3A  mutants (Dr. Jonathan Kearsey, Institute of Molecular Medicine, personal 
communication). As in the case of RAD24, there are two general explanations for this 
r. .. I suppression. First, topoisomerase m  could be involved in the resolution of intermediates 
; “ generated by Rad52p. : Second; in the absence of>to;x)isomerase jlH DNA lesions might be 
generated in which are then processed inappropriately by the recombinational repair 
apparatus.
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Chapter 6
Conclusions
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6.1 Summary of key findings
The overall aim of this thesis was to improve our understanding of how defects in 
RecQ helicases in humans can lead to gross genomic stability, that in turn can lead to 
cancer predisposition or features of premature replicative senescence. The structural 
similarity of human BLM and S.cerevisiae Sgslp, and the potential similarity of the 
cellular phenotypes when either of these proteins are defective, alerted us to the use of 
yeast as a model system (German, 1993; Watt et al., 1996). In the first instance, 
heterologous complementation studies were performed, which showed that BLM could 
complement a subset of the sgslA  phenotypes. SGSl deletion suppresses the slow 
growth phenotype of mutants defective in ,topoisomerase m . Ectopic expression of wild 
type SGSl in an sgslAtop3A mutants re-induces the < slow growth phenotype, an effect 
that is reproduced by ectopic expression of BLM. This suggested that the interaction 
between the RecQ family helicases and this topoisomerase is highly conserved. Thus, the 
remaining part of this study focused upon the functional role of topoisomerase IQ using 
yeast as the model system.
Loss of topoisomerase IQ results in a cell cycle delay at the G2/M phase of the ceU 
cycle and this delay is dependent upon the DNA damage checkpoint genes 
RAD24IRAD9. This suggested a potential role for topoisomerase IQ in the resolution of 
abnormal DNA structures/damage arising during S-phase. Consistent with this concept, 
top3A mutants are defective in the intra-S checkpoint that slows the rate of S-phase 
progression following exposure to DNA damaging agents. Furthermore in the presence 
of the DNA replication inhibitor hydroxyurea, mutants demonstrate a rapid loos of 
viability associated with fragmented nuclei and abnormal nuclear spindles. Whether this 
latter finding truly represents loss of the S/M checkpoint is not clear since it has proven 
difficult to interpret changes in spindle elongation in cells that even in the absence of HU 
show a defective cell cycle. DNA damage checkpoints operating outside S-phase were 
shown to be unaffected by deletion of T0P3. Consistent with this S-phase specific role, 
expression of the TOP3 mRNA is activated in late G1 and the T0P3 gene contains a 
putative SCB motif in the 5' region upstream of the translation initiation codon. Most of 
the phenotypic consequences of loss of topoisomerase IQ are partially suppressed by 
deletion of SGSl, although the effect of SGSl deletion in a top3A background upon the 
intra-S or S/M checkpoint was not examined.
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6.2 Topoisomerase IQ- a role in checkpoints or repair?
Loss of topoisomerase HI confers specific loss of S-phase checkpoints. A number of 
findings, however, suggest that a primary function of topoisomerase IQ is to mediate 
repair of DNA lesions. First, assuming the S/M checkpoint is defective in top3A mutants, 
these cells were exquisitely sensitive to HU and to an extent that was greater than other 
mutants defective in the S/M checkpoint. Second, although the G 1/S checkpoint is 
proficient in top3A mutants a role in DNA repair at this phase of the cell cycle cannot be 
excluded. This is suggested by the extended delay following irradiation in G1 phase as 
compared to wild type cells, the failure to rescue MMS sensitivity of top3A cells by 
holding them in G1 with a-factor, and the aberrant ^ phosphorylation of Rad53p in a- 
factor arrested cells. The potential upregulation of the TOPi transcript following 
exposure of wild type cells to MMS is also consistent with a role in repair. Finally, the 
genetic interactions between top3A and rad24 or rad52, are suggestive of functional 
relationships between topoisomerase HI and proteins with DNA repair/processing 
functions.
There is increasing evidence, both in prokaryotes and eukaryotes, that cellular 
responses to DNA damage are dependent upon the partial processing of damage to 
intermediate structures. In bacteria, the SOS' pathway mediates the response to DNA 
damage that results in increased DNA repair and cell survival (Little and Mount, 1982; 
Friedberg et al., 1995). However, initial damage, such as DSBs is insufficient to activate 
this pathway, since partial processing of the DSB by RecBCD to generate ssDNA is 
required before RecA can bind and mediate downstream events including cell cycle 
alterations and DNA repair (reviewed in Sassanfar and Roberts, 1990).
In budding yeast, there are three lines of evidence that this type of processing is 
found in eukaryotes. First, UV-induced pyrimidine dimers cannot themselves trigger a 
checkpoint response (Siede et al., 1994; Weinert, 1997), but instead require the action of 
excision repair proteins or photolyase. Second, checkpoint mediated arrest during 
mciosis (during which DSBs arc normally degraded to generate 3' single strands) is also 
postulated to correlate with the presence of single stranded DNA (Weinert, 1997). In one 
mutant, radSOS, DSBs generated during meiosis are not degraded, and cells do not arrest 
(Alani et al., 1990). A third example provides evidence that checkpoint proteins 
themselves may be involved in the initial processing of DNA damage. Thus, in cdcl3
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mutants which arrest at G2 at the restrictive temperature, a lesion in dsDNA is converted 
to ssDNA, an effect which is dependent upon Radl7p/Rad24p (Lydall and Weinert, 
1995).
6.3 How does loss of topoisomerase III activity result in loss of checkpoint 
proficiency?
How can the above findings be incorporated into a model for the action of 
Sgsl/Top3 during replication? When cells are exposed to any insult that results in 
replication fork disruption, the cell is likely to require the integrated response of proteins 
acting not only in cell cycle checkpoint processes, but also in DNA replication, 
recombination and repair pathways. As discussed above, a common factor in mediating 
such responses is the partial processing of DNA to single-stranded D_NA intermediates. 
Since both helicases and topoisomerases can generate and process such substrates, one 
attractive possibility is that the Sgsl/Top3 complex is central to the ‘networking’ of the 
various pathways.
In Figure 6.1 a schematic model for the role of SgslpATop3p is shown. I propose 
that following inhibition of replication or DNA damage, replication forks stall and that 
Sgslp/Top3p is involved in the early processing of the resulting abnormal DNA 
structures. SgslATop3 could serve two functions in this process, which are not mutually 
exclusive: first, the preparation of lesions for repair by the RAD52-dependent 
recombination machinery, and second, the generation of DNA structures that lead to 
activation of the checkpoint, thus preventing the firing of : new replicons. Murray et al.
(1997) have suggested a similar role for fission yeast r^ /%7 ^  in preparing DNA lesions at 
blocked replication forks for the recombinational repair machinery. This model would 
also be consistent with the proposed role of the RecQ protein, the E.coli homologue of 
Sgslp, which in concert with RecA can initiate homologous recombination and disrupt 
joint molecules formed by aberrant recombination (Harmon et al., 1998). In further 
support of this general concept are the observations that recombination intermediates 
(Holliday junctions) can be detected in yeast during S-phase and that perturbation of 
replication leads to an elevation in their frequency (Zhou et al., 1997).
Deletion of SG Sl results in suppression of the HU, MMS and UV sensitive 
phenotype of top3A mutants. It has not been established, however, whether or not 
sgslAtop3A double mutants are checkpoint proficient. If the double mutant is checkpoint
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proficient, then one explanation could be that the phenotype of top3A mutants relates 
primarily to dysregulation of Sgslp activity. Such dysregulated activity could interfere 
(either directly or indirectly) with the checkpoint machinery. Alternatively, deletion of 
SGSl could allow the activation of a parallel and partially redundant pathway that could 
lead to the activation of the checkpoint. If the sgslAtop3A double mutant remained 
checkpoint defective, this would suggest that the sensitivity of top3A mutants to 
inhibition of replication or DNA damage, relates primarily to a repair rather than a 
checkpoint defect.
Recently, it has been reported that expression of a truncated form of human 
topoisomerase I l ia  can partially reverse certain phenotypes associated with ataxia 
telangiectasia cells, which are defective in the cellular response to DNA damage. Since 
the transfection of truncated topoisomerasema was shown to influence both radiation 
responses (including radioresistant DNA synthesis - which is analogous to the intra-S 
checkpoint in yeast) and hyperrecombination (Meyn et al., 1993; Fritz et al., 1997), it is 
possible that the model described here might also be applicable to higher eukaryotes.
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Figure 6.1: A model for the role of Sgsl and topoisomerase III in mediating 
responses to replication fork arrest. We propose that Sgsl/Top3 is involved in the 
early processing of aberrant structures arsing at stalled replication forks. This complex 
may have at least two functions: first, the preparation of lesions for repair by the 
recombination machinery and second, the activation of a checkpoint that leads to the 
inhibition of cell cycle progression. Thus, in the absence of a RecQ helicase, there is a 
failure to integrate the cellular response to a frequent event, that is, the stalling of 
replication forks and this leads ultimately to chromosomal instability.
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6.4 The role of topoisomerase HI in the late stages of replication
As two replication forks converge, a build up of positive supercoils and/or steric 
hindrance between advancing replisomes could inhibit the final stages of DNA 
replication (reviewed in Wang, 1996). It has been proposed that Sgslp could act to 
unwind the non-replicated region between the advancing replisomes, thus generating 
intertwinings between the daughter molecules. These catenanes could then be resolved 
by topoisomerase m  prior to the ‘filling-in’ of the small single-stranded gaps left at the 
sites of converging forks. A prediction of this model therefore is that top3 mutants fail to 
resolve these structures leading to a failure to complete DNA replication or chromosome 
non-disjunction.
At present it is not possible to refute this model entirely. Thus, it is possible that 
incompletely replicated DNA is sufficient to cause the arrest of top3A mutants at G2/M, 
yet cannot be detected by the pulse field gel electrophoresis study employed in this study. 
Furthermore, assays to detect chromosome non-disjunction have not been performed. 
However, the finding that top3 mutants are sensitive to HU which blocks cells in early S- 
phase and the demonstration that the TOP3 transcript is upregulated in G l, both suggest 
that topoisomerase HI is required at a much earlier phase in the cell cycle. Furthermore, 
if the main activity of topoisomerase m  is as a decatenase, it is surprising that the other 
topoisomerases cannot substitute fully for this function. The failure to observe the 
accumulation of abnormal replication intermediates in 2D gels derived from top3A 
mutants also appears inconsistent with this model.
6.5 Topoisomerase HI - a potential therapeutic target?
DNA topoisomerases are important targets for antimicrobial and anticancer 
therapeutics (Liu, 1994). Anti-cancer drugs acting on type IB topoisomerases (e.g. 
campothecin) and type II topoisomerases (e.g. etoposide) are now used commonly. The 
majority of these drugs act by trapping the covalent enzyme-DNA intermediate, thus 
converting a normal cellular enzyme to a DNA damaging agent (Liu, 1989). In general, 
the cytotoxicity of this class of agent increases with increasing cellular concentration of 
the enzyme. Other drugs act by inhibition of the topoisomerase catalytic activity (e.g. 
merbarone) and perhaps are less dependent upon the concentration of enzyme (Drake et 
al., 1989). No agents active against type lA topoisomerases have so far been identified,
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although it is reported that topoisomerase III expression is much lower than either 
topoisomerase I or II in manunalian cells. The most likely class of a^ent to be effective 
therefore is one that inhibits catalytic activity, rather than one which inhibits the enzyme- 
DNA covalent intermediate. If mammalian topoisomerase m  has a similar role to that of 
its yeast counterpart in mediating S-phase checkpoint responses, then it is possible to 
conceive that a topoisomerase III inhibitor and an S-phase specific agent may have 
synergistic effects in combination.
6.6 Future work
Although the genetic interaction between SGSl and T0P3 is clear cut, the extent to 
which the proteins encoded by them physically interact has not been determined in great 
detail. Co-immunoprecipitation analyses could confirm this interaction and assess 
whether it was cell cycle phase-specific or related to extrinsic effects such as DNA 
damage. A stepwise dissection of functional domains for both proteins could be 
performed, linked to 2-hybrid and overexpression analyses. Thus, identification of a 
minimal Sgslp-interaction domain in topoisomerase HI, could allow its mutation and 
determination of how it affects the function of topoisomerase m. Dominant-negative 
effects of overexpression of interaction domains could be determined.
Recently it has been reported that transient inhibition of DNA synthesis leads to a 
subsequent failure to complete chromosomal replication in rad53 or mecl point mutants 
(Desany et al., 1998). This aberrant replication may result from a failure to regulate 
correctly the cellular dNTP pool (Desany et al., 1998; Weinert, 1998; Zhao et al., 1998). 
The model presented in this chapter would predict that to/?JA mutants exposed transiently 
to HU should also subsequently fail to complete chromosomal replication, as assessed by 
pulse field gel electrophoresis. In this context, the effect of overexpression of either 
RNRl or RNR3 on the viability and cell cycle kinetics of top3A mutants also merits 
study.
Since this study was initiated, an S.pombe gene predicted to encode a protein with 
substantial similarity to topoisomerase III has been identified. Study of the effect of 
deleting S.pombe T0P3 is attractive for a number of reasons. First, it would allow an 
assessment of the extent to which the phenotypes observed in this thesis are conserved in 
this evolutionary distant organism. It would be of particular interest to determine 
whether deletion of rqhl had any effect upon the top3 phenotype. Another advantage to
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using S.pombe, is that it is easier to identify the position of an individual cell in the cell 
cycle (Murray and Hunt, 1993). Thus, not only is there a clear relationship between cell 
length and the point attained in the cell cycle, but also spindle formation occurs only at 
mitosis. In contrast, a short intranuclear spindle forms earlier in the cell cycle in 
S.cerevbsiue cells and the relationship between cell size and cell cycle position is less 
clear cut, since budding yeast cells divide asymmetrically.
A priority for future studies will be to confirm whether or not the interactions 
between Sgs Ip and topoisomerase m  identified in this study, are conserved in humans 
between BLM and human topoisomerase HI. At the time of writing, information derived 
from two-hybrid, co-immunoprecipitation and far western studies, suggests that this 
interaction is indeed conserved. These studies could be.extended to a comprehensive 
analysis of cell cycle regulation, immunolocalisation and;response to DNA damage, of 
the respective proteins.
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